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desde o início. Ao Ricardo Reis, por ter sido mais do que um colega de laboratório e se 
ter tornado num amigo. Apesar desse teu feitio bem particular, foi óptimo ter-te como 
companheiro de trabalho, poder partilhar ideias e desenvolver contigo ingénuos “mini-
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apresentados ao longo destas linhas. À Clara Monteiro, por todas as palavras 
simpáticas e encorajadoras.  Aos meus colegas de grupo César Monteiro, Mariana 
Costa, Miguel Falcão e Ana Pessoa, a vossa presença foi fundamental para a boa 
disposição e estabilidade existentes no seio do grupo. Obrigada pelo companheirismo 
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ABSTRACT 
 
 The correct perception of nociceptive inputs relies on the proper neuronal 
connection between specialized receptors in the dorsal root ganglia (DRG) and 
neurons in the superficial laminas of the dorsal spinal cord. One gene intimately 
related with the establishment of this circuit is Prrxl1, which emerges as one of the few 
whose presence is observed in both tissues, as well as in functional equivalent 
supraspinal areas. The importance of this transcription factor is well demonstrated by 
the phenotype of Prrxl1 null mouse embryos – spatiotemporal defects in the 
penetration of afferent sensory fibers in the spinal gray matter together with 
anomalies in the morphology of dorsal horn of the spinal cord are observed. All these 
abnormalities are correlated with a significant reduction in sensitivity to noxious 
stimuli. Despite Prrxl1 relevance for the development of the nociceptive system, little 
was known about the genetic cascade and molecular mechanisms that govern its gene 
expression and activity in these tissues. Evidence from previous studies pointed to the 
existence of tissue-specific mechanisms of Prrxl1 transcriptional regulation – for 
instance, Tlx3 controls the expression of Prrxl1 only in the dorsal spinal cord but not in 
the DRG and Islet1 induces the transcription of Prrxl1 at early stages of DRG 
development but later on, Prrxl1 expression is not affected in Islet1 null mice. In order 
to further explore such issues, this thesis mainly focused on investigating the function 
of evolutionary conserved cis-regulatory elements present in the Prrxl1 gene and 
trans-acting factors that may modulate those sequences. It was first shown here 
(Publication I) that Prrxl1 transcription is regulated by an alternative promoter usage 
mechanism – three alternative promoters (named P1, P2 and P3) give rise to three 
distinct Prrxl1 5’-UTR variants, named 5’-UTR-A, 5’-UTR-B and 5’-UTR-C. These 5’-UTR 
sequences confer distinct rates of mRNA decay and translation efficiency to the Prrxl1 
transcript. The neuronal-specific promoter P3 is well conserved along the phylogenetic 
tree and contains a TATA-box, displaying in vivo enhancer activity in a pattern that 
overlaps with the zebrafish Prrxl1 homologue, drgx. Regulatory elements present in 
this region were identified and are binding sites for Phox2b and Tlx3 transcription 
factors. It was demonstrated that zebrafish Phox2b is required for the expression of 
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drgx in the facial, glossopharyngeal, and vagal cranial ganglia. In Publication II it was 
depicted that Tlx3 induces the transcriptional activity of promoter P3 by directly 
binding to a bipartite DNA motif and synergistically interacts with Prrxl1 in order to 
indirectly act on the TATA-less promoters P1/P2, via the action of Brn3a. In addition to 
its action on Prrxl1 alternative promoters, Tlx3 proved to have the ability to induce 
Prrxl1 phosphorylation. Altogether, these results demonstrated that Tlx3 uses distinct 
mechanisms to tightly modulate Prrxl1 activity, either by controlling its transcriptional 
levels or by increasing Prrxl1 phosphorylation status. 
 The outcome of this work adds new information to the literature about the 
transcriptional cascades involved in the neuronal specification and differentiation in 
primary sensory ganglia and respective relay centers in the central nervous system. 
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 RESUMO 
 
A perceção correta de estímulos nociceptivos depende do estabelecimento de 
conexões neuronais entre recetores especializados que formam os gânglios das raízes 
dorsais (DRG) e neurónios presentes nas lâminas superficiais da medula espinal dorsal. 
Um dos genes relacionado com o estabelecimento deste circuito é o Prrxl1, que surge 
como um dos poucos cuja presença é observada nestes dois tecidos, assim como em 
áreas supra-espinais funcionalmente equivalentes. A importância deste fator de 
transcrição é demonstrada pelo fenótipo de ratinhos mutantes para o Prrxl1 – são 
observados defeitos espaço-temporais na penetração das fibras aferentes sensitivas na 
matéria cinzenta espinal, assim como anomalias na morfologia do corno dorsal da 
medula espinal. Todas estes defeitos estão relacionadas com uma redução significativa 
na sensibilidade a estímulos nóxicos. Apesar da relevância do Prrxl1 no 
desenvolvimento do sistema nociceptivo, pouca informação é conhecida sobre a 
cascata genética e os mecanismos moleculares que governam a sua expressão e 
atividade nestes tecidos. Informação recolhida em estudos anteriores aponta para a 
existência de diferentes mecanismos de regulação da transcrição do Prrxl1 – por 
exemplo, o Tlx3 controla a expressão do Prrxl1 apenas na medula espinal dorsal mas 
não nos DRG e o Islet1 induz a transcrição do Prrxl1 em estados iniciais do 
desenvolvimento dos DRG, mas em estados embrionários posteriores, a expressão do 
Prrxl1 não é afetada em ratinhos mutantes que não expressam o Islet1. De forma a 
explorar mais profundamente estas questões, esta tese focou-se principalmente na 
investigação da função de elementos cis-reguladores conservados evolutivamente e 
nos fatores de transcrição que modulam essas sequências. Foi primeiro demonstrado 
(Publication I) que a transcrição do Prrxl1 é regulada por um mecanismo de 
promotores alternativos – três promotores (chamados P1, P2 e P3) originam três 
variantes Prrxl1 5’-UTR distintas, chamadas 5’-UTR-A, 5’-UTR-B e 5’-UTR-C. Estas 
sequências 5’-UTR conferem diferentes ritmos de degradação de mRNA e eficiência de 
tradução proteica ao Prrxl1. O promotor P3, com atividade específica de células 
neuronais, é bastante conservado ao longo da árvore filogenética e contém uma TATA-
box, apresentando atividade enhancer in vivo, num padrão que se sobrepõe com o do 
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homólogo do Prrxl1 no peixe-zebra, o drgx. Elementos reguladores presentes nessa 
região foram identificados e são locais de ligação para os fatores de transcrição Phox2b 
e Tlx3. Foi demonstrado que no peixe-zebra, o Phox2b é necessário para a expressão 
do drgx nos gânglios cranianos facial, glossofaríngeo e vago. Na Publication II foi 
demonstrado que o Tlx3 induz a atividade de transcrição do promotor P3 através da 
ligação direta a um motivo de DNA bipartido, e interage de forma sinérgica com o 
Prrxl1 para atuar indiretamente nos promotores P1/P2, através da ação do Brn3a. Para 
além da sua ação sobre os promotores alternativos do Prrxl1, o Tlx3 também tem 
capacidade para induzir a fosforilação do Prrxl1. Estes resultados demonstram que o 
Tlx3 recorre a mecanismos distintos para modular a atividade do Prrxl1, quer através 
do controlo dos seus níveis de transcrição, quer através do aumento do estado de 
fosforilação do Prrxl1. 
 O resultado deste trabalho traz nova informação à que é conhecida sobre 
cascatas de transcrição envolvidas na especificação e diferenciação de neurónios nos 
gânglios sensitivos primários e nos seus respetivos centros de transmissão de 
informação, no sistema nervoso central.  
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1. INTRODUCTION 
 
1.1. THE SOMATOSENSORY SYSTEM 
 
According to the International Association for the Study of Pain, pain is defined 
as “a sensory and emotional experience associated with real or potential injuries, or 
described in terms of such injuries. Pain has an individual connotation and suffers the 
influence of previous experiences” (Merskey and Bogduk, 1994). Intense thermal or 
mechanical stimuli, and environmental or endogenous chemical irritation, capable of 
provoking real or potential injury, can be detected by specialized receptors 
(nociceptors), interpreted by the nervous system as a noxious input and generate 
acute pain (Basbaum et al., 2009). This is advantageous for the organism, as the acute 
manifestations of pain alert for the damage (impending or real) and proper 
mechanisms of defense and repair can be initiated. However, in certain circumstances 
pain symptoms persist over an extended period of time and become associated with 
chronic pathological processes, causing suffering in multiple systems and resulting in a 
chronic pain condition. All the findings that guide scientists to a better understanding 
of the development and function of the nociceptive system and associated molecular 
mechanisms, may be useful to improve the knowledge about novel therapies to 
ultimately relieve severe pain conditions. 
A sensory stimulus can be defined as a physiologic “event or object that is 
received by the senses and elicits a response from a person. The stimulus can come in 
many forms such as light, heat, sound, touch, as well as from internal factors” and it is 
primary registered by the somatosensory system (Lestrude, 2013). The proper 
functioning of the somatosensory system depends on the accurate contact established 
between discrete populations of primary afferent neuronal fibers, whose cell bodies 
are located in the cranial trigeminal ganglion (TG) and trunk dorsal root ganglia (DRG), 
and second order neurons located in brainstem and spinal cord, respectively. These 
neurons will then relay the information to major integrative somatosensory centers in 
the thalamus and midbrain (McGlone and Reilly, 2010; Braz et al., 2014). TG and DRG 
are essentially clusters of afferent nerve cell bodies and supporting glial cells (satellite
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and Schwann cells that myelinate the peripheral nerve fibers). The morphology of 
primary afferent neurons is characterized by the lack of dendrites and the presence of 
a single axon that bifurcates soon after leaving the ganglion (therefore named 
“pseudo-unipolar”). One branch of the axon projects peripherally and terminates in 
specialized sensory receptors that innervate skin, muscles, bones or viscera, whereas 
the other one centrally connects with secondary neurons and interneurons in spinal 
cord or brainstem (Kandel, 2012). There, neuronal populations are organized in 
discrete layers (laminas) that consist of a unique combination of cells distinguished by 
features such as their morphology, projections and gene expression (Rexed, 1952; 
Jessell, 2000; Caspary and Anderson, 2003). The layers of neuronal subpopulations 
located in the dorsal half of the spinal cord and hindbrain are responsible for the 
integration of the sensory inputs, whereas layers of neurons in the ventral half 
regulate the motor output. The existence of a wide range of sensory modalities urged 
the neurons in the DRG to evolve into a diversity of classes with receptors dedicated to 
the correct perception and transduction of electric impulses in response to different 
inputs. As a consequence, distinct modalities of somatic sensation can be classically 
defined, comprising tactile, thermal, pain and itch sensing, and proprioception 
(McGlone and Reilly, 2010; Le Pichon and Chesler, 2014). The diversity of neuronal 
phenotypes is mainly determined by the specific combination of early extracellular 
signaling and precise expression of diverse transcription factors during embryonic 
development (Wolpert, 2007). The unique transcriptional code of each neuronal 
population confers distinct molecular and functional features, resulting in cells 
possessing different morphologies and axonal projections, as well as specialized 
terminal receptors. Albeit considerable data is available nowadays, in regard to the 
network of transcription factors required for the determination and differentiation of 
each neuronal class, many issues still remain to be explored. One of them is the 
elucidation of the genetic cascade and molecular relationships that surround the 
expression of a set of transcription factors involved in the development of certain 
neuronal populations in the DRG and spinal cord, with the ultimate goal of 
understanding their contribution to the establishment of the nerve circuit responsible 
for the perception and integration of the pain (nociceptive) sensation. This was the 
focus of this thesis. 
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1.2. NEURONAL POPULATIONS AND NOCICEPTION IN THE ADULT DRG 
 
Primary somatosensory neurons were classically organized according to defined 
morphological and functional features that include the size of cell body, degree of fiber 
myelination, laminar location of afferent projections to the spinal cord, and the 
morphology and specialization of the nerve endings (Kandel, 2012). The anatomical 
diversity is the consequence of differences in the genetic background of each class of 
neuronal fibers and correlates well with specific properties, such as the sensitivity to 
distinct types of stimuli, transduction of electrical impulses and neurotransmitter 
release. Additionally, the presence of specific ion receptors and sensory channels 
defines subsets of the main classes of sensory neurons. Adult somatosensory neurons 
can be categorized into four general major classes: i. the proprioceptors (or Aα), that 
sense body position; ii. the receptors that deal with cutaneous sensitivity and include 
the low threshold mechanoreceptors Aβ that respond to innocuous touch, pressure 
and vibration; iii. the Aδ and iv. C fibers that conduct innocuous cold or warm signals, 
as well as noxious and itch-inducing stimuli (Figure 1) (McGlone and Reilly, 2010; Le 
Pichon and Chesler, 2014). 
Proprioceptors and Aβ fibers have the largest cell bodies (>50μm) and are 
heavily myelinated, a property that confers them the fastest conduction velocities (Le 
Pichon and Chesler, 2014). Proprioception deals with information related to body 
position, limb and trunk movements, sense of effort and heaviness. Mechanically 
sensitive proprioceptors are activated through the detection of muscle tension and 
contraction of muscle spindles and Golgi tendon organs at periphery (Proske and 
Gandevia, 2012). These nerve fibers centrally project to deep laminas in the motor-
stretch reflex circuit in the ventral spinal cord. The Aβ are low-threshold 
mechanoreceptors and have different subclasses that are specialized in the 
transduction of discrete mechanical stimuli, such as touch, vibration and hair 
deflection, a competence conferred by nerve endings morphologically distinct. The Aβ 
fibers synapse predominantly with neurons in the internal dorsal spinal cord laminas 
(III-V), where the sense of touch is mediated (Le Pichon and Chesler, 2014). 
Fibers dedicated to the perception of other senses besides innocuous touch, 
such as pain, itch and temperature comprise the Aδ and C categories. The lightly 
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myelinated Aδ have medium diameter and are slower conducting than the 
aforementioned nerves. Specific subpopulations of these fibers are thermosensory and 
respond to innocuous warmth or cold stimuli, whereas others are uniquely activated 
by noxious low and high temperatures (<20 °C and >45 °C). They project their axons 
centrally to the superficial layers of the spinal cord (laminas I and II) but also target 
deeper layers (lamina V), where they initiate nocifensive reflexes, such as the innate 
withdrawal provoked by a noxious stimuli (Basbaum et al., 2009; Gascon and Moqrich, 
2010). 
 
 
 
Figure 1: Schematic representation of the different subclasses of DRG afferent fibers centrally projecting 
to distinct laminas of the spinal cord. Ia, II and Ib comprise the proprioceptive fibers innervating muscle 
spindles and Golgi tendon organs (GTO) that project to motor neurons in the ventral spinal cord. The 
mechanoreceptors innervate the skin and establish synapses mostly with neurons in laminas III-V. 
Neuronal fibers that sense noxious, thermo and itchy (pruriception) stimuli comprise the Aδ and C 
(peptidergic and non-peptidergic) categories. Aδ centrally projects to laminas I, II and V, whereas C 
fibers mainly project to laminas I and II. Image withdrawn from (Lallemend and Ernfors, 2012). 
 
C fibers are unmyelinated, slowly conducting and the most abundant type in 
the DRG. They have small cell bodies and terminate as free nerve endings in the skin, 
organs and bone. These are the primary afferent nerves mainly responsible for the 
detection of harmful stimuli such as tissue damage, chemical irritants and different 
combination of temperatures. Whereas some of these are discrete receptors that have 
been reported to respond to a unique type of stimuli, others are considered to be 
polymodal nociceptores, as they are activated by a combination of signals, including 
intense mechanical stimulation, heat and noxious chemicals. Within the class of C 
fibers, two major subclasses can be defined considering whether these neurons 
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express or not neuropeptides – the ones that express substance P and the calcitonin 
gene related-peptide (CGRP) are peptidergic neurons while the ones bound by the 
isolectin B4 (IB4) are the non-peptidergic class of C fibers. The mechanism of 
recognition and encoding the noxious stimuli into an electrical signal to be processed 
as pain sensation afterwards, is termed nociception (Basbaum et al., 2009; Gascon and 
Moqrich, 2010). Distinct noxious stimuli activate specific members of membrane 
receptors present in nociceptores, such as the acid-sensing ion channels (ASIC) and 
sodium channels (including Nav1.8 and Nav1.9) that generate the perception of sting 
and pain when activated by protons, or the capsaicin receptor subtype-1 of the family 
of thermo Transient Receptor Potentials (TRPV1), one of the most studied cation 
channels expressed in cutaneous sensory fibers and associated with pungent irritants 
and heat pain (Gascon and Moqrich, 2010). Similarly to Aδ, C fibers also target 
superficial layers of the spinal cord (laminae I-II), a region known to be critical for the 
first stage processing of noxious and thermal stimuli. A given stimulus sensed by a DRG 
neuron passes directly from the distal part of the axon to the proximal fiber, to enter 
the dorsal half of the spinal cord. There, pain and thermal Aδ fibers synapse 
ipsilaterally with second order neurons – forming the Lissauer’s tract – that decussate 
at the entry level of primary afferents and relay the information to the thalamus 
trough the spinothalamic tract. Exceptionally, C fibers enter the lamina II and synapse 
on interneurons (which do not project outside the spinal cord) that relay the signal to 
secondary afferents in marginal nucleus (lamina I) and nucleus proprius in lamina III. 
The spinothalamic tract ascends the entire length of the spinal cord and brainstem to 
enter the thalamus, together with the medial lemniscus. The thalamus plays a crucial 
integrative role in the brain, relaying both sensory and affective pain information to 
primary sensory cortices (Basbaum et al., 2009). 
Most important is the existence of a set of molecular traits that also define the 
classes of developing neurons in the DRG. Those are specific transmembrane receptors 
expressed at early embryonic stages that transduce diffusible signals from distinct 
neurotrophic factors, essential for cell survival and differentiation, and are tightly 
correlated with the diversity of primary sensory neuronal populations and their central 
projection pattern (Snider, 1994; Bibel and Barde, 2000). Hence, proprioceptors are 
well defined by the expression of the Tyrosine-kinase receptor C (TrkC; receptor for the 
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neurotrophin 3 or NT-3), whereas Aβ mechanoreceptors are marked by the expression 
of TrkB (the receptor for the brain-derived growth factor or BDNF) or Ret (the receptor 
for the glial-derived growth factor or GDNF family of neurotrophin factors). The small-
diameter nociceptores, thermoceptors, pruriceptors and C-fiber low threshold 
mechanoreceptors are generally defined by the presence of TrkA (receptor for the 
nerve growth factor, NGF) (Barbacid, 1994). Furthermore, near postnatal stages, the 
class of TrkA-positive neurons segregates in two subpopulations, since some of the 
neurons downregulate TrkA and begin to express Ret. This recently expressing class of 
Ret-positive neurons comprises the non-peptidergic fibers that mainly innervate the 
skin, whereas the ones that maintain TrkA are the peptidergic and innervate most 
tissues. 
 
 
1.3. EARLY NEURAL TUBE DEVELOPMENT 
 
The birth and development of neuronal populations that will give rise to both 
DRG and spinal cord structures begin at an early developmental stage. The process 
starts during gastrulation, when the ectoderm lying along the dorsal midline and above 
the notochord of the vertebrate embryo becomes specified as neuroectoderm and is 
modified to a thickened plate of tissue, constituting the open and flat neural plate 
(Figure 2). Between 7.7 and 8.5 mouse embryonic days (E) the anterior part of the 
embryo grows and the neural plate invaginates and begins to close, creating a groove 
with the neural folds at the edges. As the neural folds fuse along the rostrocaudal axis 
of the embryo, a tube of epithelium is formed (the neural tube), in a process called 
neurulation, which initially leaves the anterior and posterior ends open. The midline of 
the dorsal neural tube becomes the roof-plate, a signaling structure that commands 
the induction of different dorsal cell types. In the region of the prospective head, the 
neural tube expands to form the brain, whereas the more caudal regions originate the 
spinal cord. Following neurulation, the neural tube detaches from the adjacent 
ectoderm, which becomes the epidermis. Another group of cells is induced at the folds 
of the dorsal neural tube to give rise to neural crest cells. They undergo an epithelial-
to-mesenchymal transition, delaminate and migrate away from the neural tube 
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throughout the entire body to give rise to a wide range of descendants, including 
neurons and glia of the peripheral nervous system (somatic and autonomic), 
melanocytes, neuroendocrine cells and bone and cartilage from the facial skeleton. 
The neural crest cells that arise at trunk levels of the neural tube are the ones 
contributing to the formation of neurons in the DRG, whereas the cranial sensory 
ganglia originate partially from cranial neural crest cells (Butler and Bronner, 2015). 
 
 
Figure 2: Scheme representing the formation of the neural tube. The ectoderm tissue that becomes 
specified as the open and flat neuroectoderm constitutes the neural plate. The invagination and closure 
of the neural plate creates the neural tube with neural folds at the edges. The most caudal regions of 
the neural tube originate the spinal cord. Signals from either the roof-plate or the floor-plate will 
orchestrate the formation of neuronal populations in the spinal cord. Neural crest cell delaminate from 
the neural folds and migrate away from the neural tube throughout the whole body. These cells will give 
rise to neurons and glia of the peripheral nervous system (among other tissues).  
 
1.4. NEUROGENESIS AND PRIMARY SENSORY SPECIFICATION 
 
The continuous progress of developmental biology studies associated with the 
emergence and priming of molecular biology experimentation revealed that the 
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creation of neuronal diversity is an intricate process that starts early in development to 
extend into postnatal life. The characterization of the genetic transcriptional cascades 
that regulate the specification and differentiation of peripheral somatosensory 
neurons from progenitor cells has been crucial to understand their diversification into 
functional subclasses. Sensory neurogenesis in the trunk mainly occurs in two 
successive waves and it is initiated in the transient neural crest population of cells. The 
progenitor neural crest cells are induced by a set of signalling molecules (BMP, Wnt or 
FGF) that are diffused from either the ventral ectoderm or the paraxial mesoderm, and 
initiate the transcription program that determines the fate of these cells (Mayanil, 
2013). Early expression of a set of transcription factors that includes Pax3, Pax7, Msx1, 
Zic1 and AP-2 prevents premature cell differentiation and induces the neural crest cells 
by switching on the expression of another set of genes that establish and specify the 
prospective neural crest (Sato et al., 2005; Mayanil, 2013). Subsequently, the 
activation of Snail1, Snail2, FoxD3 and members of the SoxE family prompts the cells to 
undergo an epithelial-to-mesenchymal transition and become highly motile due to the 
rearrangement in cytoskeletal organization (Cheung et al., 2005). This transition leads 
to alterations in cell shape and upregulation of cell surface low adhesion molecules 
(type II cadherins and the regulators RhoB) and signaling receptors, which confer cells 
the ability to detach and migrate away from the neural tube (Cheung et al., 2005; Lim 
and Thiery, 2012). Twist is required for cells to identify their correct new position, as 
they will invade different sites according to the distinct membrane receptors they 
express, before they differentiate into the various cell types they give rise to (O'Rourke 
and Tam, 2002). Eventually, trunk sensory neuronal precursors become fate restricted 
and migrate away from the neural folds in chain-like structures that then coalesce into 
ganglia at regular intervals in the anterior half of each somite, adjacent to the 
developing neural tube. Sox10 precedes the expression of two proneural genes 
encoding the basic-Helix-Loop-Helix (bHLH) transcription factors Neurogenin1 (Ngn1) 
and Neurogenin2 (Ngn2) (Carney et al., 2006), that instruct the progression from 
neurogenesis to the segregation into major classes of sensory populations 
(proprioceptors/mechanoreceptors and thermoceptors/nociceptors/pruriceptors) 
(Fode et al., 1998; Ma et al., 1999). It has been demonstrated that the expression of 
these factors is the imperative event in the decision of progenitor cells to become 
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sensory neurons. Cells that express Mash1 at this point, instead of Ngn1 or Ngn2, 
differentiate towards the autonomic lineage instead of to the somatosensory one 
(Johnson et al., 1990; Lo et al., 1998). 
 
1.4.1. FIRST AND SECOND WAVES OF DRG NEUROGENESIS 
The first wave of neurogenesis is marked by the presence of Ngn2, which is 
initially detected around E9 in a set of migratory neural crest cells near the edges of 
the neural tube (Figure 3). The expression is transient and maintained until early stages 
of DRG condensation, being extinguished around E10.5 (Sommer et al., 1996). This 
group of cells have acquired a sensory neuronal fate and exclusively gives rise to the 
large-diameter myelinated DRG neurons (the TrkB/TrkC-positive Aβ mechanoreceptors 
and proprioceptors). Due to limited cell division of the early migrating neural crest 
cells, the first wave of neurogenesis only gives rise to about 4% of the adult neurons in 
the DRG (Marmigere and Ernfors, 2007). The second wave of neurogenesis is 
controlled by Ngn1 and occurs at E10.5 in mouse, lasting until E13.5 (Lawson and 
Biscoe, 1979). Ngn1 is expressed in the progenitor cells lying in the coalescing DRG that 
did not have undergone neurogenesis or express little or none Ngn2 (Figure 3). These 
cells mainly generate the small-diameter lightly- or non-myelinated neurons that are 
mostly TrkA-positive at early embryonic stages (nociceptores/pruriceptors/ 
thermoceptors), although a residual birth of additional large proprioceptive/ 
mechanoreceptors is also observed (Ma et al., 1999; Zirlinger et al., 2002). This wave 
accounts for the largest bulk of adult DRG neurons – about 91% (Marmigere and 
Ernfors, 2007). Redundancy is observed during the development of sensory ganglia, as 
the absence of Ngn2 is later compensated by the onset of Ngn1 expression, resulting in 
the formation of large-diameter neurons regardless the deficiency of Ngn2. 
Nevertheless, a similar mechanism is not observed the other way around, as mutant 
mice for Ngn1 develop DRG with a diminished size, due to the loss of about 70% of 
neurons that populate this tissue. Mutants for both Ngn1 and Ngn2 fail to develop 
sensory ganglia at all, indicating that these transcription factors act together to 
promote the DRG formation (Ma et al., 1999). Indeed, Ngn1 is fundamental for the 
precursor cells in the DRG to adopt a neuronal fate, as the absence of it thrust these 
cells to become glia and not neurons (McGraw et al., 2008). In all of the fate-
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determined sensory neurons, the expression of Ngn1 and Ngn2 is followed by the 
activation of the bHLH factor Neurod, which is dependent on the Neurogenins (Ma et 
al., 1999). 
 
 
Figure 3: Schematic representation of the first and second waves of neurogenesis. The onset of Ngn2 by 
E9, in a set of migratory neural crest cells, marks the first wave of neurogenesis. Cells that contain Ngn2 
will exclusively give rise to mechanoreceptors and proprioceptors expressing TrkB and TrkC. By E10.5, 
Ngn2 is downregulated and Ngn1 expression was initiated in cells that have already migrated to the 
place where prospective DRG cells will coalesce. Besides the large-diameter mechanoreceptors and 
proprioceptors, this second wave of neurogenesis originates the small-diameter nociceptors, 
pruriceptors and  thermoceptors that are TrkA-positive. This wave accounts for 91% of neurons in the 
DRG.  
 
1.4.2. TERMINAL DIFFERENTIATION OF SENSORY NEURONS 
Following the early neurogenic phase, the differentiation programs that control 
the sensory neuronal fate determination are switched off and by E12.5 the 
specification in different classes of DRG neurons is initiated. This transition requires 
the combined expression of Homeobox genes (that encode Homeodomain 
transcription factors) and neurotrophic growth factors that regulate the activation of 
downstream key genes, crucial to ascertain the diverse subclasses of sensory neurons 
by ascribing the distinct physiologic functions to each population (Anderson, 1999). 
Two pan-neuronal transcription factors – Islet1 and Brn3a, members from the LIM and 
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a POU subfamilies of Homeodomain (HD) proteins, respectively – stand out as major 
players in this process (Sun et al., 2008; Lanier et al., 2009; Dykes et al., 2011). Genetic 
studies using mutant mice for these genes revealed that, as they influence the cell 
cycle exit, they hold a role in suppressing the expression of proneural genes (including 
Ngn1, Neurod1, Neurod4 and Neurod6), as well as molecules specifically associated 
with dorsal spinal cord development (such as Lhx1, Lhx2, Olig1 and Olig2)  (Eng et al., 
2004; Lanier et al., 2007; Sun et al., 2008; Lanier et al., 2009; Dykes et al., 2011). In 
contrast, they are intimately related with the activation of a set of genes that regulate 
the mechanisms that eventually result in the generation of neuronal diversity in 
sensory ganglia, through the activation of neural transmission mediators, such as ion 
channels, neuropeptides and membrane receptors that participate in signal 
transduction, or are involved in axon guidance and synapse establishment formation. 
Among these are the sodium channel Nav1.8, the capsaicin receptor TRPV1 and the 
neuropeptide galanin (Sun et al., 2008; Dykes et al., 2011). In Islet1 conditional knock-
out (CKO) embryos, the expression of TrkA in the DRG is reduced by E12.5, while the 
onset of TrkC is delayed by two days (Sun et al., 2008). As expected in systems lacking 
neurotrophic receptors, defect in neuronal survival is observed, resulting in mutant 
mice with sensory ganglia presenting smaller size than their control littermates. 
Although not observed in the DRG, the decrease of TrkA and TrkB expression is 
detected in the trigeminal ganglia of E13.5 Brn3a null mice, whereas the expression of 
TrkC is not initiated at all (Huang et al., 1999). This effect is enhanced when the 
expression of Klf7, a zinc finger transcription factor, is ablated. The activity of Klf7 is 
required for the correct expression of TrkA and consequent development of 
nociceptive sensory neurons. Loss of Klf7 expression results in the exclusive apoptosis 
of nociceptive neurons, whereas other somatosensory populations develop normally 
(Lei et al., 2005). In Brn3a/Klf7 double mutants, a severe reduction of TrkA-positive 
neurons is observed at E12.5, indicating that Klf7 acts together with Brn3a to promote 
the expression of TrkA in trigeminal sensory neurons (Lei et al., 2006). Moreover, at 
trunk level, both Brn3a and Islet1 have been shown to be required for the correct 
formation of sensory afferent axon projections to periphery and spinal cord (Dykes et 
al., 2011). Brn3a mutants exhibit defective axon trajectories – the TrkA-positive 
afferents are not able to enter the dorsal root entry zone, remaining outside of spinal 
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cord; the TrkC-positive fibers also fail to accurately project into the ventral horn of 
spinal cord (Zou et al., 2012). In Islet1 CKO mice, loss of cutaneous innervation 
subserving pain, touch and temperature is apparent – probably due to excessive 
apoptosis – which is in accordance with a reduced response to mild noxious stimuli 
applied to the skin of newborn animals. Concomitantly, the inactivation of Islet1 
specifically affects the central projections of TrkA-positive fibers, which are markedly 
reduced in spinal cord by E14.5 (Sun et al., 2008). In zebrafish, Islet1 is also necessary 
to promote the axon growth of Rohon-Beard primary sensory neurons to spinal cord 
(Tanaka et al., 2011). 
 
1.4.3. SEGREGATION OF TRKA-DERIVED CELLS INTO PEPTIDERGIC AND NON-PEPTIDERGIC NEURONS 
The cooperative action of Brn3a and Islet1 also profoundly affects the 
transcription of Runx1 and Runx3, members of the Runt domain-containing factors 
family that function as key regulators of lineage-specific genes (Dykes et al., 2011). 
Globally, the expression of Runx1 is mainly associated with definitive hematopoiesis 
mechanisms and with certain occurrences of human leukemia (Ichikawa et al., 2013). 
Runx3 is a tumor suppressor and apoptosis inducer in many types of human cancer 
(Chuang et al., 2013; Yang et al., 2014). During peripheral nervous system 
development these factors act complementarily in the diversification of somatic 
sensory neurons, through the recruitment of known transcriptional regulators (Kramer 
et al., 2006). Runx1 is selectively expressed in small-diameter TrkA-positive neurons 
and considered to be a master regulator of the terminal specification of nociceptive 
sensory neurons in DRG. Runx3 is found in large TrkC-positive neurons and its 
expression is fundamental for the correct consolidation of the proprioceptive 
phenotype (Inoue et al., 2002; Levanon et al., 2002). The postmigratory large-diameter 
precursors of proprioceptors and mechanoreceptors that arise from the first wave of 
neurogenesis, initiate the expression of Runx3 and TrkC at early developmental stages 
(by E10.5). At later stages, cells that maintain Runx3 expression remain TrkC-positive 
and become proprioceptors. Neurons that lose or strongly decrease Runx3 expression 
become either TrkB/TrkC-positive, only TrkB-positive, only Ret-positive or TrkB/Ret-
positive and acquire the mechanoreceptive trait (Chen et al., 2006a; Kramer et al., 
2006). Further gain-of-function studies have shown that Runx3 acts to specify the 
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proprioceptive class by suppressing the TrkB expression while maintaining TrkC 
(Kramer et al., 2006). In addition, at postnatal stages, Runx3 mutant mice exhibit 
altered axonal trajectories of proprioceptive fibers to spinal cord, which fail to project 
to the ventral and intermediate laminas, whereas the peripheral branch of the axons 
project to skin but not to muscle (Inoue et al., 2002; Nakamura et al., 2008). 
In parallel with Runx3, Runx1 is involved in the diversification of nociceptive 
neurons arising from neural crest cells. Cells that are born during the second wave of 
neurogenesis are characterized by the presence of Ngn1, Brn3a and Foxs1 (Montelius 
et al., 2007) and at early embryonic stages, start to express either Runx1 or Runx3. This 
moment is the defining event in the determination of the nociceptive or 
proprioceptive specification, respectively. The potential nociceptors initiate the 
expression of TrkA between E10.5-E11.5 and soon after that, 88% of them begin to 
express Runx1 (Chen et al., 2006b). During embryonic development and until postnatal 
stages, Runx1 expression is restricted to TrkA-positive neurons but afterwards Runx1 
acts to segregate the Runx1/TrkA-positive population in two main subpopulations of 
nociceptors (Figure 4): 
i) the class of peptidergic neurons, that extinguishes the expression of Runx1, 
maintains TrkA and upregulates Met receptor (Gascon et al., 2010). This is followed by 
the induction of the neuropeptides CGRP and substance P. The downregulation of 
Runx1 is essential for the maintenance of TrkA, the expression of CGRP and thus, for 
the establishment of the nociceptive peptidergic phenotype (Chen et al., 2006b; 
Kramer et al., 2006; Yoshikawa et al., 2007). 
ii) the class of non-peptidergic neurons that preserves the expression of Runx1, 
which in turn induces Ret and represses TrkA. The emergence of Ret in Ngn1-
dependent population occurs at E17 (Molliver et al., 1997), resulting in the formation 
of a subpopulation of TrkA/Runx1/Ret-positive neurons. At perinatal stages, these 
neurons acquire the ability to bind the IB4. A few weeks after birth, Runx1 have 
progressively downregulated TrkA and suppressed the expression of Met and CGRP 
(Chen et al., 2006b; Kramer et al., 2006). 
In the absence of Runx1, prospective non-peptidergic neurons acquire 
peptidergic identity because CGRP expression is upregulated (Chen et al., 2006b). 
Peptidergic neurons extend their central branches to lamina I and outer lamina II, 
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regions associated with the mediation of inflammatory pain. The non-peptidergic 
Runx1/Ret-positive afferent fibers centrally project to the inner lamina II, an area 
associated with the modulation and integration of neuropathic pain (Figure 4) (Snider 
and McMahon, 1998). Runx1 is also essential to coordinate these processes, as in its 
absence, projections of nociceptive afferent nerves from the periphery to spinal cord 
are impaired. In Runx1 CKO, both CGRP/SP-positive and IB4-positive fibers reach the 
dorsal horn of the spinal cord. However, there is a dorsal shift in the projections of the 
Runx1-expressing non-peptidergic afferents, which no longer extend their processes to 
the inner lamina II but instead send projections to outer lamina II (Chen et al., 2006b). 
 
 
Figure 4: By E10.5, all the neurons in the DRG are Brn3a- and Islet1-positive. Brn3a and Islet1 
donwregulate the expression of genes associated with primary neurogenesis and dorsal spinal cord 
(dSC) development and increase the expression of genes associated with primary sensory perception 
and transmission. Later on, by E12.5, the population of large-diameter neurons have upregulated TrkC 
and Runx3, whereas the small-diameter neurons have upregulated TrkA and Runx1. At E14.5, the initial 
population of TrkC-/Runx3-positive cells segregates into different neuronal classes: mechanoreceptors 
shut down Runx3 expression, increase TrkB or Ret and in a few cases maintain TrkC; proprioceptors 
maintain the levels of TrkC and Runx3. At perinatal/postnatal ages, the TrkA-/Runx1-positive small-
diameter neurons segregate into neurons that maintain the levels of TrkA, stop expressing Runx1 and 
upregulate CGRP and SP (peptidergic neurons) or neurons that downregulate TrkA, maintain Runx1 
levels, increase Ret and are bound by IB4 (Non-peptidergic neurons). Peptidergic neurons extend their 
central branches (in red) to dSC lamina I and outer lamina II (I/oII), regions associated with the 
mediation of inflammatory pain. The non-peptidergic Runx1/Ret-positive afferent fibers (in green) 
centrally project to the inner lamina II (iII), an area associated with the modulation and integration of 
neuropathic pain. 
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Highly consistent with the exclusion of Runx1 expression from most neurons 
that innervate deep tissues in adult (mostly peptidergic), it was recently demonstrated 
that Runx1 suppresses the molecular program associated with these neurons (Yang et 
al., 2013). Hence, Runx1 is a seminal factor in the selective determination of the 
nociceptive cutaneous identity as it tightly activates the expression of many high 
threshold ion channels and thermal, pain and itch receptors in the Ret-positive DRG 
neurons – among the ones controlled by Runx1 are the cold receptors TRPM8 and 
TRPA1; capsaicin/heat receptors TRPV1, TRPV2 and TRPC3; the Mas-related G-protein 
coupled receptor members Mrgprd, Mrgprb4 and Mrgprb5 that sense mechanical pain 
and innervate exclusively cutaneous/epidermal tissues; the purinergic receptor P2X3 
channel and sodium channel Nav1.9 (Chen et al., 2006b). In fact, Runx1-dependent 
genes are mainly expressed in Mrgprd-positive polymodal nociceptors. In contrast, no 
specific markers associated with deep tissue TrkA lineage neurons have been identified 
up to this date, as they express genes that are expressed as well in cutaneous sensory 
neurons (Yang et al., 2013). 
Chen and colleagues (Chen et al., 2006b) also demonstrated that the induction 
of some of the pain-related receptors and ion channels activated by Runx1 does not 
require the cooperation of Ret or TrkA, suggesting that it was likely that Runx1 would 
work in cooperation with other unknowing factors to do so. This remained unclear 
until recently, when Lopes et al. showed that Runx1 is dependent on the Tlx3 presence 
to establish the Runx1-dependent nociceptive lineage in the DRG (Lopes et al., 2012). 
The pivotal role of Tlx3 in the development and fate specification of sensory relay 
neurons of the dorsal spinal cord and hindbrain has been widely reported (Shirasawa 
et al., 2000; Qian et al., 2002; Cheng et al., 2004). In contrast, and despite Tlx3 is 
broadly expressed in the DRG neurons at embryonic stages, little relevance for the 
development of primary sensory neurons had been credited to this transcription factor 
up to this date (Qian et al., 2002). At postnatal stages, Tlx3 is selectively required to 
increase Ret levels and to suppress TrkA, as well as to contribute to the Runx1-
dependent molecular identity in non-peptidergic neurons, as the ion channels and 
sensory receptors upregulated by Runx1 (such as the TRP, Mrgprd/b, P2X3 and 
Nav1.9), are decreased in the absence of Tlx3 (Lopes et al., 2012). The genetic 
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regulation of Runx1 and Tlx3 are independent of each other, suggesting that these two 
factors act in combination and not in a cascade fashion. 
 
 
1.5. DEVELOPMENT OF SPINAL CORD NOCICEPTIVE PROCESSING NEURONS 
 
The vertebrate dorsal spinal cord is considered the organizing and relay centre 
of the sensory inputs that arrive from the periphery via DRG primary afferent nerves. 
The proper assembly and transmission of the somatosensory information and the 
production of the consequent adequate response, depend on the existence of 
functionally distinct types of spinal neurons. The adult spinal cord is structured in ten 
discrete laminas, organized in a dorsoventral patterning (Rexed, 1952; Altman and 
Bayer, 1984). Each lamina contains a unique combination of cells with dedicated 
functions in the integration and transmission of sensory information to the appropriate 
centers in the brain (Figure 1). Neurons in the most superficial laminas (I and II) 
establish synapses with small-diameter DRG afferent fibers that sense nociceptive, itch 
and thermal stimuli, whereas other neurons located deeper in the dorsal spinal cord 
(laminas III, IV and V) integrate the mechanical inputs arriving from the periphery. 
Proprioceptive information can travel straightforward across the dorsal half and 
interact directly with motor neurons located in the nucleus dorsalis in the ventral 
spinal cord, to produce spinal reflexes without ascending to higher brain centers. The 
ventral half of the spinal cord is mainly associated with the response of the motor 
output that comes from the brain, and neurons laying there connect back to the 
muscle via efferent fibers to control movement (Bonanomi and Pfaff, 2010). The 
neuronal populations that define the laminas in the dorsal spinal cord are classified 
according to the well known expression of molecular markers, the synapses 
established with different classes of DRG projecting neurons, type of 
neurotransmitters, firing properties and physiological functions (Butler and Bronner, 
2015). Nevertheless, the genetic cascade of events and the detailed molecular 
mechanisms that drive the specification of progenitor cells into distinct subpopulations 
of postmitotic neurons remain to be fully unveiled.  
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The laminar organization of the spinal cord is specified early in the 
development of the neural tube. At the trunk level of the organism, diffusible signals 
emitted from a dorsal and ventral midline cluster of neuroepithelial cells (the roof and 
the floor plate, respectively; see Figure 2) control the dorsoventral patterning of the 
spinal cord through the activation or repression of transcriptional regulators (Ulloa and 
Briscoe, 2007; Wolpert, 2007; Le Dreau and Marti, 2012). Rapidly dividing cells in the 
inner ventricular zone of the early neural tube are the mitotic progenitors for all the 
neurons and glia that will constitute the spinal cord. It is the combined action of 
extracellular signals secreted from either the roof-plate (BMP and Wnt) or floor-plate 
and the notochord (Shh) and downstream transcription factors that orchestrate the 
patterning and the identity of cells during spinal neurogenesis (Wolpert, 2007). 
Signaling in a dosage-dependent manner induces the expression of proneural genes, 
which encode bHLH transcription factors and are required between E9.5 and E12.5 to 
impel the differentiation of the mitotic progenitors in the ventricular zone (Bertrand et 
al., 2002). At E9.5, neural progenitors arise in 11 discrete population domains and 
migrate laterally towards the mantle layer of the developing spinal cord, soon after 
they exit the cell cycle and initiate differentiation. These progenitor populations are 
defined by the unique combinatorial code of bHLH and HD transcription factors they 
express, which coordinate their migration and posterior rearrangement of cellular 
patterns. At this stage, the dorsal part of the neural tube is subdivided in six domains 
of cell progenitors (dP1-dP6, dorsal to ventral), whereas the remaining five progenitor 
domains form the ventral half (p3, pMN, p2-p0, ventral to dorsal) (Caspary and 
Anderson, 2003; Helms and Johnson, 2003; Dessaud et al., 2008; Matise, 2013). In the 
dorsal half of the developing embryo, the combination of BMP and Wnt signaling with 
HD factors such as Pax3 and Pax7, induces the expression of the different proneural 
genes (Math1, Ngn1, Mash1) that define the six progenitor domains. Math1 is 
expressed in the cells most adjacent to the roof plate (dP1), Ngn1 expression defines 
the domain below (dP2) and Mash1 is expressed in the dP3-dP5 progenitors. Ngn1 is 
also present in the dP6 progenitors, but does not restrict its expression to this 
population, expanding it to domains in the ventral part of the spinal cord (Ma et al., 
1997; Gowan et al., 2001; Helms et al., 2005). Later on (at E10), the prospective 
neurons in the mantle layer that evolve from each progenitor population domain are 
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distinguished according to the Homeobox genes they begin to express and six 
populations of dorsal interneurons are characterized (dI1 to dI6). The dP1-dP3 
progenitors give rise to dI1-dI3 neurons that will settle in the deep layers of the adult 
dorsal spinal cord (Caspary and Anderson, 2003; Helms and Johnson, 2003). 
 
1.5.1. GENERATION OF CLASS A AND CLASS B EARLY-BORN NEURONS 
Experiments consisting in the ablation of the roof plate resulted in the exclusive 
loss of the three topmost dorsal progenitor populations (dP1-dP3), pointing to the 
dependence of these populations on the signaling diffused through this tissue (Lee et 
al., 2000). These progenitors comprise the prospective Class A neurons (dI1-dI3), the 
ones that are born in the dorsal alar plate and require BMP and Wnt signaling in order 
to be generated. Early studies performed using explants cultures demonstrated that 
high and low concentration of BMP signaling, respectively determined the fate of dI1 
and dI3 neurons (Liem et al., 1997) and that although levels of BMP family members 
are similar along the whole dorsoventral axis shortly before the closure of the neural 
tube, afterwards they become restricted to the region of the presumptive dP1-dP3 
(Tozer et al., 2013). Ablation of BMP type 1 receptors, Bmpr1a and Bmpr1b, in mouse 
neural tube, results in the complete loss of the dP1 population as demonstrated by the 
absence of Math1. As a consequence, the population of dI1 interneurons is not 
formed, whereas the dI2 domain is strongly reduced, highlighting the influence of 
BMPs in the differentiation of these progenitors (Wine-Lee et al., 2004). In contrast, 
the dP4-dP6 domains are expanded, confirming that BMP signaling does not affect the 
generation of this group of neurons – hence, neurons that differentiate from these 
populations of progenitors are classified as Class B neurons. Moreover, BMP acts as an 
instructor to restrict the ventral spinal fate in the spinal cord since it functions as an 
activator of the expression of Pax7 (Mansouri and Gruss, 1998). Analysis of mouse 
Pax3/Pax7 double mutant demonstrated that these factors act together to impel the 
correct development of the neural crest lineage and of spinal cord progenitor cells that 
give rise to a subset of commissural interneurons, as well as to proper restrict the 
dorsal boundary of ventral cell types (Mansouri and Gruss, 1998). 
Concurrently with the major role of Wnt signaling in the proliferation of dorsal 
progenitors, the canonical Wnt/β-catenin pathway is also involved in the patterning of 
INTRODUCTION 
 
47 
 
dorsal spinal neuronal populations. Members of the Wnt family, Wnt1 and Wnt3a, 
start to be expressed in the roof plate soon after neural tube closure. Disruption of 
these genes results in mouse embryos with an altered number of dI1-dI3 interneurons 
at E10.5. A reduction in the number of dI1 to dI3 neurons is confirmed by a decrease in 
the expression of Lhx2 and Islet1, which serve as molecular markers for two of these 
subpopulations. On the other hand, the dorsal expansion of Pax2, a transcription 
factor typically expressed in the dI4 interneurons, revealed the dorsal spreading of this 
subpopulation, at the expense of dI1-dI3 neurons (Muroyama et al., 2002). Moreover, 
the Wnt/β-catenin signaling is intimately related with the activation of Olig3 (Figure 5) 
(Zechner et al., 2007), encoding a bHLH transcription factor common to the 
specification of all dP1-dP3 progenitors. The expression of Olig3 is first detected in 
mouse spinal cord by E9 in a continuous broad stripe of cells that encompasses these 
progenitor domains, and later in a small set of postmitotic neurons in the ventral spinal 
cord (Takebayashi et al., 2002). Müller and colleagues (Muller et al., 2005) ascribed a 
crucial role for Olig3 in the generation of the dI1-dI3 neurons. They demonstrated that 
null mutant mice for the gene encoding this bHLH protein present a shortage in the 
number of dI1 neurons and that the reduced number of Math1 expressing cells in 
Olig3 mutants may contribute to this phenotype. More drastically, the dI2 and dI3 
neurons failed to be generated at all, since the markers for these populations (FoxD3 
and Tlx3/Islet1, respectively) are absent in these embryos. The fact that Olig3 is 
required to maintain the levels of Ngn1 and Ngn2 is the most likely reason for the 
failure in the formation of dI2 neurons in these mutants. Instead, these neurons 
appear to be misspecified and express molecular markers characteristic of dI4 
interneurons, such as Lbx1, Pax2 and Lhx1/5 transcription factors. In addition, cell 
lineage analyses showed that neurons where Olig3 expression was abolished went to 
occupy a more lateral position in the dorsal spinal cord, which is a place typically 
occupied by Class B neurons (Muller et al., 2005). All the data suggests that in the 
absence of Olig3, Class B neurons are formed at the expense of Class A. 
The specification of the neurons that evolve from dP4-dP6 progenitors is 
regulated by a different genetic network, given the fact that these cells develop 
independently of the presence or signaling from the roof plate (Lee et al., 2000). This 
process was first unveiled by Müller and colleagues, who thoroughly characterized the 
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presence of the HD protein Lbx1 in the mouse embryonic spinal cord (Muller et al., 
2002). They found out that Lbx1 appears at E10 in a group of postmitotic neurons that 
are outside the ventricular zone and no longer express Pax7, which marks proliferating 
neuronal progenitors. These correspond exclusively to the dI4-dI6 classes of 
interneurons, as demonstrated by co-localization of Lbx1 with other proteins – dI4 and 
dI6 are both defined by Lbx1 and Lhx1/5 expression and are intercalated by the dI5 
population, which is defined by the presence of Lbx1, Lmx1b, Brn3a, Tlx3 and Prrxl1 
(Figure 5). The mechanisms that regulate the differentiation of these neurons are 
intricate. Albeit dI4 and dI6 interneurons are defined by a similar code of HD 
transcription factors, they emerge at distinct positions in the spinal cord and evolve 
from progenitors whose fate determination is differentially regulated. Conversely, dI4 
and dI5 Lbx1-expressing neurons emerge from the same Mash1- and Pax7high-positive 
domain, despite the fact they later diverge in their molecular identities (Lbx1/Lhx1/5-
positive vs. Lbx1/Lmx1b/Brn3a-positive neurons, respectively). Lbx1 emergence is 
favored in the presence of high doses of Pax7, since lower concentrations of Pax7 and 
Mash1 stimulate the specification of the Lbx1-negative dI3 interneurons. In the 
absence of Lbx1, Class B neurons assume the molecular characteristics of Class A 
neurons. Conversely, its ectopic expression in the most dorsal part of spinal cord forces 
prospective Class A neurons to differentiate towards the Class B phenotype, strongly 
resembling the Olig3 null mutant mice. Therefore, the specification of the early-born 
neuronal populations in two main classes during dorsal spinal cord development, relies 
on the antagonistic role exerted by Olig3 and Lbx1. 
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Figure 5: Schematic representation of the inductive signals and transcription factors acting during the 
early neurogenesis in the dorsal spinal cord. BMP and Wnt signals released from the roof-plate (RP) and 
Shh released from the floor-plate (FP) and the notochord orchestrate the initial patterning of the eleven 
progenitor populations (dP1-P3) in the developing spinal cord, in a dosage-dependent manner. In the 
dorsal half of the spinal cord, only the dorsal progenitors dP1-dP3 respond to the inductive signals from 
the roof-plate (Class A), whereas Class B progenitors (dP4-dP6) generate independently from those 
signals. The Wnt/β-catenin pathway is required to activate Olig3, which encodes a bHLH factor essential 
for the generation of Class A neurons. Complementarily, Lbx1 is required for the development of Class B 
neurons. Olig3 and Lbx1 are antagonist factors. By E9, the distinct populations of dorsal progenitors in 
the ventricular zone (vz) can be distinguished according to the bHLH transcription factors present there: 
dP1 – Math1; dP2 – Ngn1; dP3-dP5 – Mash1; dP6 – Ngn1/2. At E10, the dividing progenitor cells have 
exited the cell cycle (postmitotic neurons), migrated laterally to the mantle layer (ml) and have switched 
on the expression of several HD transcription factors that define the six populations of dorsal 
interneurons (dI1-dI6). dI1, dI2, dI3 and dI5 will originate glutamatergic excitatory neurons and dI4 and 
dI6, GABAergic inhibitory neurons. 
 
1.5.2. GENERATION OF LATE-BORN NEURONS 
Approximately two days later (by E12.5), the second wave of spinal 
neurogenesis is initiated. Two newly mutually exclusive populations of neurons 
emerge from the dI3-dI5 Lbx1/Mash1-positive domain of dividing progenitors and 
express the same molecular markers as dI4 and dI5 neurons (Gross et al., 2002; Muller 
et al., 2002). These late-born populations are named dILA and dILB and their primary 
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difference accounts for the distinct combinatory code of HD transcription factors: dILA 
neurons are defined by the presence of Lbx1, Lhx1/2 and Pax2, whilst dILB are 
Lbx1/Lmx1b/Tlx3 and Prrxl1-positive. Unlike their early-born counterparts, which are 
also Lbx1-positive, late-born neurons will migrate dorsally and populate the most 
superficial layers (laminas I-III) of the spinal cord dorsal horn in an intermingled 
pattern. There, dILA and dILB arise as association interneurons that express, 
respectively, gamma-amino butyric acid (GABA) and glutamate as predominant 
neurotransmitters in inhibitory and excitatory neurons, and are responsible for the 
integration of sensory information arriving from the periphery (Figure 6). In order to 
do it properly, the correct balance of these excitatory and inhibitory neurons is 
mandatory. Functional studies that consisted on the disruption of genes involved in 
the specification and differentiation of the late-born populations, resulted in animals 
with impaired nociceptive function (Chen et al., 2001; Gross et al., 2002; Muller et al., 
2002; Xu et al., 2013). In Lbx1 null mice, both the dI4/dILA (Lhx1/5-positive) and 
dI5/dILB (Lmx1b/Brn3a-positive) assume the molecular characteristics of the Class A 
dI2 (Lhx1/5/Brn3a-positive) and dI3 (Islet1/Brn3a-positive), respectively. This indicates 
that Lbx1 acts by repressing conditioners of Class A subtypes, such as Islet1/2. Unlike 
Class B neurons, these cells are faded to establish as commissural interneurons that 
relay the somatosensory information in the deep dorsal spinal cord. Therefore, a 
shortage of dorsally migrating cells to the surface is observed and, in consequence, 
these embryos develop a defective dorsal horn with impaired nociceptive integrative 
centers (Muller et al., 2002). This is reflected in the incomplete penetrance of 
peripherin- and TrkA-positive projecting afferent fibers to the spinal gray matter and in 
the reduced production of excitatory and inhibitory neurotransmitters (Muller et al., 
2002). 
Following early neuronal determination (E10 – E12.5) and further in dorsal 
spinal cord development, it is of great importance to activate transcription programs 
involved in terminal differentiation processes. These include genes that deal with 
maintenance of cell survival, axon guidance and synapse establishment, as well as with 
the activation of genes that control the expression of molecules that confer the proper 
identity and specify different neuron types (neurotransmitters synthesizing enzymes 
and transporters, ion channels, sensory receptors and signaling factors) (Hobert, 
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2011). Most of these specifiers are HD transcription factors. Although late-born 
neurons develop from a common Mash1/Lbx1-positive domain of progenitors, they 
soon divide into neuronal populations with opposing functions. By E13.5, the presence 
of the HD factors Pax2 and Tlx3 represent the two intermingled developing late-born 
populations in the dorsal horn of the spinal cord, in a way complementary to the 
mutually exclusive development of GABAergic and glutamatergic neurons (Cheng et 
al., 2004). Tlx3 is solely expressed in VGLUT2-positive cells (a vesicular glutamate 
transporter) and almost never co-localizes with Pax2, which in its turn, highly co-
localizes with two enzymes involved in GABA synthesis, the glutamic acid 
decarboxylases GAD67 and GAD65, as well as the inhibitory amino acid transporter 
that packages GABA or glycine into synaptic vesicles (encoded by the gene Viaat) 
(Cheng et al., 2004). By suppressing the activity of Lbx1 in dILB neurons, Tlx3 and its 
paralogue gene Tlx1 are essential for the development of the glutamatergic 
neurotransmitter phenotype in the superficial laminas of the dorsal horn (Cheng et al., 
2005). This regulation is specific of the late-born population dILB, as the disruption of 
both genes (Tlx3 and Tlx1) does not affect the development of glutamatergic neurons 
that derive from the dP1 and dP2 progenitors and settle in the profound laminas of the 
dorsal spinal cord, which is somehow consistent with the lack of Tlx1 and Tlx3 
expression in the early-born dI1 and dI2 populations (Caspary and Anderson, 2003; 
Helms and Johnson, 2003; Cheng et al., 2004). Opposed to the development of 
glutamatergic neurons, Ptf1a appears as a master regulator of the fate of GABAergic 
populations. This HD factor starts to be expressed at E10.5 in postmitotic cells in the 
Mash1-derived dI4 domain, but by E11.5 it has expanded its expression both dorsally 
and ventrally (dI3 to dI5). At E12.5, Ptf1a marks the Pax2/Lhx1/5-positive dILA 
population but not the dILB, which is Tlx3/Lmx1b/Prrxl1-positive. Indeed, Ptf1a is 
crucial for the development of the dI4 and dILA populations of interneurons, as seen 
by the loss of Pax2/Lhx1/5-positive cells in Ptf1a null mutants. Moreover, Ptf1a 
contributes to inhibit the generation of dILB neurons, as the number of cells that 
express Tlx3 and Lmx1b are increased in Ptf1a null mice. In fact, a cell fate switch 
occurs in the absence of Ptf1a, as demonstrated by fate mapping analysis. In Ptf1a 
mutants, the presence of Tlx3 and Lmx1b is detected in cells where the expression of 
Ptf1a was ablated, contrasting with the non-overlapping expression of Ptf1a and 
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Tlx3/Lmx1b in mouse embryos heterozygous for Ptf1a (Glasgow et al., 2005). In 
accordance with this, dILA cells fail to become GABAergic, whereas the number of 
Tlx3/VGLUT2-positive neurons increase. The Class A dI2 and dI3 interneurons are not 
affected by the disruption of this gene (Glasgow et al., 2005). Thus, Ptf1a and Lbx1 are 
upstream targets of Pax2, and all act together to select and determine the GABAergic 
inhibitory fate of neurons that emerge from the Mash1-positive domain of the dorsal 
spinal cord progenitors (Figure 6). 
 
 
 
Figure 6: Schematic representation of transcription factors acting during the generation of late-born 
neurons in the dorsal spinal cord. At E12.5, two mutually exclusive populations of neurons emerge from 
the dI3-dI5 Lbx1/Mash1-positive domain of dividing progenitors and express the same molecular 
markers as dI4 and dI5 neurons (respectively, dIL
A
 expresses Lhx1/5/Lbx1/Ptf1A/Pax2 and dIL
B
 expresses 
Tlx1/3/Lmx1b/Brn3a/Prrxl1). dIL
A
 neurons will express GABA and dIL
B
 will express glutamate as main 
neurotransmitters. Both populations migrate in a dorsolateral fashion and establish in the superficial 
laminas of the spinal cord dorsal horn, in an intermingled pattern of GABAergic inhibitory and 
glutamatergic excitatory neurons. 
 
Regarding the neuronal populations in the dorsal horn of the spinal cord, the 
combinatorial code that leads to the generation and maintenance of excitatory and 
inhibitory neurons, is relatively well-known. The entire pool of GABAergic neurons 
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derives from Lbx1-positive postmitotic cells and requires the presence of Ptf1a and 
Pax2 to maintain the inhibitory features, as these factors regulate the transcription of 
genes characteristic of the GABAergic phenotype. The coordinated action of these 
genes promote the expression of GABA, glycine and a set of peptides essential for the 
inhibitory phenotype, such as neuropeptide Y (NPY), dynorphin (DYN), galanin (GAL), 
somatostatin (Sst) and enkephalin (ENK) (Figure 7) (Glasgow et al., 2005; Huang et al., 
2008). The genetic mechanisms involved in the differentiation and specification of 
glutamatergic excitatory neurons are mainly regulated by the differential action of Tlx1 
and Tlx3, Lmx1b, Brn3a and Prrxl1. From those genes, Tlx3 emerges as the master 
regulator in the determination of the glutamatergic excitatory phenotype in the dILB 
neuronal population. Indeed, in Tlx3 null mutant mice, typical markers of GABAergic 
inhibitory neurons are increased, including Pax2, Gad1 and Viaat (Cheng et al., 2004). 
A set of neuropeptides responsible for the modulation of nociceptive sensory 
information are expressed in Tlx3-positive neurons or their derivatives (Xu et al., 
2008). Among them, are included the CCK (which originates the anti-opioid peptide 
cholecystokinin) and Tac1 (encoding the precursor for SP and Neurokinin A), whose 
expression is abolished in double Tlx3/Tlx1 null mutants, from E13.5 to E18.75, in 
intermediate and deep laminas, respectively. Remarkably, though the expression of 
Tlx3 is transient in most of these neurons, a strong requirement of Tlx3 (and the 
redundant role of Tlx1 in the rostral spinal cord) to establish the peptidergic 
transmitter phenotype is acknowledged. However, Tlx3 needs to act in combination 
with other factors in order to accomplish such functions. Specifically, it has been 
reported that Tlx3 first activates the transcription of Brn3a (as verified by the partial 
loss of Brn3a expression in Tlx3/Tlx1 double mutants), which then acts to positively 
control the Tac1 expression in Tlx3-expressing neurons. The expression of other 
peptides controlled by Tlx3 appears to be more intricately regulated. For instance, Tlx3 
exerts both a positive and a negative regulation in the transcription of the Sst encoding 
gene. In the double Tlx3/Tlx1 null mice, the number of Sst-expressing neurons is 
prominently decreased in the superficial dorsal spinal cord by E18.75, whereas its 
expression in deeper laminas is not affected. Nevertheless, only the late wave of Sst-
positive neurons is affected in these mutants. At earlier stages, the number of Sst-
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expressing neurons increases by five-fold in Tlx3/Tlx1 mutant embryos and are 
confined to the intermediate and deep dorsal laminas (Xu et al., 2008). 
Once the glutamatergic cell fate is determined in the dorsal horn of the spinal 
cord, other molecular players are required to maintain neurons in a functional 
excitatory condition. Nonetheless, the nature of the genetic relationships of the 
transcription factors involved in the proper integration and transmission of noxious 
stimuli remains elusive. Albeit not involved in the initial specification of the 
glutamatergic fate, Lmx1b stands out as an essential regulator of the transcriptional 
program that coordinates the assembly of the nociceptive circuitry. In the developing 
spinal cord, the expression of this gene begins at E10.5 in the dI5 and dILB and is 
mediated by Lbx1 (Ding et al., 2004). Subsequently, it is required for the spinal cord 
specifier Prrxl1 (Chen et al., 2001) to initiate its expression, as this is completely absent 
in Lmx1b null mutants, from its time of onset until E15.5; it is not essential for the 
onset but for the maintenance of Tlx3 and Ebf3 expression, which are drastically 
downregulated or absent by E15.5 in the developing dorsal horn of Lmx1b mutants; it 
controls the expression of several molecular cues important for axon guidance and 
neuronal migration, such as receptors for the chemorepellent Sema3a, Neuropilin1 
and PlexinA2, Slit1, Robo2 and Netrin1 (Ding et al., 2004), as well as the extracellular 
matrix glycoprotein Reelin in laminas I and II (Szabo et al., 2015). Altogether, Lmx1b 
disruption conducts to severe anatomical deficiencies in the superficial spinal cord due 
to the incorrect differentiation and patterning of Lmx1b-expressing neurons (lamina I 
and II become indistinguishable in Lmx1b mutants) and absent projections of TrkA-
positive sensory afferent fibers to the prospective laminas I and II (Ding et al., 2004). 
Moreover, Lmx1b is required for the correct development and survival of dorsal horn 
excitatory neurons without affecting the number of inhibitory neurons (Szabo et al., 
2015), contrasting to observations in the trigeminal nucleus principalis (PrV) where 
Lmxb1 facilitates the glutamatergic phenotype and suppresses the GABAergic one by 
reducing the expression of Pax2 at late embryonic stages (after E14.5) (Xiang et al., 
2012). The absence of Lmx1b in pain-processing spinal cord neurons affects 
mechanical (possibly related to the loss of Sst expression) and thermal nociception 
(Szabo et al., 2015). 
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Figure 7: Schematic representation of the genetic relationships established between transcription 
factors acting on the terminal differentiation processes of glutamatergic (yellow) and GABAergic (green) 
neurons in the dorsal spinal cord. Lbx1, Ptf1A and Pax2 are essential genes in the generation and 
maintenance of inhibitory features in GABAergic neurons, as they promote the expression of genes 
characteristic of GABAergic phenotype - neuropeptide Y (NPY), dynorphin (DYN), galanin (GAL), 
somatostatin (Sst) and enkephalin (ENK), and the glycine transporter GlyT2. Tlx3 emerges as the master 
regulator of the glutamatergic fate, inducing or maintaining the expression of Lmx1b, Prrxl1 and Brn3a, 
as well as genes essential for the establishment of the excitatory and peptidergic phenotype, such as 
VGlut2, CCK, Sst (only at E18.75 but not at E14.5) and Tac1, via activation of Brn3a. Lbx1 activates the 
transcription of Lmx1b at E10.5, which is in its turn, is required for the onset of Prrxl1. At late stages of 
the trigeminal nucleus principalis (PrV) development, Lmx1b facilitates the glutamatergic phenotype and 
suppresses the GABAergic one, by antagonizing the expression of Pax2. 
 
All the information gathered in the past years points towards the major role of 
Tlx3 coordinated with other HD transcription factors, such as Lmx1b and Prrxl1, in the 
control of differentiation, migration and generation of distinct subpopulations of 
nociceptive glutamatergic excitatory lamina I and II neurons, as well as the in 
establishment of synapses with the incoming primary afferent neurons. Nevertheless, 
whether and when these factors act together or in transcriptional cascades, and what 
are the precise molecular mechanisms that regulate their relationship and define their 
tissue-specific function are questions that still remain to be unraveled. In order to 
pursue this issue, this thesis focused on the study of the molecular mechanisms that 
regulate Prrxl1 expression, since it is, among the many genes playing important roles in 
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the development and establishment of the pain circuit, one of the few exclusively 
present in nociceptive sensory neurons. 
 
 
1.6. THE HOMEODOMAIN TRANSCRIPTION FACTOR PRRXL1 
 
During the assembly of the peripheral-to-central pain circuit, Prrxl1 stands out 
as an important regulator of the nociceptive neuronal identity both in DRG and spinal 
cord. This is remarkable, as many critical nociceptive determinants are present 
exclusively in DRG (such as Runx1) or dorsal spinal cord (such as Lbx1 and Lmx1b). 
Prrxl1 (formerly known as Drg11) is a HD transcription factor expressed from E10.5 in 
mouse peripheral sensory ganglia (DRG and TG), as well as in neurons that will 
populate the dorsal horn of the spinal cord and trigeminal nucleus, responsible for the 
modulation of the nociceptive sensory information. There, its expression persists at 
significant levels until P14-P21 (Saito et al., 1995; Rebelo et al., 2007). In the DRG, 
Prrxl1 initiates its expression in TrkA-positive small-diameter neurons and later on it 
accompanies the segregation of C fibers into peptidergic and non-peptidergic, 
maintaining its expression in both subpopulations (Rebelo et al., 2006). Although the 
onset of Prrxl1 is observed quite early during the development of primary afferent 
sensory neurons, this factor is not apparently involved in the initial differentiation or 
specification of these fibers. Instead, Prrxl1 is required at postnatal stages for the 
survival of peptidergic and non-peptidergic small primary neurons in the DRG, as 
verified by the decrease of both CGRP- and IB4-positive cells in Prrxl1 null mice by P7 
(Rebelo et al., 2006). Concomitantly with the equally distributed levels of Prrxl1 in 
these fibers, the innervation of cutaneous, visceral and deep tissues is affected (Rebelo 
et al., 2006). 
Similar to the functionally related proteins Tlx3 and Lmx1b, Prrxl1 is detected in 
the developing spinal cord at E10.5 in postmitotic dI3 (akin to Tlx3) and dI5 (akin to 
Tlx3 and Lmx1b) interneurons (Rebelo et al., 2007). By E12.5, Prrxl1 expression is 
observed in a subset of late-born Tlx3-positive neurons (dILB) that will migrate 
dorsolaterally to establish in the superficial laminas of the dorsal horn. Indeed, Prrxl1 
acts alongside Tlx3 and Lmx1b to define various subpopulations of both glutamatergic 
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early- and late-born neurons, in accordance with their differential expression (Rebelo 
et al., 2010). Prrxl1 expression appears to be particularly required in lamina I and II 
neurons. Prrxl1 null mouse embryos display defects in the spatio-temporal projection 
patterning of small-diameter sensory afferent fibers to the dorsal horn. Cutaneous 
afferent projections fail to properly enter the spinal gray matter, as determined by the 
delay in the penetrance of calbindin-positive fibers in the dorsal horn of E13.5 Prrxl1 
mutants, a stage when no apparent morphological defects are observed in the 
developing spinal cord. In contrast, in wild-type mice, afferent fibers expressing 
calbindin already have penetrated the gray matter by this age. Although the ingrowth 
of afferent fibers occurs at last (by E16.5), these enter the gray matter in a 
disorganized manner, towards the spinal midline instead of to the lateral-most portion 
of the dorsal horn, as observed in wild-type embryos. A similar derangement is 
detected when the expression of TrkA is analysed (Chen et al., 2001). The impaired 
connection established between primary and second order neurons may be the cause 
of posterior cell death, evident in the dorsal horn of mutant mice, beginning at E17.5. 
Cell death persists by postnatal stages, as a reduction of 60-70% of mostly lateral 
dorsal horn neurons is observed in adult mice. Moreover, the absence of PKCγ-positive 
cells in Prrxl1 mutants is indicative of the failure in the correct formation of second 
order neurons involved in the processing of the nociceptive information. Altogether, 
these anatomical deficiencies lead to alterations in pain sensitivity in adult mutants. In 
comparison to wild-types, these animals display a significant delay in the perception of 
thermal stimuli (as assessed in the hot plate, tail-flick and paw withdrawal tests), as 
well as a reduced sensitivity to chemical noxious inputs (as demonstrated by the use of 
formalin or capsaicin) (Chen et al., 2001). These abnormalities are strikingly similar to 
the Tlx3 CKO mice, whose Tlx3 expression was specifically removed from the dI5 and 
dILB lineage (Xu et al., 2013) – the sensorimotor and proprioceptive function are intact 
but normal sensitivity to noxious thermal, chemical and mechanical is compromised. 
As Prrxl1 is essential for the survival of TrkA-derived neurons and establishment 
of nociceptive circuit, one would wonder that its transcription in primary sensory 
neurons could be controlled at least by one of the main effectors of the nociceptive 
phenotype described above – Runx1 or Tlx3. However, genetic studies performed in 
mice with disturbed expression of Tlx3 (Qian et al., 2002) or Runx1 (Yang et al., 2013) 
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in the DRG, did not demonstrate any evidence pointing to the regulation of Prrxl1 gene 
expression by these transcription factors. In contrast, Islet1 and Brn3a do have an 
important role in its transcriptional activation, as double mutant mice for these genes 
display a strong decrease in the expression of Prrxl1 (Dykes et al., 2011). Specifically, 
Islet1 control of Prrxl1 transcription in the DRG is observed at E12.5, but not at later 
stages, since by E14.5 Prrxl1 expression is no longer decreased in Islet1 mutants (Sun 
et al., 2008). In the cranial visceral sensory neurons, it was demonstrated that Phox2b 
has the potential to shut down Prrxl1, after an early wave of expression, in a process 
mediated by the direct repression of Brn3a (D'Autreaux et al., 2011). Phox2b is a 
strong regulator of the visceral sensory phenotype in cranial ganglia, and in its absence 
these neurons switch to a somatic fate. Hence, Phox2b has an important role in the 
repression of genes characteristic of the somatic phenotype, such as Brn3a, Runx1 and 
Prrxl1 (D'Autreaux et al., 2011). Nonetheless, Prrxl1 expression in the nucleus of the 
solitary tract (nTS) of the hindbrain is not affected by Phox2b inactivation, suggesting 
that the repression of Prrxl1 by Phox2b only occurs at a specific time frame in the 
visceral sensory ganglia. In spinal cord, Prrxl1 requires Lmx1b to trigger its 
transcription, as Prrxl1 expression is not initiated at all in Lmx1b mutant mice (Ding et 
al., 2004). In contrast to what is observed in the DRG, Tlx3 inactivation strongly affects 
Prrxl1 expression in spinal cord, resulting in the downregulation of Prrxl1 (Qian et al., 
2002). Altogether, this data indicates that Prrxl1 expression is regulated by distinct 
tissue-specific genetic programs. 
 
 
Figure 8: Available data regarding transcriptional pathways involved in the regulation of Prrxl1 
transcription. In the trigeminal ganglia (TG), Prrxl1 expression is inhibited by Phox2b, possibly via direct 
repression of Brn3a. In the dorsal root ganglia (DRG), it is known that Prrxl1 transcription is induced both 
by Islet1 and Brn3a. In the spinal cord, Prrxl1 expression is activated by Lmx1b and requires Tlx3 in order 
to be maintained. 
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2. OBJECTIVES 
 
 Despite the findings regarding the importance of Prrxl1 for the proper 
differentiation and assembly of the nociceptive circuit, little is known about the way 
Prrxl1 controls such processes. In order to address these questions, a better 
understanding of the genetic transcriptional programs and detailed mechanisms that 
control the expression of Prrxl1 would be required, to put Prrxl1 in context with other 
players, whose functions are better known. To add some information on this subject, 
different approaches were used in order to dissect the molecular machinery that 
controls the spatiotemporal expression of Prrxl1 during the development of 
nociceptive neurons. Therefore, in this study we mainly sought: 
 
I. To identify and characterize conserved tissue-specific cis-regulatory elements that 
control Prrxl1 transcription during the development of nociceptive neurons; 
 
II. To identify and characterize trans-acting factors that bind the elements identified in 
I. and to ascribe a functional significance to such binding. 
 
Most of these analyses were performed in vitro using an immortalized cell line 
(ND7/23) that displays nociceptive properties characteristic of sensory ganglia and 
recapitulates some molecular mechanisms occurring in DRG or spinal cord nociceptive 
neurons. In addition, considering that Prrxl1 expression had been described in the 
zebrafish and displays a pattern similar to what is observed in mouse (McCormick et 
al., 2007), we concluded this would be a suitable model to evaluate the functional 
relevance of the conserved regions identified in the first tasks of this study. 
The data collected during this study was published in two original papers and is 
presented in this thesis in the form of Publication I and Publication II. In the first 
publication (Publication I), the identification of several cis-regulatory elements that 
control Prrxl1 transcription and translation is described. Among them, there are three 
alternative promoter regions and a binding motif for Phox2b, which is required for 
Prrxl1 expression in zebrafish visceral sensory neurons. In this publication, binding sites 
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recognized by the HD transcription factors Tlx3 and Brn3a were also identified. The 
relationship between Prrxl1, Tlx3 and Brn3a was further explored in Publication II. 
There, we reported that Tlx3 controls the expression and activity of Prrxl1 by two 
different mechanisms, either by controlling its transcription or by inducing alterations 
in its phosphorylation state. 
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Several Cis-regulatory Elements Control mRNA Stability,
Translation Efficiency, and Expression Pattern of Prrxl1
(Paired Related Homeobox Protein-like 1)*□S
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Background: The mechanisms that control the Prrxl1 expression are poorly understood.
Results: Several regulatory elements present in Prrxl1 alternative promoters are functionally characterized, including a binding
motif for Phox2b required for Prrxl1 expression in visceral sensory neurons.
Conclusion: We define diverse regulatory modules, which control the spatiotemporal expression of Prrxl1 in nociceptive
neurons.
Significance: A new mechanism involved in the ganglion specific action of Prrxl1 is described.
The homeodomain transcription factor Prrxl1/DRG11 has
emerged as a crucial molecule in the establishment of the pain
circuitry, in particular spinal cord targeting of dorsal root gan-
glia (DRG) axons and differentiation of nociceptive glutamater-
gic spinal cord neurons. Despite Prrxl1 importance in the estab-
lishment of the DRG-spinal nociceptive circuit, the molecular
mechanisms that regulate its expression along development
remain largely unknown. Here, we show that Prrxl1 transcrip-
tion is regulated by three alternative promoters (named P1, P2,
and P3), which control the expression of three distinct Prrxl1
5-UTR variants, named 5-UTR-A, 5-UTR-B, and 5-UTR-C.
These 5-UTR sequences confer distinct mRNA stability and
translation efficiency to the Prrxl1 transcript. The most con-
served promoter (P3) contains a TATA-box and displays in vivo
enhancer activity in a pattern that overlaps with the zebrafish
Prrxl1 homologue, drgx. Regulatory modules present in this
sequencewere identified and characterized, including a binding
site for Phox2b. Concomitantly, we demonstrate that zebrafish
Phox2b is required for the expression of drgx in the facial, glos-
sopharyngeal, and vagal cranial ganglia.
Sensory perception of peripheral stimuli is primarily medi-
ated by different types of afferent neurons, which are located in
the trunk dorsal root ganglia (DRG)2 and send processes to the
periphery and the spinal cord. In the spinal cord, specialized
neurons integrate and relay the information to somatosensory
centers in the brain where appropriate responses are generated
(1, 2). Spinal sensory neurons differentiate from several classes
of proliferating progenitor cells, whose establishment requires
the expression of proneural genes encoding for basic helix-
loop-helix (bHLH) transcription factors (3–5). The various cell
lineages are specified according to the combined expression of
a set of homedomain transcription factors that confer neural
identity to each class (4, 5). One of these factors is Prrxl1 (also
known as DRG11). Prrxl1 has emerged as a crucial molecule in
the development of the pain-perception circuitry, especially in
the establishment of the nociceptive DRG-spinal pathway.
Prrxl1 is also expressed in sensory cranial ganglia and their
target relay neurons in the hindbrain (6, 7). Nevertheless, the
role of Prrxl1 in these tissues is poorly studied.
Prrxl1 null mutant mice present a distorted spinal dorsal
horn with scarce superficial nociceptive-responsive neurons
(8–10), reduced DRG neuronal population (10), and a marked
decrease in nociceptive response capacity in various pain tests
(8). Interestingly, although involved in the embryonic differen-
tiation of various subpopulations of superficial dorsal horn
excitatory neurons (10), Prrxl1 appears not to be required for
the normal development of DRG neurons before birth but
rather to be essential for their survival in early postnatal life (9).
Although Prrxl1 expression in various cell lineages in DRG and
spinal cord is well known, the mechanisms of transcriptional
control exerted by different bHLH and homeodomain proteins
that modulate Prrxl1 transcription are still poorly understood.
Recently, a Prrxl1 alternative spliced variant was identified,
and multiple variants of exon 1 in both Prrxl1 mRNA isoform
sequences were discovered, suggesting the existence of various
5-untranslated regions (5-UTRs) controlled by distinct pro-
moters (11).Modulation of gene expression through alternative
promoter usage is now widely accepted following evidence
gathered in the past years (12, 13). According to Baek et al. (14),
* This work was supported by the Fundação para a Ciência e a Tecnologia
(SFRH/BD/65300/2009 (to I. R.) and PTDC/SAU-OBD/099886/2008),
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1 Towhomcorrespondence should be addressed: Dept. of Experimental Biol-
ogy, 4th floor, Faculty of Medicine of Porto, 4200-319 Porto, Portugal. Tel.:
351-220426743; E-mail: cregueng@med.up.pt.
2 The abbreviations used are: DRG, dorsal root ganglia; bHLH, helix-loop-he-
lix; TSS, transcription start site; HD, homeodomain; TBP, TATA-bindingpro-
tein; MO, morpholino oligonucleotide; RRA, regulatory region A; RRB, reg-
ulatory region B; eGFP, enhanced-GFP; hpf, hours post fertilization; Ngn1,
neurogenin1.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 288, NO. 51, pp. 36285–36301, December 20, 2013
© 2013 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
DECEMBER 20, 2013•VOLUME 288•NUMBER 51 JOURNAL OF BIOLOGICAL CHEMISTRY 36285
about 40–50% of human and mouse genes contain alternative
promoters, a condition that seems to be required to initiate
transcription in a tissue-specific manner (15–17). The use of
multiple promoters, each one controlling at least one transcrip-
tion start site (TSS), usually originates different 5-UTRs that
might have a role in the control ofmRNAstability or translation
efficiency (18, 19).
Here, we characterize three Prrxl1 5-UTRs variants and the
corresponding promoter regions, whichmay explain the differ-
ential involvement of Prrxl1 in the DRG and spinal cord devel-
opment. We also present in vitro and in vivo evidence that the
most evolutionarily conserved Prrxl1 promoter region is suffi-
cient to drive expression to neuronal cells and is regulated by
Phox2b specifically in primary afferent neurons.
EXPERIMENTAL PROCEDURES
Animal Care—NMRI mice were bred and housed at the Insti-
tuto de Biologia Molecular e Celular, Porto, animal facility under
temperature- and light-controlled conditions. The embryonic
day 0.5 (E0.5) was considered to be the midday of the vaginal
plug. The animals were euthanized (isoflurane anesthesia fol-
lowed by cervical dislocation), and tissues were collected.
Experiments were carried out in compliance with the animal
ethics guidelines at Instituto de Biologia Molecular e Celular
and approved by the Portuguese Veterinary Ethics Committee.
Wild-type AB/Tuebingen (AB/TU) zebrafish strain were
maintained in the breeding colony in CABD, Seville, according
to standard procedures. Fertilized eggs were kept at 28 °C in E3
medium with 0.003% 1-phenyl-2-thiourea to prevent pigmen-
tation and were staged according to Kimmel et al. (20).
Reverse Transcriptase-PCR—The different 5-UTR-Prrxl1
molecules were amplified by reverse transcriptase-PCR (see
supplemental Table S1 for primers) from spinal cord total RNA,
extracted from mice at different developmental stages (E11.0,
E12.5, E14.5, and E16.5) using the Micro-to-midi total RNA
purification System (Invitrogen) following the manufacturer’s
instructions. The first-strand cDNA synthesis was prepared at
42 °C during 1 h from 1 g of total RNA using 200 units of
transcriptase enzyme (Bioline) and 500 ng of oligo(dT)12–18
(Bioline). To assess for potential contaminants, a control con-
taining all reagents except the reverse transcriptase enzymewas
included for each sample. Normalization was performed by
amplification of mouse -actin using the primers pair listed in
supplemental Table S1. The PCR conditions were the follow-
ing: denaturation at 94 °C for 30 s, annealing at 58 °C for 45 s,
and elongation at 72 °C for 45 s. Thirty-two cycles were per-
formed for the amplification of Prrxl1 5-UTR-B and
5-UTR-C, 29 for 5-UTR-A andORF, and 20 cycles for-actin.
The amplification for each gene was in the linear curve (data
not shown). Equal amounts of the PCRproductswere subjected
to a 1% agarose gel electrophoresis and visualized by ethidium
bromide staining under UV light source. The signals were
acquired by a Kodak digital camera DC290, and the densito-
metric analyses were conducted using the computational pro-
gram Kodak 1D Image Analysis Software.
In Vitro Transcription-Translation Assay—The different
full-length 5-UTR-Prrxl1 cDNA sequences (see supplemental
Table S1 for primers) were PCR-amplified from mouse E14.5
spinal cord cDNA and cloned by TA overhangs in the pCR2.1
(Invitrogen). The resulting vectors were selected for orienta-
tion and used to perform the coupled transcription-translation
assay in rabbit reticulocyte lysates using the PROTEINscript II
T7 kit (Ambion). A sequence corresponding to nucleotides1
to50 shared by all isoforms was also cloned into the pCR2.1
plasmid and used as a control. The Prrxl1 expression was mea-
sured by Western blotting using our homemade rabbit anti-
Prrxl1 antibody as described previously (6) and normalized
with a mouse anti-tubulin antibody (Sigma).
Expression Vectors—Plasmids used in this work were pRSK-
Brn3a (a gift from Dr. Mengqing Xiang), pcDNA3.3-Tlx3,
pCAGGS-mPhox2b (a gift from Dr. Christo Goridis), pcDNA3-
Islet1 (a gift from Dr. Chunyan Zhou), pcDNA3.1-His-Ngn1 (a
gift from Dr. Soyeon Kim) pcDNA3.3-Lmx1b, and pCAGGS-
FLAG-Mash1 (a gift from Dr. Diogo S. Castro). The sequences
corresponding to the Tlx3 and Lmx1b open reading framewere
amplified frommouse E14.5 spinal cord cDNA (for primers see
supplemental Table S1) and cloned in the pCDNA3.3-TOPO
TA cloning vector (Invitrogen). Protein expression in trans-
fected cells was assessed byWestern blotting using the antibod-
ies mouse anti-Brn3a (Santa Cruz Biotechnology), rabbit anti-
Tlx3 (Santa Cruz Biotechnology), rabbit anti-Phox2b (a gift
from Dr. Qiufu Ma), mouse anti-Islet-1 (40.2D6, Developmental
Studies Hybridoma Bank), mouse anti-polyhistidines (Sigma),
rabbit anti-Lmx1b (a gift fromDr. ThomasMüller), andmouse
anti-FLAG (Sigma).
For the mRNA stability assays, the different 5-UTR-specific
sequences were amplified from E14.5 mouse spinal cord cDNA
and cloned by TA overhangs in the pCR2.1 plasmid (Invitro-
gen). These sequences were then subcloned in the HindIII site
of the pGL3-Control vector (Promega) between the SV40 pro-
moter and the luciferase coding region.
To determine the Prrxl1 alternative promoters, the entire
and overlapping fragments of the 1401/50-bp region
upstream of the start codon were PCR-amplified (for primers
see supplemental Table S1) from mouse genomic DNA and
cloned in the pBlue-TOPO vector (Invitrogen). The sequences
were then subcloned in the HindIII site of the promoter-less
vector, pGL3-Basic (Promega).
Site-directed mutagenesis of TATA box and HD element
were performed from pGL3-REG1 using the QuikChange Site-
directed Mutagenesis kit from Stratagene and following the
manufacturer’s instructions. Primers used are depicted in sup-
plemental Table S1.
Cell Culture—ND7/23, HeLa, HEK293, and PC12 cell lines
were maintained and grown in Dulbecco’s modified Eagle’s
minimal essential medium (DMEM; Invitrogen) containing
10% fetal bovine serum (Invitrogen) and 50 units/ml penicillin
and streptomycin (Invitrogen). All cells were kept at 37 °C and
5% CO2 gas phase. Transfection was performed using Lipo-
fectamine2000 agent (Invitrogen), and 24 h later cells were har-
vested for posterior analysis. Overexpression in differentiated
PC12 cells was performed by transfecting PC12 cells, and 6 h
later differentiation was induced with 100 ng/ml NGF (Sigma).
Luciferase reporter assays were performed 2 days after trans-
fection. To infer themRNAstability, 24 h after transfection, 100
g/ml actinomycin D (A9415, Sigma) was added to DMEM
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(Invitrogen), and luciferase activity was measured 0, 3, and 6 h
later.
DRG Primary Culture and Cell Electroporation—DRG were
extracted from newly bornmice and, after a 2-h treatment with
10% collagenase (Sigma), were electroporated using the
NeonTM Transfection System (Invitrogen) according to the
manufacturer’s instructions. Afterward, cells were cultured in
polyornithine-coated wells in DMEM-F-12 (Invitrogen) con-
taining 10% fetal bovine serum (Invitrogen), 2 mM glutamine
(Invitrogen), 4% Ultroser G (Pall), 1 B27 (Sigma), and 10
ng/ml NGF (Sigma). Twenty-four hours later the cells were
harvested and processed for luciferase reporter assays.
Luciferase Reporter Assays—Transfected cells from a 96-well
plate format were resuspended in 50 l of lysis buffer (Pro-
mega), and the protein extract was cleared by centrifugation. 5
l of the extract were mixed with the luciferase reagent (Pro-
mega), and the signals were measured using a luminometer
reader (Tecan). Transfection efficiency was normalized by
assessing the -galactosidase activity using 2-nitrophenyl -D-
galactopyranoside (Sigma) as substrate.
Electrophoretic Mobility Shift Assay—Recombinant TATA-
binding protein (sc-4000, Santa Cruz Biotechnology, Inc.) was
incubated with 50 fmol of the double-stranded oligonucleotide
TATA containing the TATAbox promoter sequence (5-TTA-
TGCGTGAGATTATAAAGGCGAGTGCTGAGCGGCGG-
CGCGCGCTG-3) and end-labeled with a dyomic dye DY682
(Thermo Scientific) in a buffer containing 12 mM Tris-HCl, pH
8.0, 0.15 mM EDTA, 6 mM MgCl2, 90 mM KCl, 1 mM DTT, 10%
glycerol, 0.5 mg/ml BSA, and 0.4 g/l poly(dI/dC) (adapted
from Riquet et al. 21). Competition experiments were per-
formed using a non-labeled oligonucleotide with the same
sequence. For supershift experiments, 200 ng of the anti-TBP
antibody (sc-273, Santa Cruz Biotechnology, Inc.) were used.
All samples were run in a 5% PAGE with 10 mM MgCl2.
Nuclear proteins were extracted from ND7/23 cells previ-
ously transfected with pcDNA3.3, pcDNA3.3-Tlx3, pCAGGS-
mPhox2b, or pRSK-Brn3a using first a low salt lysis buffer (30
mM Tris-HCl, pH 7.8, 20 mM NaCl, 1 mM EDTA, 1 mM DTT,
0,1% Triton X-100, and proteases and phosphatases inhibitors
cocktails). After nuclear fractionation, proteins were resus-
pended in 10 mM Tris-HCl, pH 7.5, 60 mM KCl, 200 mM NaCl,
10% glycerol, 5 mM MgCl2, and 0.1% Triton X-100, cleared by
centrifugation, and incubated with 50 fmol of the double-
stranded oligonucleotide HD (5-CTGGAAATAATCAGAT-
TAAGGC-3) end-labeled with dyomic dye DY682. The sam-
ples were run in a 5% polyacrylamide electrophoresis get. The
fluorescent signals were detected using the Odyssey Infrared
Imaging System (LI-COR Biosciences).
Chromatin Immunoprecipitation Assays—For TATA-bind-
ing protein (TBP) chromatin immunoprecipitation (ChIP)
assays, dorsal spinal cords from E14.5 mouse embryos were
dissected and fixed with 2 mM di(N-succinimidyl) glutarate
(Sigma) in phosphate buffer saline (PBS) for 45min followed by
1% formaldehyde in PBS for 10 min and lysed in 50 mM Tris-
HCl, pH 8.0, 1% SDS, and 10 mM EDTA. Chromatin shearing
was performed using Bioruptor (Diagenode) at high power set-
tings for 60 cycles (30 s on/30 s off). ChIP assays with orwithout
(mock control) mouse monoclonal anti-TBP antibody (Mab-
002–100, Diagenode) were performed using 80 g of chroma-
tin/assay in ChIP buffer (20 mM Tris, pH 8.0, 150 mM NaCl, 2
mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 5
mg/ml BSA), and protease inhibitor mixture (Roche Applied
Science). Immunoprecipitates were retrieved with 50l of Pro-
tein G Dynabeads (Invitrogen) per assay and washed once with
wash buffer I (20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM EDTA,
1% Triton X-100, 0.1% SDS), once with wash buffer II (20 mM
Tris, pH 8.0, 250mMNaCl, 2mMEDTA, 1%TritonX-100, 0.1%
SDS), twice with wash buffer III (10 mM Tris pH 8.0, 250 mM
LiCl, 1 mM EDTA, 1%Nonidet P-40, 1% sodium deoxycholate),
and once with TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA) and
eluted with lysis buffer at 65 °C for 10 min. Eluted and input
chromatin were subjected to proteinase K (Roche Applied Sci-
ence) treatment for 2 h at 42 °C and reverse-cross-linked at
65 °C overnight. Immunoprecipitated and input DNA samples
were purified by phenol-chloroform extractions followed by
isopropyl alcohol precipitation. DNA sequences were quanti-
fied by real-time PCR (primers are listed in supplemental Table
S1) using a StepOnePlus Real Time PCR system (Applied Bio-
systems) and a SYBR Green chemistry for quantitative PCR
(Maxima master mix, Fermentas). Quantities of immunopre-
cipitated DNA were calculated by comparison with a standard
curve generated by serial dilutions of input DNA. Data were
plotted as the means of at least two independent ChIP assays
and three independent amplifications; error bars represent S.E.
Phox2b ChIP assays were performed essentially as described
above, with the following modifications: (i) chromatin samples
were extracted from dorsal medulla oblongata of E14.5 mouse
embryos; (ii) mouse monoclonal anti-Phox2b antibody (sc-
376997, Santa Cruz Biotechnology) was used; (iii) NaCl con-
centration of ChIP buffer was reduced to 20 mM; (iv) immuno-
precipitates were washed 6 times with wash buffer III
containing only 0.7% sodium deoxycholate.
Production of Transgenic Zebrafish—A sequence (751/584
bp) that includes the P3 core promoter was PCR amplified from
mouse genomic DNA, cloned in the pCR/GW/TOPO vector
(Invitrogen), and then recombined by the Gateway in vitro
recombination technology using the Gateway LR Clonase II
Enzyme mix (Invitrogen) into a Tol2 vector (22) containing an
iroquois enhancer with midbrain activity (Z48; Refs. 23 and 24)
and the enhanced GFP reporter gene. This vector was assem-
bled by cloning a SalI/NotI fragment of pCS2eGFP (25) con-
taining the CMV promoter, the enhanced GFP reporter gene,
and the poly(A) of SV40 into SalI/NotI restriction sites of a
modified pminiTol2/MCS vector (26) that has a fragment of the
pUC19polylinker that goes fromEcoRI toHindIII. Z48 iroquois
enhancer was isolated from the Z48 TOPO vector (23) by cut-
tingwith EcoRI and cloned intoNotI restriction site after blunt-
ing with Klenow. Finally, a gateway cassette (Invitrogen) was
cloned in blunt between the SalI/BamHI restriction sites,
replacing the CMVpromoter. This vector lacks a promoter and
does not drive GFP reporter expression. Therefore, it is useful
to test for promoter activity of selected DNA sequences. The
following primers were used for amplification: 5-TAAGGCC-
CAATAGACCTATC-3 and 5-CAGGACCAGAGAAGTGA-
CTG-3). About 5 nl of the reaction mix containing 50 ng/l
transposase mRNA, 50 ng/l phenol/chloroform purified vec-
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tor, and 0.05% phenol red were injected in the cell of one-stage
zebrafish embryos. The GFP expression was then documented
from the next 24 to 72 h.
The fragment containing the Ebox and the HD element was
PCR-amplified from human genomic DNA, cloned in the pCR/
GW/TOPO plasmid (Invitrogen), and then recombined to the
ZED vector (23) by the Gateway in vitro recombination tech-
nology described above. The following primers were used for
amplification: 5-GTGGTGGTTGTATCGTTCTC-3 and 5-
GCATAATTGGCCTTAATCTG-3. The injections were
performed as described above. Positive transgenic embryos
strongly expressing red fluorescent protein were selected 72 h
later. Those F0 embryos were raised, and the F1 generation of
embryos expressing GFP was analyzed.
RNAProbe Synthesis andWhole-mount in SituHybridization—
The drgx and tlx3b sequences were amplified from zebrafish
cDNA using the following primers: 5-ATGTTTTACTTTCA-
CTGTCCTCCA-3 and 5-CATTTCTTATCCGGACCCT-
C-3 for drgx and 5-TTCGGGTGGTGAGGATGGAC-3 and
5-GATTTTGGGATGCAACAGCA-3 for tlx3b. PCR prod-
ucts were cloned in the pGEM-T Easy vector (Promega), and a
phenol-chloroform purification was performed after lineariza-
tion with NsiI (for drgx) or NcoI (for tlx3b). Each vector was
used as a template for the in vitro synthesis of a DIG-labeled
RNA probe for zebrafish drgx and tlx3b.
Wild-type embryos at 48 and 72 h post fertilization were
fixed overnight with 4% paraformaldehyde at 4 °C. After brief
washes with PBS, 0.1% Tween 20 (PBST), they were treated
with 10 g/ml proteinase K and fixed for 20 min with 4% para-
formaldehyde at room temperature. After a 20-min wash with
PBST, embryoswere incubated in hybridization buffer for 1 h at
70 °C. The respective RNAprobewas then added to the hybrid-
ization buffer (50% formamide, 2 SSC, and 0.1%Tween 20) to
a final concentration of 1 ng/l, and embryos were incubated
overnight at 70 °C. The next day embryos were sequentially
washed at 70 °C in solutions containing different concentra-
tions (75, 50, 25, and 0%) of hybridization buffer diluted in 2
SSC (75 mM NaCl and 7.5 mM sodium citrate, pH 7.0). After a
further wash with 0.05 SSC for at least 1 h at 70 °C, embryos
were finally washedwith PBST for 10min at room temperature.
Embryos were blocked in 2% normal goat serum/PBST for at
least 1 h at room temperature. Anti-digoxigenin coupled with
alkaline phosphatase was added in fresh 2% normal goat serum,
PBST (1:5000) for 2 h and then allowed to wash overnight in
PBST. The next day embryos were washed with AP reaction
buffer without MgCl2 (100 mM Tris, pH 9.5, 100 mMNaCl, and
0.1% Tween 20). Detection was performed with 3.5 l of nitro
blue tetrazolium (50 mg/ml) and 1 l of 5-bromo-4-chloro-3-
indolyl phosphate (50mg/ml) per 1ml of completeAP-reaction
buffer (100 mM Tris, pH 9.5, 50 mM MgCl2, 100 mM NaCl, and
0.1% Tween 20). The signal was allowed to develop for 3–5 h.
AntisenseMorpholinoOligonucleotide (MO)Analysis—Anti-
sense MO targeted to the translation initiation site of Phox2b
(CATTGAAAAGGCTCAGTGGAGAAGG) was obtained from
GeneTools, LLC, diluted to aworking concentration inMilli-Q
water (0.4 ng/nl) with 0.05% phenol red, and about 5 nl were
injected into 1- to 2-cell-stage embryos.
Statistical Analysis—In the present study, all the data pre-
sented (except for ChIP experiments; see above) were derived
from at least three independent experiments with three repli-
cates. When necessary, a two-tailed t test was performed. Both
mean and S.D. values were calculated and included in the
figures.
RESULTS
Prrxl1 5-UTRVariants Present Distinct mRNA Stability and
Translation Efficiency—Prrxl1 is a transcription factor first
identified by Saito (27) in a subtractive hybridization screening
with rat DRG. The Prrxl1 mRNA sequence described by these
authors contained the start codon in exon 2, whereas exon 1
corresponded to a 5-UTR.More recently, by the use of 5-rapid
amplification of cDNA ends assays with mice spinal cord RNA
extracts, we described two novel variants of Prrxl1 containing
alternative exon 1 that gives rise to distinct 5-UTRs (11).
BLAST searches of GenBankTM database led us to identify
sequences that correspond to all the three 5-UTRs that con-
tained both the first and the last coding exons of the annotated
Prrxl1. We named these Prrxl1 5-UTR variants 5-UTR-A,
5-UTR-B, and 5-UTR-C, which encompass, respectively,
nucleotides 622 to 485, 484 to 298, and 148 to 85
relative to the start codon (Fig. 1A).
To assess for the presence of the different Prrxl1 5-UTR
variants, we performed reverse transcriptase-PCR experiments
using a common reverse primer mapping within exon 7 (con-
taining the stop codon), shared by all isoforms, and isoform-
specific forward primers mapping within alternative exon 1
(arrows in Fig. 1A).With this primer design, wewanted tomake
sure that the amplicons contained the entire coding region and
to exclude from our analysis other putative non-annotated
Prrxl1 splicing variants. The three transcripts are detected in
the spinal cord at developmental stages where Prrxl1 expres-
sion has been previously reported (6). The levels of amplifica-
tion are suggestive that 5-UTR-A variant is themost abundant
transcript, being detectable three PCR cycles earlier than the
other two 5-UTR transcripts (Fig. 1B). The semiquantitative
reverse transcriptase-PCR analysis with spinal cord extracts
from E11.0 to E16.5, a period that includes the early-born
(E10.5-E12.0) and late-born (E12.5-E14.5) neurogenesis waves,
showed that 5-UTR-A reaches the maximum level at E14.5, a
profile similar to the ORF (Fig. 1B). On the other hand, the
highest expression levels of 5-UTR-B and 5-UTR-C are
reached at E12.5 (Fig. 1B), which is suggestive of a more pre-
ponderant role of these two isoformsduring early neurogenesis.
Prrxl1 5-UTR variants result from alternative processing of
non-coding exon 1 and, therefore, have no consequences in the
Prrxl1 coding region. Because mRNA-untranslated regions
have been associated to post-transcriptional regulation mech-
anisms (18, 19), we wondered if 5-UTR sequences confer dis-
tinct mRNA stability or translation efficiency to Prrxl1 tran-
scripts. To address this question, we performed coupled
transcription-translation in vitro assays using different vectors
containing thePrrxl1ORF associated to each 5-UTRunder the
control of the bacterial T7 RNA polymerase. The amount of
Prrxl1 translatedwas determined byWestern blotting (Fig. 1C).
Prrxl1 transcript containing 5-UTR-A was about three times
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FIGURE 1. Differential expression and stability of Prrxl1 5-UTR variants. A, scheme of the Prrxl1 gene. The gene gives rise to three alternative
transcripts that are composed by eight exons and differ on their untranslated first exon (1A, 1B, or 1C). Those untranslated regionswere named 5-UTR-A,
5-UTR-B, and 5-UTR-C. B, expression studies of Prrxl1 transcripts containing different 5-UTRs (5-UTR-A, 5-UTR-B, and 5-UTR-C) and Prrxl1 ORF by
reverse transcriptase-PCR and gel electrophoresis analysis usingmouse spinal cord at different developmental ages (E11 to E16.5). The graph illustrates
a typical expression profile, normalized with -actin signal intensity, from three independent experiments. C, Western blot analysis of Prrxl1 in vitro
translated frommRNA containing distinct 5-UTR and transcribed by T7 RNA Polymerase. The graph represents themean of signal intensity (normalized
with -tubulin) from three independent experiments. D, luciferase reporter assays in ND7/23 and HeLa cells transfected with vectors containing the
different 5-UTR fused to the luciferase encoding gene. E, analysis of the stability of the luciferase mRNAmolecule conferred by the distinct 5-UTR. The
constructs used in D were used to transfect the ND7/23 and HeLa cell lines. Transcription was halted using actinomycin D and luciferase activity
measured at different time points (0, 3, and 6 h of treatment). F, comparison of luciferase expression regulated by different versions of 5-UTR-B.
5-UTR-B contains an upstream ATG (uATG), which was replaced by a GTG sequence (5-UTR-B mut). In C–E, 5-UTR control represents a fragment
encompassing nucleotides 1 to 85 and shared by all isoforms.
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more efficiently translated than the UTR control (a fragment
immediately upstream of the start codon encompassing nucle-
otides1 to85 and shared by all isoforms). On the contrary,
5-UTR-B led to a loss of translational rate, whereas 5-UTR-C
was as expressed as the 5-UTR control. Similar results were
obtained in luciferase reporter assays using theND7/23 cell line
transfected with each 5-UTR cloned between the SV40 pro-
moter and the firefly luciferase coding region (Fig. 1D). The
ND7/23 cells are an appropriate in vitromodel for the study of
Prrxl1-associated mechanisms as they endogenously express
this transcription factor and display a phenotype characteristic
of nociceptive neurons (28). Interestingly, the increased lucif-
erase activity of the 5-UTR-A construct observed in ND7/23
cells was not observed in the non-neuronal HeLa cell line. To
test if the neuron-specific activity induced by 5-UTR-A could
be due to an increase in the transcript stability, mRNA decay
associated to each 5-UTR variant was inferred by measuring
the luciferase activity at different time points upon treatment
with actinomycin D in both cell lines (Fig. 1E). All the different
5-UTRs promoted a similar mRNA decreasing rate in HeLa
cells. In ND7/23 cells, 5-UTR-B- and 5-UTR-C-containing
transcripts displayed decay similar to the control, whereas the
5-UTR-A was more stable. This result suggested that the
5-UTR-A sole effect, both in the mRNA translation rate and
stability, is conferred by a neuronal context likely mediated by
specific RNA-binding proteins.
On the contrary, the 5-UTR-B variant reduced the in vitro
translation efficiency (Fig. 1C) and protein expression both in
ND7/23 and in HeLa cells (Fig. 1D) without interfering with
mRNA stability (Fig. 1E). A careful analysis of the 5-UTR-B
sequence led us to the identification of an ATG located
upstream (uATG) of the Prrxl1 main ATG that could be mis-
taken as an alternative start codon,modifying the reading frame
and thereby explaining the feature of this variant (Fig. 1F).
Upstream ORFs are widely recognized as cis-regulatory ele-
ments that can affect mRNA translation and thus are the
molecular base of severe disorders (29, 30). By changing this
upstream ATG to GTG, the luciferase activity of the mutated
5-UTR-B increased to values similar to the control sequence
(Fig. 1F), suggesting that 5-UTR-B sequence works as a nega-
tive modulator of Prrxl1 expression levels. 5-UTR-C did not
confer any particular trait to the mRNA molecule.
Identification of Prrxl1 Alternative Promoter Regions and
Evolutionarily Conserved Regulatory Elements—The existence
of TSSs specific to each Prrxl 5-UTR suggested that Prrxl1
expression is controlled by a mechanism of alternative pro-
moter usage. To identify these promoter regions and further
dissect the mechanisms of Prrxl1 regulation, we selected a
region of 1351 bp (1401/50) upstream of the Prrxl1 trans-
lation initiation site (1) based on the high degree of conserva-
tion observed in a genomic alignment of homologous region
in various species (human, chick, Xenopus tropicalis, and
zebrafish) (Fig. 2). This sequence (namedREG-1) was amplified
and cloned into the promoter-less pGL3-basic vector. Upon
transient transfection intomouseDRGprimary cell culture and
neuronal derived ND7/23 cells, the luciferase reporter gene
expression was activated indicating the presence of promoter
activity in the cloned region (Fig. 2). We then evaluated the
luciferase activity of shorter overlapping sequences (named
REG-2 to REG-16) in ND7/23 cells. When the entire fragment
was divided in two (REG-2 and REG-11), we verified that both
sequences were able to drive the transcription of the luciferase
gene. Because we used a promoter-less vector, this result indi-
cated that each fragment harbored at least one promoter. The
reduction of the most distal fragment (REG-2) from its 5 end
(REG-3 to REG-7) led to the identification of a minimum
sequence displaying transcriptional activity (REG-7, 772/
584). This sequence is adjacent to 5-UTR-A TSS and, there-
fore, was considered to be a promoter region. The same analysis
was performed for the fragment most proximal to the Prrxl1
start codon (REG-11), and two minimal fragments eliciting
luciferase activity (REG-13, 622/-481 and REG-14, 157/
50), located in the vicinity of the TSS of 5-UTR-B and
5-UTR-C, were considered as promoter regions. By this anal-
ysis, we identified three alternative promoters, named P1 (85/
157), P2 (485/604), and P3 (622/772) that likely con-
trol, respectively, the transcription of Prrxl1 5-UTR-C,
5-UTR-B, and 5-UTR-A variants.
Some fragments, even though containing promoter regions,
did not display any transcriptional activity (REG-6 and REG-9)
(Fig. 2). When these fragments were shortened (REG-7 and
REG-10), the luciferase activity increased to values closer to
fragments of similar size, which is suggestive of the existence, in
the region encompassing nucleotides811/772, of a regula-
tory element (termed regulatory region A (RRA)) with the
capacity to strongly suppress the transcription of the three
alternative promoters. Interestingly, by the 5 expansion
(REG-4 and REG-8) of the fragments containing the RRA, the
luciferase activity increased, again revealing the presence of a
new regulatory element in the region891/922 (termedReg-
ulatory Region B, RRB), with the potential to inhibit the action
of the repressivemotif RRA and consequently to activate Prrxl1
transcription.
It is also important to note the presence of transcriptional
regulatory elements located in the sequence between 1401
and 958 bp. The abrogation of this region, which originates
REG-8 construct (958/50), resulted in a strong decrease
(about 75%) in the luciferase activity when compared with the
full sequence (REG-1). Given that the deletion of the region
between 1401 and 958 bp did not significantly alter the
reporter activity of fragments containing P3 as sole promoter
(compare the activity of REG-2 with REG-3 and REG-4 in Fig.
2), we concluded that these elements are required for transcrip-
tion driven by promoters P1 and P2 rather than for the P3 pro-
moter activity.
Because Prrxl1 expression has only been detected in neuro-
nal tissues, namely all sensory ganglia and second order relay
sensory neurons (6), we found it pertinent to investigate
whether the promoter regions here identified could also drive
transcription in non-neuronal cell models. Thus, we performed
similar luciferase reporter assays using HeLa and HEK293 cells
and compared the results with those obtained for the ND7/23
cells (Fig. 3A). The longer sequence in analysis (REG-1) exhib-
ited the capacity to drive the luciferase transcription 10 (HeLa)
to 15 (HEK293) times lower than when transcription was pro-
moted in the neuronal-derived cells ND7/23 (Fig. 3A). An
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individual analysis of each promoter and its correspondent
luciferase activity demonstrated a neuron-specific activity for
promoters P1 (REG-14) and P3 (REG-7), as no relevant activity
in theHeLa andHEK293 cells was detected. On the other hand,
promoter P2 still led to some expression of the reporter enzyme
in non neuronal cells. We assume that the potential displayed
by promoter P2 to drive transcription in these cells is probably
responsible for the transcriptional activity exhibited by the
whole fragment (REG-1) due to the presence of constitutive
regulatory elements (see below).
Additionally, both regulatory regionsRRAandRRBappeared to
act exclusively in the neuronal model, as little differences in the
transcriptional activity of the fragments REG-8 (958/50) and
REG-9 (811/50) in comparison to REG-10 (751/50) were
observed in HeLa and HEK293 cells (Fig. 3A).
Interestingly, a careful search for chromatinmodifications in
the human REG-1 sequence (chr10:50,603,551–50,604,877;
GRCh37/hg19 assembly) using the UCSC Genome Browser
and ENCODE annotations (31) of ChIP-seq assays revealed tri-
methylation in the lysine 4 of the histone H3 (H3K4me3) in all
the three promoter regions (Fig. 3B). This is a chromatin signa-
ture of promoters actively transcribing protein-coding genes
(32, 33) and was detected in human embryonic stem cells (H7/
H1-hESC) and in different types of neuronal cells, such as a
neuroblastoma cell line (SK-N-SH) and neurons derived from
embryonic stem cells (H1-neurons) but not in HeLa cells (Fig.
3B). Moreover, binding events for RNA Polymerase II, TBP,
and the enhancer-associated protein P300 (34, 35) are also
detected in the Prrxl1 promoter regions in H1-neurons,
H1-hESC, and SK-N-SH cells but not in HeLa cells. Note that
FIGURE 2. Identification of regulatory cis-elements involved in the modulation of Prrxl1 transcription. Genomic alignment using the UCSC Genome
Browserof the1401-bp sequenceupstreamofPrrxl1 coding region fromevolutionarily distant species (human, chick,X. tropicalisandzebrafish) is shown.Black
peaks correspond tomammal conservation. Luciferase reporter assays using the1401/50-bp regionwere performed inmouse E15.5 DRGprimary cultures
andND7/23 cells to test its transcriptional capacity. By successive deletion analysis from the longer region, three regions displaying promoter activity (termed
P1, P2, and P3) were identified aswell as two regulatory regions (A and B). Each promoter is located in the vicinity of the transcription start site of Prrxl1 5-UTR.
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the three-peak pattern observed with RNA Polymerase II and
P300 overlaps with the three alternative promoter regions (Fig.
3B). These data reinforce our previous observation that Prrxl1
promoters displayed neuron-specific activity.
The Promoter P3 Displays Neuron-specific Activity—Nucleo-
tide alignment of Prrxl1 alternative promoter sequences from
different species revealed that the region comprising promoter
P3 presents a high degree of conservation, from zebrafish to
human,whereas promoters P1 andP2 appeared to be specific to
mammals (Fig. 4). We screened these sequences to identify
conserved DNA binding elements for transcription factors
using the bioinformatics prediction tool MatInspector from
Genomatix. Some putative motifs known to be important for
transcriptional regulation during embryonic developmentwere
identified.
Promoter P1 has no evident conserved motifs, whereas pro-
moter P2 contains a GC box element (Fig. 4), known to be a
binding site for Sp1, Sp3, and Sp4 transcription factors (36).
CpG islands are elements often associated with the transcrip-
tion of genes whose expression is ubiquitous and feature50%
FIGURE 3. Dependence on neuronal context for the transcriptional activity of Prrxl1 alternative promoters. A, the luciferase activity induced by some
selected fragments was compared in ND7/23 and the non-neuronal HeLa and HEK293 cells. P1 and P3 only promote significant transcription in neuronal-
derived cells, whereas P2 exhibits activity in the three cell lines. The repressive or activator transcriptional effect induced by the regulatory elements A and B
inND7/23 cells was no longer observed inHeLa andHEK293 cells. B, the presence of binding peaks of H3K4me3, RNAPolymerase II, P300, and TBP on the Prrxl1
promoters was specifically detected in neuronal cells, using the UCSC genome Browser and ENCODE annotations of ChIP-seq assays.
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of vertebrate regulatory sequences (37). The presence of this
GC-box may explain the activity displayed by the promoter P2
in HeLa cells (Fig. 3A). Moreover, a conserved binding site for
the activator protein 2 family was also predicted on the P2 pro-
moter (Fig. 4). Activator protein 2 transcription factors are
general regulators of vertebrate development, controlling the
balance between proliferation and differentiation during
embryogenesis (38, 39).
Analysis of the P3 sequence highlighted a putative TATA
motif, a conserved element of some basal promoters (Fig. 4).
To test if this sequence could bind a TBP, the binding of a
recombinant TBP to an oligonucleotide spanning the P3
TATAmotif present in the promoter P3 was tested by EMSA
(Fig. 5A). A gel shift, which was impaired by the use of com-
petitor oligonucleotides, was observed, demonstrating the
specificity of the binding to this region (Fig. 5A). The incu-
bation with an antibody directed to TBP resulted in a super-
shift (arrow in Fig. 5A), strongly indicating that P3 is a TATA
box-containing promoter. The in vivo association of the TBP
to the TATA motif of the P3 sequence was tested in mouse
embryonic spinal cord by performing ChIP assays combined
with real-time PCR (Fig. 5B). In these experiments a clear
enrichment in the binding of the TBP was observed in the P3
region comprising the TATA motif compared with the
FIGURE 4.Nucleotide alignment of the regulatory regionsA andB and the Prrxl1 alternative promoters. The nucleotide alignmentwas performed using
the UCSC Genome Browser and sequences from several mammals, chick, and zebrafish. The boxes that delimit the regulatory regions A and B are depicted. P3
is themost conservedpromoter and contains binding sites for the TFIID complex (TATAbox), bHLH (Ebox), andhomeodomain transcription factors (HD). P2 and
P1 are only present in mammals. P2 contains putative motifs for the binding of SP1-like family transcription factors (GC box) and for the activation protein 2
(AP2). The TSSs of each 5-UTR are also represented. TSS1 corresponds to 5-UTR-C, TSS2 to 5-UTR-B, and TSS3 to 5-UTR-A. Binding siteswere predicted by the
bioinformatics toolMatInspector (Genomatix).Black peaks representmammal conservation. Thegray boxhighlights thehuman sequenceused toproduce the
zebrafish transgenic line (see Fig. 6). Not to scale.
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downstream site (Fig. 5B, compare position737 to 3247)
and the control ChIP (mock).
Moreover, to evaluate the importance of the TATA box in
the transcriptional activity displayed by the fragment REG-1 in
the ND7/23 cells, we compared the luciferase activity of this
fragment with a fragment containing a mutated TATA motif
(Fig. 5C). This mutation resulted in a 3-fold decrease of lucifer-
ase expression, indicating that this element is required for
correct transcription. The remaining luciferase expression
observed for the fragment REG-1/TATAmut is probably due to
the activity of the alternative promoters P1 and P2, which was
unaltered.
Taking into account that the P3 sequence is well conserved
among species, we used the zebrafishmodel to test the potential
of this TATA promoter to drive transcription in vivo. One- to
two-cell- stage embryos were injected with a vector containing
the enhanced-GFP (eGFP) reporter gene under the control of
the P3 minimum region combined with a zebrafish iroquois
enhancer that could direct the expression of eGFP to the mid-
brain (24). Twenty-four hours post fertilization (hpf), eGFPwas
already observed in the midbrain of the embryos (Fig. 5D), an
expression that lasted at least until 72 hpf. This result indicated
that the P3 region exhibits promoter activity in vivo in this
transgenic zebrafish assay.
Adjacent to the TATA motif, the P3 region contains evolu-
tionarily conserved motifs potentially bound by bHLH (Ebox
motif) andhomeodomain (HDmotif) transcription factors (Fig.
4). Transcription factors belonging to these families play
important roles in the determination of neuronal fates from
undifferentiated progenitor cells (for review, see Refs. 5 and 40).
To evaluate their functional relevance, a region of 172 bp con-
taining these sites but excluding the TATAmotif was cloned in
a Tol2 vector, specifically designed to analyze cis-regulatory
elements in zebrafish (23) and carrying the eGFP reporter gene
FIGURE 5. Validation of P3 as a TATA-containing promoter. A, electrophoretic mobility shift assay using recombinant TBP and a fluorescent probe (TATA
DY680) corresponding to a region of P3 with the TATA boxmotif. A shift, corresponding to a complex formed between TBP and the probe, was detected, and
decreases of intensitywhendifferent amounts (2.5 and5) of non-labeled competitorweremixed. The supershift (arrow) represents thebindingof anti-TBP
to the protein-DNA complex. B, chromatin immunoprecipitation-quantitative PCR assays with (anti-TBP) or without (mock) an anti-TBP antibody were per-
formed using dorsal spinal cord chromatins from E14.5 mouse embryos followed by quantitative PCR using primers targeting P3 region (Prrxl1737) and a
downstream region (Prrxl1 3247). Enrichment is observed in the region where the TATA box is present (737). A region corresponding to Prrxl1 intron was
usedas control (3247).Mock represents the conditionwithout antibody.C, the evaluationof the functional importanceof theTATAbox for the transcriptional
potential of the fragment REG-1 was assessed by luciferase reporter assays in ND7/23 cells, comparing the REG-1 fragment with a sequence containing a
mutated TATA motif (REG-1/TATA mut). D, to evaluate the ability of the P3 core promoter to activate transcription in zebrafish, a region encompassing
nucleotides 584/751 bp was cloned upstream to an Irx (Iroquois) enhancer, which drives expression to the zebrafish midbrain (white arrowheads). The
vector was injected in zebrafish embryos at one-cell stage, and 48 hpf GFP signal was recorded.
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under the control of the gata2aminimal promoter (Fig. 6). This
vector was used to generate a zebrafish stable transgenic line.
eGFP signal was recorded in F1 embryos at different develop-
mental ages and compared with endogenous expression of
drgx, the Prrxl1 zebrafish homologue. The expression of drgx
was previously reported (41) as restricted to dorsal spinal cord,
DRG, and, in the developing brain, to sensory neuron popula-
tions of the midbrain and hindbrain, cranial sensory ganglia,
and the habenula. From 48 hpf, a strong eGFP signal was
detected in the developing hindbrain and cranial ganglia (Fig. 6,
B and F) in a pattern that only partially overlaps the expression
of endogenous drgx, as revealed by in situ hybridization (Fig. 6,
A andE). Indeed, eGFP expressionwas prematurely observed in
a posterior region of the hindbrain (marked by an arrowhead in
Fig. 6,B and F) that only expresses drgx later at 72 hpf (compare
the arrowheads in Fig. 6,C andG, with the arrowheads in Fig. 6,
B and F). Due to the very small length of this fragment (172 bp),
it is conceivable that repressive elements may be missing.
Expression of eGFP in cranial ganglia displayed a spatiotempo-
ral pattern that perfectly matched with drgx staining (figure
6E-H). At 72hpf, a decrease in the eGFP staining was observed
(compare Fig. 6,D andH, with Fig. 6, panels C andG). Albeit the
expression of drgx in DRG and spinal cord is well reported in
zebrafish (41), the 172-bp sequence does not drive eGFP tran-
scription to these tissues (data not shown). Together, these
experiments pointed out that the region of 172 bp containing
the conserved Ebox and HD elements was sufficient to drive
expression of the reporter gene in drgx-expressing neurons.
Phox2b Controls Prrxl1 Expression by Binding the HD Motif
in P3 Promoter—To unravel the trans-acting factors that may
be responsible for the modulation of Prrxl1 transcription via
Ebox orHDelement, we tested the overexpression effect of a set
of transcription factors previously implicated in the control of
Prrxl1 expression, as described in diverse epistatic studies
employing mutant mice. In Tlx3 and Lmx1b null mutant mice,
Prrxl1 expression is affected in the spinal cord but not in the
DRG (42, 43), whereas studies performed with DRG of islet1
inducible conditional knock-out mice suggested that Prrxl1
expression is regulated by islet1 only at an early stage of neuro-
genesis (44). Moreover, Prrxl1 is activated by Brn3a in the DRG
and trigeminal ganglion (45) and repressed by Phox2b in the
facial, glossopharyngeal, and vagal cranial ganglia (7). Mash1
and Neurogenin1 (Ngn1) are proneuronal genes implicated in
the specification of progenitors cells from which Prrxl1-ex-
pressing neurons arise either in the DRG or the neural tube (3,
46–48). Ngn1 andMash1 belong to the bHLH transcription fac-
tor family and bind the Ebox consensus motif CANNTG (49),
whereas the remaining proteins belong to homeodomain family
and recognize the HD bipartite element TAATNNNATTA (50,
51). Thus, we assessed the expression of luciferase under the
control of the REG-1 fragment in ND7/23 cells overexpressing
Brn3a, Tlx3, Phox2b, Islet1,Ngn1, Lmx1b, andMash1 (Fig. 7A).
Three transcription factors strongly induced the transcrip-
tional activity of the fragment REG-1. Those were Brn3a, Tlx3,
and Phox2b. As homeodomain proteins, they are candidates to
bind theHDelement present in the P3 promoter. Therefore, we
evaluated by luciferase reporter assays the effect of the overex-
pression of these transcription factors on the REG-1 construct
containing the mutated HD motif compared with wild-type
REG-1 (Fig. 7B). Tlx3 and Brn3a overexpression displayed the
same luciferase activity in both constructs, whereas the induc-
tion of Phox2b decreased about 50% when the HD motif is
mutated. To ascertain if Phox2b binds directly to the HD ele-
ment present in Prrxl1 P3 promoter, EMSA and ChIP-PCR
were performed (Fig. 7, C and D). By EMSA, a DNA-protein
shift was detected after the incubation of an oligonucleotide
comprising the HD motif sequence and nuclear protein
extracts from ND7/23 cells overexpressing Phox2b. On the
FIGURE 6. Expression patterns of endogenous drgx and eGFP in the head region of a P3 promoter-eGFP zebrafish stable line. A, C, E, and G, analysis of
endogenous drgx expression by in situ hybridization. drgx expression is detected in embryos at 48 hpf in the anterior region of the hindbrain (hb), in the
tegmentum (teg) (see dorsal view (A) and lateral view (E)), and in cranial ganglia (cg) (see E). At 72 hpf, drgx expression ismorewidespread in the hindbrain, and
it stillmaintains its expression in the cranial ganglions and in the tegmentum (see dorsal view (C) and lateral view (G)). B,D, F, andH, analysis of eGFP expression
in transgenic zebrafish embryos. eGFP expression is regulated by a module that encloses the gata2minimal promoter and a region of the Prrxl1 P3 promoter
that contains the Ebox andHD elements, excluding the TATAmotif (see the scheme). In 48 hpf embryos, eGFP expression is distinguished in the hindbrain and
in cranial ganglia (see dorsal view (B), lateral view (F)). The arrowhead indicates a region where eGFP is apparently activated prematurely in the transgenic
embryos at 48 hpf (B and F) but whose drgx expression is only detected at 72 hpf (C and G). Although eGFP expression is reduced at 72 hpf, it is still detected
in a small region of the anterior hindbrain and in the cranial ganglia (see dorsal view (D) and lateral view (H)).
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contrary, overexpression of Tlx3 or Brn3a only led to a weak
basal shift in the gel, which is also observed in extracts contain-
ing Phox2b overexpressed (marked by an arrowhead in Fig. 7C).
We assume that this interaction represents a binding with
another homeodomain protein that remains to be identified.
The binding of Phox2b on Prrxl1 promoter was further vali-
dated by ChIP-PCR assays (Fig. 7D). A chromatin enrichment
(relative to the no antibody control, mock) was only observed
with primers that amplified the region comprising the HD ele-
ment (Fig. 7D, position737).
Co-expression of Phox2b and Prrxl1 or its zebrafish ortho-
logue, drgx, was only reported in some sensory ganglia, namely
in the facial, glossopharyngeal, and vagal cranial ganglia, and
their target relay neurons in the hindbrain (6, 7). As Phox2b is
not detected in the ND7/23 cell line, we performed the same
analysis using non-differentiated and differentiated PC12 cells,
which endogenously expressed Phox2b and Prrxl1 (52). Again,
overexpression of Phox2b increased the luciferase activity of
REG-1 fragment, which is impaired by mutating the HD motif
(Fig. 7E).
To better investigate the regulation of Prrxl1 expression by
Phox2b in vivo, we used a validated specific antisense MO to
interfere with the translation of zebrafish Phox2b protein.
According to what was previously reported by Elworthy et al.
(53), our zebrafish Phox2b morphants also presented scarce
Hu-positive cells in the hindgut at 5 dpf (53%, 8 in 15 embryos).
We injected Phox2b MO in the transgenic zebrafish line
described above (Fig. 6), which contains eGFP under the con-
trol of the 172-bp sequence comprising the Phox2b binding
element (HD motif). A decrease in the eGFP expression was
observed (Fig. 7F), supporting our hypothesis that Phox2b
binds to the HD element present in the P3 promoter region of
Prrxl1 and is required for this promoter activity.
Phox2b Is Required for drgx Expression in the Glossopharyn-
geal, Vagal, and Facial Ganglia—To further address the role of
Phox2b in the control of drgx expression, we injected Phox2b
MO in wild-type zebrafish embryos at one- to two-cell stage.
Expression analysis of drgx by in situ hybridization showed that
in 48 hpfmorphant animals, drgx is still maintained in the hind-
brain, in the tegmentum, and in the trigeminal ganglia (Fig. 8,
FIGURE 7. Phox2b modulates Prrxl1 transcription by binding to the HD element in the P3 promoter. A, the effect on REG-1 transcriptional activity by
overexpressing the bHLH transcription factors Mash1 and Ngn1 and the homeodomain proteins Lmx1b, Islet1, Phox2b, Tlx3, and Brn3a in ND7/23 cells was
assessed by luciferase reporter assays. The immunoblot confirms the protein expression and corresponds to one representative experiment. B, luciferase
activity induced by REG-1 and REG-1/HDmut wasmeasured in ND7/23 cells overexpressing Tlx3, Brn3a, and Phox2b or transfected with an empty pcDNA3.3.
C, electrophoretic mobility shift assay using nuclear extracts fromND7/23 cells overexpressing Brn3a, Tlx3, or Phox2b or transfectedwith an empty pcDNA3.3
and a fluorescent probe (HD DY680) that comprises the HD motif present in the P3 promoter. The shift (arrow) is only observed in ND7/23 cells that overex-
pressed Phox2b. The arrowhead indicates a basal shift detected in all samples.D, chromatin immunoprecipitation assays with (anti-Phox2b) or without (mock)
an anti-Phox2b antibodywere performed using dorsalmedulla oblongata chromatins from E14.5mouse embryos followed by quantitative PCR using primers
targeting regions, which comprises the HD motif (Prrxl1737) and an upstream control sequence (Prrxl13568). An enrichment was only observed in the
regionwhere theHDelementwaspresent (737). E, luciferase activity inducedbyREG-1 andREG-1/HDmutwasmeasured inND7/23, PC12, anddifferentiated
PC12 cells overexpressing Phox2b. F, analysis of eGFP expression in transgenic zebrafish embryos at 72 hpf, containing the module that comprises the
Phox2b-binding site (HDmotif) present in the P3 promoter. Expression of eGFP was reduced in Phox2bMO-injected embryos when compared with controls.
The fluorescence acquisition settings were exactly the same in both images.
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compare drgx expression in control with Phox2b MO). Nev-
ertheless, in 44% of embryos, drgx expression is much weaker
or absent in the glossopharyngeal, vagal, and facial ganglia
(Fig. 8), suggesting that, as predicted by in vitro assays,
Phox2b is required for the transcriptional control of drgx.
To discard the hypothesis that the absence ofdrgx expression
was due to a failure in the development of these ganglia induced
by Phox2b knockdown, in situ hybridizations were performed
using a tlx3b probe. Tlx3 expression has been shown to exten-
sively overlap with Prrxl1 (10, 42) and thus was used here as a
reliable marker of neuronal differentiation. As expected, tlx3b
expression is maintained in Phox2b morphants (Fig. 8, Phox2b
MO tlx3b).
DISCUSSION
Prrxl1 is a transcription factor with an important role in the
establishment and maintenance of the nociceptive DRG-spinal
cord neuronal circuit. The function of Prrxl1 in this process has
been characterized in detail, but the molecular determinants
causing its activation or repression are not yet understood. To
shed some light on the molecular mechanisms regulating
Prrxl1 gene expression, we isolated and characterized the alter-
native promoters that control the expression of three distinct
Prrxl1 5-UTR variants, named 5-UTR-A, 5-UTR-B, and
5-UTR-C. These variants are originated from different exon 1
during Prrxl1 splicing and do not have any consequence in
the protein reading frame as the AUG start codon is present in
exon 2.
The alternative use of different exon 1 has been recognized as
another mechanism of control of gene expression. Within the
human and mouse genome, 3000 genes with multiple first
exons have been identified (54). 5-UTR-mediated regulation
were shown tomodulate gene expression throughmechanisms
that influence post transcriptional modification of RNA (sec-
ondary structure and mRNA stability) and translational effi-
ciency (18). This proved here to be also the case for Prrxl1
5-UTR variants. The 5-UTR-A displayed a neuron-specific
effect, increasing both the rate of Prrxl1 protein translation and
the stability of the mRNAmolecule. This observation implies a
contribution of neuronal specific RNA-binding proteins. Tak-
ing into account that Prrxl1 has an important role in the devel-
opment of the neuronal circuit connecting the DRG to the spi-
nal dorsal horn (8, 9), possible candidates are Hu RNA-binding
proteins (human homologues ofDrosophila ELAV), namely the
neuronal specific HuC and HuD isoforms, which are long used
as markers of neuronal differentiation. Overexpression of HuC
or HuD in PC12 cells increased the rate of neuronal differenti-
ation, whereas down-regulation resulted in an impairment of
neurite growth (55, 56). Likewise, a decrease in neuronal differ-
entiationwas observed inHuDnullmutantmice (57). Although
HuC/Dproteins are strong candidates tomodulate the neuron-
specific activity of Prrxl1 5-UTR-A, their involvement remains
to be demonstrated.
On the contrary, the 5-UTR-B reduced mRNA half-life and
suppressed mRNA translation, resulting in a decrease in the
luciferase expression both in the neuronal-derivedND7/23 and
HeLa cells. This was due to the presence of an AUG in the
5-UTR-B, as shown by luciferase reporter gene assays and site-
directed mutagenesis. This AUG is used as an alternative start
codon, modifying, therefore, the protein reading frame. AUG
codons upstream of themain open reading frame are present in
10% of all mRNAs (58). Although the functional impact of
this mechanism has not been investigated in detail, a recent
study onmale-specific lethal-2mRNA suggested an important
role in negative translational control by increasing initiation of
scanning ribosomes at the upstream open reading frame and
blocking downstream translation (58). The cis-regulatory
upstreamORF present in the Prrxl1 5UTR-B exerts a negative
influence on translational efficacy, as seen in Fig. 1C, and is
probably responsible for controlling the amount of Prrxl1 pro-
tein during early neurogenesis, the stage where 5-UTR-B is
most expressed.
By studying deletion derivatives of the Prrxl1 5-flanking
region, we demonstrated that transcription of each Prrxl1
5-UTR variants is controlled by specific promoters. The here-
named promoter P1, P2, and P3 controlled, respectively, the
expression of 5-UTR-C, 5-UTR-B, and 5-UTR-A. Recent
genome wide analyses indicated that alternative promoter
usage is a common event that occurs at least with the same
order of frequency as alternative splicing, affecting about 52%of
human genes (37). On average, there are 3.1 alternative pro-
moters per gene, with the composition of one CpG-island-con-
taining promoter per 2.6 CpG-less promoters.Moreover, it was
demonstrated that genes that undergo complex transcriptional
regulation often include at least one CpG island-containing
promoter, expressed ubiquitously, and are accompanied by
other promoters used for tissue-specific or signal-dependent
expression (37). Our results on the Prrxl1 promoters are in
accordancewith these observations. Indeed, aGC-rich region is
contained within promoter P2, whereas P3 is a TATA pro-
moter. P2 displayed activity in all cell lines tested, whereas P3
and P1 were regulated depending on the cellular context being
only active in neurons (for a summary of these findings see the
model in Fig. 9).
Among the threePrrxl1 alternative promoters, P3 is themost
conserved and displays in vivo activity in the zebrafish. Reverse
FIGURE 8.Phox2b is required for the expression ofdrgx in the glossopha-
ryngeal, vagal, and facial ganglia of zebrafish embryos. Analysis of the
tlx3b and drgx expression by in situ hybridization in control or Phox2bMO-in-
jectedembryos is shown. Theupperpanels showthecontrol embryos, and the
lower panels show representative images of morphant embryos. tlx3b and
drgx expression aremaintained in the hindbrain and trigeminal ganglion (tg)
of both control and Phox2b MO-injected animals. Expression of drgx in the
facial (f), glossopharyngeal (g), and vagal (v) ganglia is greatly reduced in
Phox2b MO-injected animals, whereas tlx3b expression was still observed in
all these ganglia.
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transcriptase-PCR experiments also showed that the P3-de-
rived transcript, Prrxl1 5-UTR-A, is more abundant than the
other two variants. These two observations led us to conclude
that promoter P3 may play a more prominent role in Prrxl1
transcriptional regulation and prompted us to focus our study
on transcriptional mechanisms modulating P3 activity. Core
promoters were shown to comprise DNA sequence motifs,
such as the TATA box, the Initiator (Inr), and the downstream
promoter element, located within30 to30 nucleotides rel-
ative to theTSS and tomediate the recognition and recruitment
of the RNA polymerase II to the transcriptional apparatus (59,
60). Prrxl1 P3 core promoter contained a TATA motif located
at 35 bp upstream of 5-UTR-A TSS. The functional validation
of this motif was attained by in vitro and in vivo evidence, such
as (i) TBP interacted with the TATA motif as detected by
EMSAandChIP usingmouse spinal cord samples, (ii)mutation
of the TATA motif greatly reduced promoter activity, and (iii)
P3 core promoter, which contains the TATA element, is suffi-
cient to drive the reporter gene expression in the zebrafish.
Located upstream of the P3 promoter, a highly conserved
region (1401/958) was identified as an important modula-
tor of Prrxl1 transcription. This region contains binding sites
for actively transcribing protein such as RNA Polymerase II,
TBP, andP300. By sequence deletion experiments, the presence
of still uncharacterized regulatory modules was predicted.
These elements appeared to be mainly associated with P1 and
P2 promoters and thereby to the transcription of 5-UTR-B and
5-UTR-C. Because these Prrxl1 mRNA variants are enriched
in early-born neurons of the developing spinal cord, we hypoth-
esize that the modules included in the1401/958 bp region
may be responsible for enhancing temporal-specific transcrip-
tion controlled by promoters P1 and/or P2 promoters.
We also defined two neuron-specific elements, RRA (811/
772) andRRB (891/922), which exhibit the opposite effect
on Prrxl1 transcription. RRA has the potential to strongly sup-
press the transcription of the three alternative promoters,
whereas RRB counteracts the action of the RRA repressive
motif and consequently induces Prrxl1 transcription (see the
model in Fig. 9). Such tight regulation could be understood as a
way to modulate Prrxl1 expression in different neuronal types,
namely in glutamatergic (Prrxl1-positive) over GABAergic
(Prrxl1-negative) neurons during the developing spinal cord.
Because these two neuronal populations derived from the same
progenitor domain and aremutually exclusive,molecular inter-
repression between inhibitory and excitatory interneurons has
been suggested. For instance, Tlx3 acts as an inhibitor of Lbx1
expression inducing the glutamatergic transmitter phenotype
(61), whereas Ptf1a represses Tlx3 specifying a GABAergic cell
FIGURE 9. Schematic representation of the regulatory elements that control the expression of Prrxl1 5-UTR variants. Promoter regions and other
regulatory elements were identified upstream of Prrxl1 translation start site (1). Transcription of the three Prrxl1 mRNA variants 5-UTR-C, 5-UTR-B, and
5-UTR-A is controlled by distinct promoters, termed P1, P2, and P3, respectively. 5-UTR-A is the most stable Prrxl1 transcript and is enriched at E14.5 spinal
cord, a developmental age associated with late neurogenesis. Located between958 and772 bp, two preponderant elements were identified: RRA is able
to totally suppress the transcriptional activity regulated by the three promoters, and RRB inhibits the repressive effect of RRA resulting in an increase of
transcription. In addition, the Ebox andHDmotifs located upstreamof the TATAboxdrive the transcription of Prrxl1 to hindbrain and cranial ganglia. Although
the bHLH transcription factor that binds the Eboxmotif remains to be identified, the homeodomain protein Phox2b binds the HD element and is required for
Prrxl1 expression in visceral cranial ganglia. uAUG, AUG codons upstream.
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fate (62). A similarmechanism could be envisaged for Prrxl1. In
GABAergic neurons, Prrxl1 expression could be prevented by a
specific transcription factor acting on the RRA element. This
repressive effect could be suppressed in glutamatergic neurons
through the RRB element. It would be interesting to assess if
one possible RRB binding candidate could be Tlx3 as this tran-
scription factor induces Prrxl1 promoter activity (Fig. 7A) and
highly co-localizes with Prrxl1 (10).
Furthermore, the 172-bp 5 region adjacent to the P3 core
promoter was sufficient to drive specific neuronal activity in
zebrafish. GFP expression under the control of putative regula-
tory elements present in this 172-bp region was only observed
in the area in which the transcript of the zebrafish Prrxl1 orto-
logue, drgx, is detected. Such specificity suggested that impor-
tant cis-regulatory modules are present in this region, and fur-
ther analysis of this sequence revealed the presence of a highly
conserved putative binding site for homeodomain transcrip-
tion factors, proteins that are expected to control the expres-
sion of Prrxl1 as a function of developmental age and neuronal
context. Among the tested candidates, Tlx3, Brn3a, andPhox2b
induced Prrxl1 promoter activity, but only Phox2b was able to
bind to this HD motif. Co-expression of Phox2b and Prrxl1 or
its zebrafish ortologue, drgx, was only detected in the visceral
sensory pathway, namely in the facial, glossopharyngeal, and
vagal cranial ganglia and their target relay neurons in the hind-
brain (6, 7, 63).We, therefore, presume that the P3 activity
observed in the transgenic line (Fig. 6) may be controlled, at
least to some extent, by Phox2b. This positive regulation is fur-
ther supported by silencing experiments with Phox2b mor-
phants (Fig. 7F).
Nonetheless, in the mouse, visceral sensory neurons switch
to a somatic fate in the absence of Phox2b acquiring amolecular
profile similar to that of somatic sensory neurons at later devel-
opmental stages, with higher expression of Prrxl1 and Brn3a
(7). This increase in Prrxl1 expression was suggested to be
mediated by the increase of Brn3a, which, in turn, is directly
repressed by Phox2b (7). On the contrary, Prrxl1 expression in
the nuclear TS progenitor domains of the hindbrain is not
affected by Phox2b inactivation, suggesting that the repression
of Prrxl1 by Phox2b only occurs in the visceral sensory ganglia
(7). In accordance, Phox2b is not required for drgx expression
in the zebrafish hindbrain. However, contrary to the mouse,
Phox2b down-regulation induced a loss of drgx expression in
the facial, glossopharyngeal, and vagal cranial ganglia. Binding
of Phox2b on the HD motif increased Prrxl1 promoter activity
in ND7/23 and PC12 cells. Our data strongly suggest that
Phox2b has the potential to work as a direct Prrxl1 activator
(see model in Fig. 9).
AlthoughPhox2b is a determinant of visceral fate, itsmode of
action varies with neuronal types (64, 65) likely due to cell type-
specific combinations of transcription factor complexes. On
the other hand, Prrxl1 is transiently expressed at early stages
of the development of the facial-glossopharyngeal ganglion and
the distal part of the vagal ganglion, as observed inmice (7) and
zebrafish (41). During this particular developmental window,
co-expression of Prrxl1, Phox2b, Tlx3, and Islet1 is observed
(7). Recently, studies performed in Islet1 inducible conditional
knock-out mice (44) suggested that Prrxl1 expression in the
DRG is regulated by Islet1 only at an early stage of neurogenesis.
Thus, it is conceivable that Phox2b, in combination with Islet1,
binds to the HDmotif on the P3 Prrxl1 alternative promoter to
activate Prrxl1 expression at early stages of sensory ganglia
development, whereas later (fromE13.5 on), as part of a distinct
transcriptional machinery, Phox2b shuts down Prrxl1 expres-
sion likely through the repression of Brn3a.Understanding how
Brn3a acts on Prrxl1 promoters will add new insight on this
mechanism. The present data thus support that the P3 alterna-
tive promoter is involved in the ganglion specific action of
Prrxl1 (see the model in Fig. 9), which appear to be controlled
by Phox2b in the case of visceral sensory neurons.
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Brn3aThe proper establishment of the dorsal root ganglion/spinal cord nociceptive circuitry depends on a group of
homeodomain transcription factors that includes Prrxl1, Brn3a and Tlx3. By the use of epistatic analysis, it was
suggested that Tlx3 and Brn3a, which highly co-localize with Prrxl1 in these tissues, are required to maintain
Prrxl1 expression. Here, we report two Tlx3-dependent transcriptional mechanisms acting on Prrxl1 alternative
promoters, referred to as P3 and P1/P2 promoters. We demonstrate that (i) Tlx3 induces the transcriptional
activity of the TATA-containing promoter P3 by directly binding to a bipartite DNAmotif and (ii) it synergistically
interacts with Prrxl1 by indirectly activating the Prrxl1 TATA-less promoters P1/P2 via the action of Brn3a. The
Tlx3 N-terminal domain 1–38 was shown to have a major role on the overall Tlx3 transcriptional activity and
the C-terminus domain (amino acids 256–291) to mediate the Tlx3 effect on promoters P1/P2. On the other
hand, the 76–111 domainwas shown to decrease Tlx3 activity on the TATA-promoter P3. In addition to its action
on Prrxl1 alternative promoters, Tlx3 proved to have the ability to induce Prrxl1 phosphorylation. The Tlx3
domain responsible for Prrxl1 hyperphosphorylation was mapped and encompasses amino acid residues 76 to
111. Altogether, our results suggest that Tlx3 uses distinct mechanisms to tightlymodulate Prrxl1 activity, either
by controlling its transcriptional levels or by increasing Prrxl1 phosphorylation state.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The establishment of the neuronal circuit connecting the dorsal root
ganglion (DRG) and the spinal dorsal horn constitutes the basis for the
transmission of sensory input from the periphery to the central nervous
system, to be ultimately processed at specified centers in the brain [1].
Various classes of sensory afferent fibers dwell in the DRG and synapse
with second-order neurons and interneurons in the dorsal spinal cord
[2–4]. The distinctive phenotypes of the various classes of DRG and
spinal sensory neurons are ascribed to the combinatorial expression of
a set of transcription factors [3,5,6]. One of these is the paired-like
homeodomain (HD) transcription factor Prrxl1 (mouse orthologue of
human DRGX). Prrxl1 null embryos display spatiotemporal defects in
the spinal gray matter penetration of afferent sensory fibers together
with defects in spinal dorsal horn morphogenesis [7,8]. Such earlyn; CIAP, calf intestinal alkaline
ain; pI, isoelectric point; TALE,
ia Experimental, Faculdade de
iro, Porto 4200-319, Portugal.developmental abnormalities are correlatedwith a significant reduction
in sensitivity to noxious stimuli [7]. Despite the recognized importance
of Prrxl1 in the establishment of the nociceptive circuitry, themolecular
mechanisms that specifically control Prrxl1 expression and function
along embryonic development remain largely unknown.
Recently, we defined multiple cis-regulatory modules that control
the spatiotemporal expression of Prrxl1 during the development of no-
ciceptive neurons. These include three alternative promoters (referred
to as P1, P2 and P3 promoters) implicated in the transcription of distinct
Prrxl1 5′-UTR variants,which confer distinctmRNA stability and transla-
tion efficiency to the Prrxl1 transcript. In addition,we showed that Prrxl1
promoter activity is induced by theHDproteins Tlx3 and Brn3a [9]. Both
Tlx3 and Brn3a co-express extensively with Prrxl1 [10–14]. Ablation of
Tlx3 gene affects Prrxl1 expression only at late stages of spinal cord de-
velopment (from E13.5 onwards) but not at the DRG [13]. When Tlx3
ablation is restricted to a subset of glutamatergic neurons that evolve
from Lbx1-positive cells, mice develop a phenotype that strongly
resembles that of Prrxl1 null mutants, with spinal cord abnormalities
and weak responses to pain-related stimuli [15]. The disruption of the
Brn3a gene results in impaired projection of DRG and trigeminal gangli-
on axons to their central target neurons and subsequent apoptosis
[16,17], abnormalities that are also observed in Prrxl1 null mutant
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a decreased expression of Prrxl1 in primary afferent neurons [18],
strongly suggesting that Brn3a holds a role in the control of Prrxl1 tran-
scription. Altogether, these observations not only imply that Tlx3 and
Brn3a control Prrxl1 expression, but also point to the use of distinct
tissue-specific genetic programs by each one.
In the present study, we shed some light on themechanisms under-
lying Brn3a and Tlx3 activity on Prrxl1 functioning. We provide evi-
dence that Tlx3 positively regulates Prrxl1 expression by modulating
Prrxl1 promoter activity and also induces Prrxl1 hyperphosphorylation.
At the transcription level, Tlx3 binds directly to Prrxl1 promoter P3 and
acts indirectly on promoters P1/P2 by forming a transcriptional complex
with Prrxl1, which activates Brn3a. Tlx3 functional domains involved
either in the dual transcriptional control of Prrxl1 or in the induction
of Prrxl1 phosphorylation were identified. Altogether, our data demon-
strate that Prrxl1 and Tlx3 are intimately related and share a genetic
pathway, which may be essential for the regulation of downstream
effectors responsible for the establishment of the nociceptive pheno-
type in the spinal cord.
2. Materials and methods
2.1. Animal care
NMRI mice were bred and housed at IBMC, Porto, animal facility
under temperature- and light-controlled conditions. The embryonic
day 0.5 (E0.5) was considered to be the midday of the vaginal plug.
The animals were euthanized (isoflurane anaesthesia followed by
cervical dislocation) and tissues were collected. Experiments were
carried out in compliance with the animal ethics guidelines at IBMC
and approved by the Portuguese Veterinary Ethics Committee.
2.2. Cell culture, plasmid transfection and luciferase reporter assays
ND7/23 and HeLa cells were maintained and grown in DMEM with
high glucose, supplementedwith GlutaMAX™ (Gibco), 10% fetal bovine
serum (Gibco) and 50 U/mL penicillin and streptomycin (Gibco). All
cells were kept at 37 °C and 5% CO2 gas phase. Transfection was
performed using Lipofectamine®2000 (Invitrogen), and 24 h later,
cells were harvested for posterior luciferase reporter assays. Transfected
cells from a 96-well plate format were resuspended in 50 μl of lysisTable 1
List of primers.
Forward primer (5′ → 3′)
Mapping of functional Tlx3 domains
Tlx3-FLAG GCCACCATGGAGGCGCCCGCCAGC
Tlx338–291-FLAG GCCACCATGCCCGACGGCGCCAGCTAC
Tlx376–291-FLAG GCCACCATGAGTGTCAACCTAAGCTTGGCCC
Tlx3111–291-FLAG GCCACCATGCCCTCGGTGCCCACGGTCTCC
Tlx3156–291-FLAG GCCACCATGCACCCCTACCAGAACCGGACGCC
Tlx31–256-FLAG GCCACCATGGAGGCGCCCGCCAGC
Tlx31–224-FLAG GCCACCATGGAGGCGCCCGCCAGC
Chromatin immunoprecipitation
RGMb ORF TGCCAACAGCCTACTCAATG
Prrxl1 (−3568) TTTAATGTCTCCCGCAGCTT
Prrxl1 (−737) TGCTGAGAAGTGACGGATTT
Prrxl1 (+3247) GAAGTCGGCAGGGTTTTCTA
Prrxl1 (+9787) ACTCCAGCACATTTTTGCAC
DNA pull-down assay
P3-prom/P3-promHD3mut CCGTAACGGGCTATTATCCTGG
P3-A GAGGGCTGGGGTTGGGGTG
P3-B ATAATCTCTTTTGGGTGGGG
P3-C CCTGATGTTTGCTGAGAAGTG
P3B-short ATAATCTCTTTTGGGTGGGG
P2/P1-prom CAGTCACTTCTCTGGTCCTG
Control ATGTTTTATTTCCACTGTCCbuffer (Promega) and the protein extract cleared by centrifugation.
Five microliters of the extract were mixed with the luciferase reagent
(Promega) and the signal measured using a luminometer reader
(Tecan). Transfection efficiency was normalized by assessing
β-galactosidase activity using ONPG (Sigma-Aldrich) as substrate.
2.3. Plasmids
Expression vectors previously constructed were pRSK-Brn3a (a gift
from Dr. Mengqing Xiang), pcDNA3.3-Tlx3 [9], pcDNA3.3-Prrxl1 [19],
pcDNA3.3-HA-Prrxl1 [19] and pCMVβ (Clontech). The sequences
used to clone Tlx3-FLAG or the truncated variants (Tlx338–291-FLAG,
Tlx376–291-FLAG, Tlx3111–291-FLAG, Tlx3156–291-FLAG, Tlx31–256-FLAG and
Tlx31–224-FLAG) into pCDNA3.3 were PCR amplified from pcDNA3.3-
Tlx3 with primers depicted in Table 1.
The following luciferase reporter constructs were previously used in
[9]: pGL3-REG-1, pGL3-P3-prom (former pGL3-REG-2), pGL3-P2/P1-
prom (former pGL3-REG-11), pGL3-P3-A (former pGL3-REG-4), pGL3-
P3-B (former pGL3-REG-5) and pGL3-P3-C (former pGL3-REG-6).
Site-directed mutagenesis of HD3 element was performed from
pGL3-P3-prom using the NZY Mutagenesis Kit (NZYTech). The primers
used were the following: 5′-GGAAATAATCAGATTAAGGCCAACCATGCG
TGAGATTATA-3′ and 5′-TATAATCTCACGCATGG TTGGCCTTAATCTGAT
TATTTCC-3′.
2.4. Small interfering RNA transfection
The appropriate siRNA sequence for Prrxl1was chosen from a set of
three RNAoligos (Invitrogen). A pre-designed siRNA oligo for Brn3awas
purchased from Ambion. ND7/23 cells were transfected with the RNA
oligos using the Lipofectamine®RNAiMAX (Invitrogen) and 48 h later
were co-transfected with the appropriate expression and reporter
vectors using Lipofectamine®2000 (Invitrogen). Cells were harvested
for luciferase assays on the next day. Scrambled sequences were used
as control siRNA.
2.5. Quantitative PCR
Following transfection of ND7/23 cells with the siRNA for Prrxl1 or
Brn3a, RNA was extracted using the GenElute™ mRNA Miniprep Kit
(Sigma-Aldrich). The first-strand cDNA synthesis was prepared atReverse primer (5′ → 3′)
TCATTTATCGTCATCGTCTTTGTAGTCTGCGGCCTGTCACACCAGAGAGGTGACAGCGG
Idem
Idem
Idem
Idem
TCATTTATCGTCATCGTCTTTGTAGTCTGCGGCCTGGATGGAATCGTTGAGGC
TCATTTATCGTCATCGTCTTTGTAGTCTGCGGCCTGCCGCCGCCACTTGGTC
GTGGAAGATGTGGGTCCATC
CACTTGATGTTCACCAGACTCA
TCACGCATAATTGGCCTTAAT
AGCCTTTCACACCTCTTTCC
TGTGGACCCTTCTACCCTTC
Biotin-CAGGACCAGAGAAGTGACTG
Idem
Idem
Idem
Biotin-GAATGTTTTTCCCTTTTTTT
Biotin-CTGGCAGACTTGTGCCTGTGC
Biotin-CTCTCTCTGTCTTCCTCCAT
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tase enzyme (Bioline) and 500 ng of oligo(dT)12–18 (Bioline). To assess
for potential contaminants, a control containing all reagents except the
reverse transcriptase enzyme was included for each sample. The levels
of mRNA expression were then quantified by PCR using a StepOnePlus
Real-Time PCR system (Applied Biosystems). For Prrxl1, a SYBR Green
chemistry for quantitative PCR (Maxima Master Mix, Fermentas) and
the following primers 5′-CCCATGTGGCATCTCTGAAAG-3′ and 5′-TCAT
ACACTCTTCTCTCCCTCGC-3′ were used. Normalization was performed
by amplification of mouse β-actin using the primers 5′-TCATGAAGTG
TGACGTTGACATCC-3′ and 5′-GTAAAACGCAGCTCAGTAACAGTC-3′.
For Brn3a, the quantitative PCR was performed using a Taqman®
Gene Expression Assay (Mm02343791_m1, Life Technologies) with a
Taqman®Fast AdvancedMasterMix (Life Technologies). Normalization
was performed using a Taqman® Gene Expression Assay for Hprt
(Mm00446968_m1).
2.6. DNA affinity pull-down assay
Nuclear proteins were extracted from ND7/23 cells transfected with
pCDNA3.3-Tlx3 using first a low salt lysis buffer (30 mM Tris-HCl
(pH 7.8), 20 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1% Triton X-100
and protease/phosphatase inhibitors cocktail (Sigma-Aldrich)). After
nuclear fractionation at 1000 × g for 10 min at 4 °C, proteins were
resuspended in 10 mM Tris-HCl (pH 7.5), 60 mM KCl, 200 mM NaCl,
10% glycerol, 5mMMgCl2 and 0.1% Triton X-100, cleared by centrifuga-
tion and incubated with biotinylated probes for one hour at room tem-
perature. Afterwards, the complexes were incubated with NanoLinK™
StreptavidinMagnetic Beads (Solulink) for two hours at room tempera-
ture. After washing and elution, samples were analysed by Western
blotting using rabbit anti-Tlx3 (sc-30185, Santa Cruz Biotechnology).
The DNA fragments used as probes were PCR-amplified from pGL3-
REG-1, pGL3-P3-prom/HD3mut and pCDNA3.3-Prrxl1 (for control
probe,which corresponds to a fragment amplified from the Prrxl1 coding
sequence) using biotinylated reverse primers (see Table 1).
2.7. Chromatin immunoprecipitation assays
Tlx3 chromatin immunoprecipitation (ChIP) assays using E14.5
mouse dorsal spinal cord tissuewere performed essentially as previously
described [9], with the following modifications: (i) a mixture of 0.5 μg
of each anti-Tlx3 antibodies (sc-23397 and sc-30185, Santa Cruz
Biotechnology) was used; (ii) immunoprecipitates were washed twice
withwash buffer I followed by twowasheswithwash buffer III. For quan-
titative PCR, sets of primers were used for assessing ChIP enrichment and
designed using Primer 3 software (http://biotools.umassmed.edu). The
primer sequences are listed in Table 1. Results are shown as the mean
of triplicates ± SD of at least two independent experiments.
2.8. Co-immunoprecipitation assays
ND7/23 cells transfected with pcDNA3.3-Tlx3-FLAG and pcDNA3.3-
HA-Prrxl1 or an empty pcDNA3.3 were lysed in 50 mM Tris (pH 7.4),
150 mM NaCl and 0.1% Triton X-100 with protease/phosphatase inhib-
itor cocktails (Sigma-Aldrich). One hundred micrograms of cell lysate
were immunoprecipitated using ANTI-FLAG® M2 magnetic beads
(Sigma-Aldrich) for twohours. The beadswerewashed and theproteins
were then eluted in 50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol,
100 mM DTT and 0.1% bromophenol blue and resolved by SDS-PAGE.
Primary antibodies used in the Western blotting were mouse anti-
FLAG M2 (Sigma-Aldrich) and rabbit anti-HA (Invitrogen).
2.9. Dephosphorylation assays
Extracts from ND7/23 cells transfected with pcDNA3.3-Prrxl1
and pcDNA3.3-Tlx3 or an empty pcDNA3.3 were homogenized indephosphorylation buffer [20] and incubated with calf intestinal
alkaline phosphatase (CIAP; Invitrogen) for 2 h at 37 °C. An inhibitor
(20 mM Na2HPO4) was added to a replicate reaction mix as control.
2.10. 2D-PAGE
ND7/23 cells transfected with pcDNA3.3-Tlx3 and pcDNA3.3-Prrxl1
were homogenized in 20 mM phosphate buffer (pH 8.0), 0.1%
Triton X-100, supplemented with phosphatase and protease inhibitors
and Benzonase nuclease (Novagen), sonicated and cleared by centrifu-
gation. Isoelectric focusing was performed on a Protean i12 Cell
(Bio-Rad) using 11 cm immobilized pH gradient strips pH 3–10 non-
linear (Bio-Rad) for 38,000 Vh and held at 750 V as previously described
[19]. Afterwards, SDS–polyacrylamide gels (12%) were run, and West-
ern blotting was performed with home-made rabbit anti-Prrxl1 anti-
body [10]. Blots were directly imaged using Chemidoc MP (Bio-Rad).
2.11. Statistical analysis
In the present study, all the data presented (except for ChIP
experiments; see above) were derived from at least three independent
experiments with three replicates. When necessary, a two-tailed
unpaired t-test was performed.
3. Results
3.1. Tlx3 and Prrxl1 synergistically act to activate Prrxl1 promoter activity
Recently, we studied the DNA region, referred to as REG-1 (Fig. 1A),
located immediately upstream of the Prrxl1 start codon (−1401/−50),
which encloses three alternative promoters (named P1, P2 and P3). Pro-
moter P3 gives rise to 5′UTR-A mRNA variant, which displays distinct
stability and translation efficiency compared to the 5′UTR-C and -B,
transcripts that originated from the activity of promoters P1 and P2,
respectively. Moreover, 5′UTR-A mRNA is expressed at late stages of
spinal cord neurogenesis, while 5′UTR-B and -C are mainly present at
early stages [9]. The HD proteins Tlx3 and Brn3a were shown in that
study to enhance the activity of Prrxl1 alternative promoters [9].
To better understand the regulatory mechanisms implicated in Tlx3
and Brn3a control of Prrxl1 expression, we performed gain- and loss-of-
function experiments in ND7/23 cells, a DRG-derived cell line previously
shown to be a suitable model for studying Prrxl1 [9,19]. Given that pro-
moters P1 and P2 sharemany features, we decided to analyse these DNA
regions as a single module. Tlx3 overexpression increased the transcrip-
tional capacity of Prrxl1 promoters tomore than 20-foldwhen compared
to mock conditions (control/Tlx3, p b 0.01; Fig. 1B). This effect was
enhanced 2 times (42-fold increase in the luciferase activity compared
to control values) by the overexpression of Prrxl1 itself. It is likely depen-
dent on other neuronal factors since no significant induction was ob-
served in HeLa cells (control/Tlx3, ns; Fig. 1B). Silencing endogenous
Prrxl1 expression reduced Tlx3 induction of luciferase activity by 3
times (siPrrxl1/Tlx3; Fig. 1C) in comparison with the control condition
(siControl/Tlx3; Fig. 1C). This result suggests that the Tlx3-inductive ef-
fect on Prrxl1 promoters is dependent on the synergistic action of endog-
enous Prrxl1. Thus, it is likely that the induction observed for Prrxl1/Tlx3
co-transfection, when compared to Tlx3 alone, would be superior, as the
latter is potentiated by endogenous Prrxl1.
This is quite surprising as the overexpression of Prrxl1 alone results
in the repression of the reporter enzyme (0.58-fold decrease, p b 0.01),
and implies that the increase in the activity of Tlx3 by Prrxl1 is due to
the combination of both transcription factors, rather than the sum of
their independent actions.
To dissect how Tlx3 alone or in combination with Prrxl1 acts upon
the Prrxl1 regulatory regions, we divided the entire region analysed
(REG-1) into two smaller fragments containing promoter P3 (P3-
prom) or promoters P1 and P2 (P1/P2-prom). We then analysed the
Fig. 1. Tlx3 usesmultiplemechanisms tomodulate Prrxl1 transcription. A. UCSC genomic alignment of evolutionarily distant species of a previously characterized sequence (referred to as
REG-1; [9]) positioned upstreamof the Prrxl1 translation start site. Blue peaks correspond to conservation inmammals. Bottom panel displays conservation across vertebrate species. This
sequence has been shown to comprise three promoters (P1, P2 and P3), which control the transcription of themRNAvariants 5′UTR-C, 5′UTR-B and 5′UTR-A, respectively [9]. B. Luciferase
reporter assays were performed in ND7/23 and HeLa cells using the pGL3 luciferase vector carrying the REG-1 sequence. The transcriptional activity of this sequence was assessed after
overexpression of Prrxl1 and Tlx3, alone or in combination, in both cell lines (ns, not significant). C. In similar reporter assays, the effect of Tlx3 overexpression upon the transcriptional
activity of the REG-1 sequence was tested after transfection with siRNA oligos for Prrxl1 (siPrrxl1), and compared to control conditions (Control; scrambled oligo). The Prrxl1 silencing
efficiency was assessed by quantitative PCR and is shown in the graph with gray bars. D. Luciferase reporter assays were performed using two different fragments originating from the
partition of REG-1 sequence. One of the fragments contains the promoter P3 (pGL3-P3-prom, −1401/−605) and the other contains the promoters P1/P2 (pGL3-P1/P2-prom,
−604/−50). The effect of Tlx3 and/or Prrxl1 overexpression upon the transcriptional activity of these fragments was assessed (ns, not significant). E. Schematic representation of the
distinct transcriptional mechanisms that control Prrxl1 gene expression. Working hypotheses are that Tlx3 acts in combination with Prrxl1 upon the promoters P1/P2 region and inde-
pendently of Prrxl1 upon promoter P3 region.
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tory regions in ND7/23 cells (Fig. 1D). When overexpressed alone,
Prrxl1 exerted its repressive action only on the DNA fragment that
contained the promoter P3 (p b 0.01, pGL3-P3-prom; Fig. 1D). No effect
was observed in the P1/P2-prom fragment (ns; Fig. 1D). Tlx3 overex-
pression caused an increase in the transcriptional activity of both
fragments, although with higher impact on P1/P2 (pGL3-P1/P2-prom;
42-fold increase, p b 0.01) than on P3 (P3-prom; 17-fold increase,
p b 0.01). Combined overexpression of Tlx3 and Prrxl1 resulted in a
70-fold increase in the activity of P1/P2 (pGL3-P1/P2-prom), confirming
the synergistic effect of both transcription factors at these promoters.
Similar to the P3, Tlx3/Prrxl1 overexpression led to a 13-fold increase
in transcriptional activity, which is the result of the isolated effects
provoked by Prrxl1 (0.6-fold) and Tlx3 (18-fold) overexpression
(Tlx3/Prrxl1/pGL3-P3-prom; Fig. 1D).
Up to this point, our results strongly indicated that Tlx3 induces
transcription from Prrxl1 promoters by two distinct mechanisms
(see model in Fig. 1E). Tlx3 (i) activates the TATA-containing promoter
P3, independently of Prrxl1 and (ii)works in combinationwith Prrxl1 to
enhance the activity of the promoters P1/P2.
3.2. Tlx3 action on Prrxl1 promoter P3 requires a bipartite regulatorymodule
To better understand how Tlx3 specifically acts on the Prrxl1 pro-
moter P3, we focused our study on the identification of cis-regulatoryelements important for this modulation. We performed successive se-
quence deletions of the P3-prom fragment (Fig. 2A) and measured the
capability of Tlx3 to enhance luciferase expression in each construct.
The transcriptional activity of P3 progressively increased with the suc-
cessive trimming of P3-prom fragment, reaching maximum activity
with P3-B (2.8-fold increase in comparison with P3-prom fragment,
p b 0.01). The data suggest the presence of important repressor motifs
located upstream of position −889 bp. The deletion of the region
encompassing nucleotides −889 to −809, which gave rise to P3-C
fragment, induced a strong decrease in activity (0.5-fold decrease in
comparison with P3-prom fragment, p b 0.01; Fig. 2B). We conclude
that this region contains important elements mainly responsible for
the modulation of Tlx3-induced promoter activity. The fact that the
P3-C fragment (−809 to−605) still responded to Tlx3 induction points
to the presence of additional enhancing motifs in this region.
Afterwards, we performed binding assays to investigate whether Tlx3
could directly bind these promoter regions. DNA pull-down experiments
were done using biotinylated DNA fragments similar to the ones previ-
ously examined (scheme in Fig. 2A). Equal amounts of each fragment
were incubated with protein extracts from ND7/23 cells overexpressing
Tlx3 and then submitted to a streptavidin-agarose pull-down procedure.
FollowingWestern blotting analysis of the precipitates, we observed that
Tlx3, as expected, did not bind the control region (a portion of the Prrxl1
coding sequence), nor the DNA fragment containing the P1/P2 promoters
(Fig. 2B), suggesting that Tlx3 induction on the P1/P2 alternative
Fig. 2. Tlx3 activates Prrxl1 P3 promoter by acting on a bipartite DNA element. A. Schematic representation of different fragments originating from successive deletions of the fragment
REG-1. B. DNA fragments derived from REG-1 sequence, depicted in A, were cloned into the pGL3 plasmid. These constructs were used to transfect ND7/23 cells and luciferase reporter
assays were performed with the cell lysates to evaluate the impact of Tlx3 on the transcriptional activity of each DNA fragment. To evaluate the Tlx3 binding capacity to these regions,
ND7/23 cells overexpressing Tlx3were incubatedwith biotinylatedDNAprobes corresponding to fragments P3-prom, P3-A, P3-B, P3-C, and P1/P2-prom. As a control, a region correspond-
ing to part of the Prrxl1 coding sequence was used. The samples were submitted to affinity pull-down assays and the protein eluates analysed byWestern blotting with an anti-Tlx3 an-
tibody. A region between −889/−809 bp is required for Tlx3 activity on P3 promoter. C. DNA pull-down assays were performed as described in B with biotinylated DNA probes
corresponding to fragments P3-B, P3-C and P3B-short. The Tlx3 action depends on a bipartite module. D. CLUSTALW nucleotide alignment of P3-B sequences from rat, mouse, human
and chicken. The stars represent conserved nucleotides. The boxes delimit the TATA-box and three putative binding sites for homeodomain transcription factors (HD1, HD2 and HD3).
The gray box highlights the “P3B-short” motif (−889/−809) used in DNA pull-down assays in C. E. Luciferase activity induced by the sequence P3-prom containing a mutated HD3
motif (P3-prom/HD3-mut) relative to P3-prom was measured in ND7/23 cells overexpressing Tlx3. The same DNA fragments were biotinylated and used in DNA pull-down assays
using ND7/23 cells overexpressing Tlx3. The eluates were analysed by Western blotting using an anti-Tlx3 antibody. The Tlx3 binding affinity to the P3-prom region decreases when
the HD3 motif is mutated. F. Chromatin immunoprecipitation assays with (anti-TLX3) or without (Mock) an anti-Tlx3 antibody were performed using dorsal spinal cord chromatins
from E14.5 mouse embryos, followed by quantitative PCR using primers targeting the P3 region (Prrxl1−737), an upstream region (Prrxl1−3568), two downstream regions (Prrxl1
+3274 and Prrxl1+9787) and a portion of the coding sequence of a non-related gene (CDS Rgmb). Strong enrichment of Tlx3 binding is observed in the regionwhere the HD3 is present
(−737). G. Schematic representation of the distinct transcriptionalmechanisms that control the Prrxl1 gene expression. Tlx3 positive effect on Prrxl1 promoter P3 depends on two distinct
modules: the HD3 motif and an element within the P3B-short region, which is the binding site of a still unknown transcription factor. The mechanisms that regulate the transcription
induced by Prrxl1/Tlx3 on promoters P1/P2 will be studied afterwards.
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that encompassed the promoter P3 (P3-prom, P3-A, P3-B and P3-C;
Fig. 2B) with a progressive increase in the binding affinity that correlates
to what was observed with transcriptional activity (Fig. 2B, graph). Like-
wise, although the band intensity decreased significantly when fragment
P3-B was trimmed to originate fragment P3-C, some degree of binding
was still observed. This raises the hypothesis that Tlx3-dependent induc-
tion requires two separate elements, one located in region−889/−809
and the other within region −809/−605, which is supported by the
fact that Tlx3 is also not able to strongly bind the DNA fragment
−889/−809 (P3B-short motif; Fig. 2C). In fact, when comparing the
Tlx3 binding affinity of the fragments P3-C and P3B-short with the entire
sequence P3-B, we observed that the band intensity for fragments P3B-
short and P3-C were similar, but significantly weaker than the band
intensity detected for P3-B (Fig. 2C).
By looking at the nucleotide sequence alignment of fragment P3-B
(−889 to −605), we only identified three conserved motifs that
could be binding sites for HD transcription factors (Fig. 2D; HD1, HD2
and HD3 boxes), including Tlx3. Recently, we showed that mutations
on the HD1 and HD2 motifs did not compromise Tlx3-induction on
Prrxl1 promoters [9], pointing to the remaining HD motif (HD3) as a
good candidate for Tlx3 binding. To test this hypothesis, we compared
the transcriptional activity displayed by the fragment P3-B in ND7/23
cells overexpressing Tlx3 with that of a fragment containing a mutated
HD3 motif (ATTA for ACCA; Fig. 2E). This mutation resulted in a two-
fold decrease of luciferase activity (p b 0.01), indicating that this ele-
ment is required for Tlx3-dependent induction. Likewise, a significant
decrease in the Tlx3 binding affinity was observed by DNA pull-down
assays using a P3-B biotinylated fragment harboring a mutation on
HD3 motif (Fig. 2E).
To further prove that Tlx3 is able to bind the DNA region containing
the HD3 motif in vivo, ChIP with anti-Tlx3 antibody was performed
using dorsal spinal cord extracts from E14.5 mouse embryos.
Immunoprecipitated genomic DNA was analysed by quantitative PCR
using primers amplifying the vicinity of P3 promoter, as well as control
primers for upstream and downstreamof Prrxl1 promoter regions and a
non-related (Rgmb) coding region (Fig. 2F). Binding of Tlx3 was much
stronger at the P3 promoter region (position−737), compared to con-
trol regions. Thus, our results indicate that Tlx3 is recruited to the DNA
region comprising the promoter P3 in the developing spinal cord, most
likely through interaction with the HD3 element.
It is important to mention that no conserved putative HDmotif was
detected inside the sequence encompassing nucleotides−889 to−809
(P3B-short), a region previously shown to be required for Tlx3 binding.
Taking into account this observation and the fact that Tlx3 induction
of Prrxl1 promoter activity is dependent on the neuronal cell context
(see Fig. 1B), we draw the hypothesis that Tlx3 binding on this region
is indirect and requires the presence of another transcription factor
(see model, Fig. 2G).
Altogether, our results indicate that a bipartite regulatory module is
required for the positive action of Tlx3 on the Prrxl1 promoter P3. Tlx3
binds directly to the HD3 motif (position −683), localized in the
vicinity of the TATA box, and in combination with a putative neuronal
specific transcription factor, which recognizes an element present with-
in region−889/−809 (see model in Fig. 2G).
3.3. Brn3a is required for the transcriptional activation of the Prrxl1
promoters P1 and P2
The cooperative effect of Prrxl1 and Tlx3 on the activity of promoters
P1/P2 raised the question ofwhether these twoproteins could be part of
the same transcriptional machinery. To unveil the existence of a physi-
cal interaction between Prrxl1 and Tlx3, co-immunoprecipitation assays
were performed using protein extracts from ND7/23 cells transfected
with pcDNA3.3-Tlx3-FLAG and pcDNA3.3-HA-Prrxl1 or an empty
pcDNA3.3 (Fig. 3A). The immunoprecipitation of FLAG-Tlx3 with ananti-FLAG affinity matrix followed by Western blotting demonstrated
that these two transcription factors are part of the same interacting
complex (Fig. 3A). It remains to be investigated whether the complex
contains other proteins.
After having established the Prrxl1/Tlx3 interaction, we focused our
attention on understanding the specific mechanisms that modulate the
regulation promoted by this complex. As shown by DNA pull-down
assays, Tlx3 is not able to bind the DNA fragment containing P1/P2 pro-
moters (P1/P2-prom; Fig. 2B). This result suggests that Tlx3-dependent
induction on these promoters is indirect and thereby requires other
molecular players. We have shown elsewhere that Brn3a induces an
increase in the luciferase gene transcription regulated by the sequence
REG-1 [9]. This protein co-expresses with Prrxl1 in primary sensory
neurons and in spinal glutamatergic neurons of early developmental
stages. Prrxl1 expression is decreased in Brn3a null mice [18], indicating
that Brn3a has a role in the control of Prrxl1 transcription. Considering
these data,we tested the effect of Brn3a overexpression in the transcrip-
tional activity of promoter P3 or promoters P1/P2 (Fig. 3B). We ob-
served a prominent activation in luciferase activity for the region that
comprised promoters P1/P2 (30-fold induction, p b 0.01; pGL3-P1/P2-
prom in Fig. 3B), at values that resembled the activation induced by
Tlx3 and Prrxl1 for this region (Fig. 1D). An effect was also displayed
on promoter P3, although less pronounced (10-fold, p b 0.01; pGL3-
P3-prom in Fig. 3B). To investigate whether Brn3a induction on P1/P2
could be related to transcriptional activation promoted by Tlx3 and
Prrxl1, we silenced endogenous Brn3a expression and assessed the
transcriptional activity of P3-prom and P1/P2-prom induced either by
Tlx3 or Tlx3/Prrxl1 (Fig. 3C). Transcription induced by combined over-
expression of Tlx3 and Prrxl1 was affected by Brn3a silencing mainly
at promoters P1/P2 (compare the decrease in luciferase activity from
siControl to siBrn3a in Tlx3/Prrxl1/pGL3-P1/P2-prom, p b 0.01;
Fig. 3C). However, downregulation of Brn3a did not affect Tlx3 activa-
tion per se of any Prrxl1 alternative promoters (see Tlx3/pGL3-P3-
prom and Tlx3/pGL3-P1/P2-prom, ns), implying that Tlx3 also acts on
P1/P2 promoters through a Brn3a-independent mechanism.
Amodel for the dual action of Tlx3 on Prrxl1 alternative promoters is
proposed (see Fig. 3D). Tlx3 exerts its positive effect by directly binding
to promoter P3 (see Fig. 2) or by acting in combination with Prrxl1 to
modulate the transcriptional activity of promoters P1/P2 via Brn3a.
Alternative mechanisms for regulation of Prrxl1 promoters by Tlx3 and
Brn3a need to be investigated in the future.
3.4. Tlx3 induces Prrxl1 hyperphosphorylation
Recently, we have shown that Prrxl1 is differentially phosphorylated
in the dorsal spinal cord and DRG along development [19]. The increase
in phosphorylation state is accompanied by conformational changes
resulting in a multiple band pattern on electrophoretic analysis [19].
Western blotting analysis of Prrxl1 in ND7/23 cells showed a clear
duplet: the lower band accounted for hypophosphorylated Prrxl1
while the upper band corresponded to hyperphosphorylated Prrxl1
(Fig. 4A; [19]). Surprisingly, overexpression of Tlx3 altered the phos-
phorylation state of Prrxl1. In Western blotting experiments, co-
expression of Prrxl1 with increasing amounts of Tlx3 resulted in a pro-
gressive disappearance of Prrxl1's lower band while the upper band
was maintained (Fig. 4A). This Prrxl1 upper band corresponded to
higher phosphorylated states as demonstrated by CIAP treatment of
protein extracts of ND7/23 cells transfected with Prrxl1 with orwithout
Tlx3 (Fig. 4B). CIAP dephosphorylation promoted the conversion of the
Prrxl1 uppermost band into the lower band while the addition of an in-
hibitor abolished this effect. These data point to the upper migrating
band being the result of phosphorylation. Likewise, taking advantage
of the isoelectric focusing technique to detect different levels of
phosphorylation, we analysed protein extracts from ND7/23 cells over-
expressing Prrxl1 or Prrxl1 together with Tlx3. 2D electrophoresis
resolved Prrxl1 in multiple spots, corresponding to different levels of
Fig. 3. The Tlx3/Prrxl1 protein complex activates Prrxl1 P1/P2 promoters via the action of Brn3a. A. Co-immunoprecipitation experiment to test the interaction between Prrxl1 and Tlx3.
ND7/23 cells were transfected with Tlx3-FLAG together or in the absence of HA-Prrxl1. Immunoprecipitation was performed against the FLAG tag and the presence of Prrxl1 in the eluate
was confirmed byWestern blotting using an anti-HA antibody. B. Luciferase activity induced by the sequence P3-promor P1/P2-promwasmeasured inND7/23 cells overexpressing Brn3a
or not (empty vector). Brn3a overexpression displays a stronger effect on promoters P1/P2. C. Luciferase reporter assayswere performed inND7/23 cells previously transfectedwith either
siRNA oligos for Brn3a (siBrn3a) or with a scrambled sequence (siControl). The relative luciferase activity induced by Tlx3 or Tlx3/Prrxl1 overexpression on P3-prom or P1/P2-prom DNA
sequences was assessed. The Pou4F silencing efficiency was determined by quantitative PCR and is shown in the upper right graph. The induction by Tlx3/Prrxl1 complex depends on the
presence of Brn3a specifically on promoters P1/P2 region (ns, not significant). D. Schematic representation of the distinct transcriptional mechanisms that control the Prrxl1 gene expres-
sion. Besides the Tlx3 action on promoter P3 described in Fig. 2, we now add the inductive effect of Tlx3 on promoters P1/P2 activity, which requires the synergistic interaction between
Tlx3 and Prrxl1 and the presence of Brn3a.
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of 8.74 and each phosphate adds a negative charge to the protein mod-
ifying the pI and thereby shifting the protein migration toward the
anode. In the presence of Tlx3, Prrxl1 displayed more intense spots in
the acidic region of the strip, likely due to the presence of more phos-
phorylated residues (Fig. 4C). Altogether, our results strongly suggest
that Tlx3 promotes Prrxl1 hyperphosphorylation.3.5. Mapping the functional Tlx3 domains related to Prrxl1 activity
To gain insight into the Tlx3 domains implicated in the control of
Prrxl1 transcription and phosphorylation, we generated truncated ver-
sions of Tlx3 based on the degree of homology of Tlx3 primary sequence
from different species (Fig. 5A). We then tested these constructs by
luciferase reporter assays, in which the reporter gene was controlled
by Prrxl1 alternative promoters P3 or P1/P2. Deletion of the C-terminal
domain (amino acid residues 256−291) reduced Tlx3-induced activity
in the promoters P1/P2 (black bars; Fig. 5B), while no impact was ob-
served on the Prrxl1 promoter P3 (white bars; Fig. 5B). Deletion of the
N-terminal (amino acid residues 1−38) greatly interfered with the
overall Tlx3 transcriptional activity (strong decrease of luciferase
expression on all the promoter regions under analysis; Fig. 5B), which
is indicative of the presence of an important activator domain for Tlx3
action. Interestingly, removal of the region encompassing amino acids
76−111 restored the Tlx3 transcriptional activity on P3 promoter
(Fig. 5B), pointing to the presence of a repressor domain in this region.
This regulatory domainwasnot implicated in the transcriptional control
of Prrxl1 promoter P1/P2, since all the Tlx3 versions with N-terminal
deletions displayed low values of luciferase activity on P1/P2 Prrxl1
promoters (Fig. 5B).In order to define the Tlx3 domain involved in the induction of Prrxl1
hyperphosphorylation, co-expression of Prrxl1 with Tlx3 truncated ver-
sions was carried out in the ND7/23 cell line. The Prrxl1 band profile
was then assessed by Western blotting (Fig. 5C). Quantification of the
upper (hyperphosphorylated Prrxl1) and lower (hypophosphorylated
Prrxl1) band intensity relatively to the total Prrxl1 signal was depicted
in a graph (Fig. 5C). As previously observed in Fig. 4A, the presence
of the wild-type Tlx3 induced the hyperphosphorylation of Prrxl1,
converting Prrxl1 from a double band pattern to a sole upper band
(black bar in the graph; Fig. 5B). While the deletion of Tlx3 C- or N-
extremity did not significantly interfere with the Prrxl1 phosphorylation
state (compare bars for Tlx3(1−224), Tlx3(1–256), Tlx3(38–291), Tlx3(76–291)
with Tlx3 in Fig. 5C), removal of the region encompassing amino
acids 76 to 111 resulted in a Prrxl1 band pattern similar to what was
observed in the absence of Tlx3 (compare Tlx3(111–291) with pcDNA3.3
in Fig. 5C). This result maps the Tlx3 domain responsible for Prrxl1
hyperphosphorylation between amino acids 76 and 111.
Altogether,wedefinedmultiple Tlx3 domains controlling different as-
pects of Prrxl1 functioning. These domains are highly conserved in the
two other members of the Tlx family (Tx1 and Tlx2), as shown in the
amino acid sequence alignment in Fig. 5D. A summary of the activity of
eachdomain is depicted in Fig. 5E:Domain I (1–38)—N-terminal activator
domain implicated in the overall Tlx3 transcriptional activity, which
contains a highly conserved Eh1 motif; Domain II (76–111)—includes
a conserved Pro-rich region, induces Prrxl1 hyperphosphorylation and
reduces Tlx3 induction of Prrxl1 promoter P3; Domain III (256–291)—
C-terminal activator domain that modulates Prrxl1 promoter P1/P2 ac-
tivity. While Domains I and III were already reported to have a tran-
scriptional action on Tlx1-target genes [21,22], the relevance of
Domain II for the function of Tlx genes was defined here for the first
time.
Fig. 4. Tlx3 induces Prrxl1 hyperphosphorylation. A. Western blotting analysis of the
Prrxl1 band pattern when co-expressed with increasing amounts of Tlx3 (none to
150 ng of plasmid) in ND7/23 cells. The Prrxl1 band intensity was quantified and the
values are graphically presented. Note the progressive disappearance of the lower band
(hypophosphorylated Prrxl1) as the concentration of Tlx3 plasmid increases. The upper
band, which corresponds to a higher phosphorylated state [19] is enriched with the
increase of Tlx3 levels. B. ND7/23 cells transfected with Prrxl1 and Tlx3 (+) or an empty
vector (−) were treated with 40 U of CIAP in the presence (+) or absence (−) of a com-
petitive inhibitor (Na2HPO4). The CIAP activity converts the Prrxl1 upper band into the
lower band, suggesting that the Tlx3-induced upper band is the result of phosphorylation.
Prrxl1(P) represents the hyperphosphorylated form of the protein. C. 2D electrophoresis
analysis of Prrxl1 from ND7/23 cells overexpressing Prrxl1 alone (Prrxl1) or together with
Tlx3 (Prrxl1 + Tlx3). Prrxl1 spots correspond to different numbers of phosphorylated
residues. By comparing Prrxl1 with Prrxl1+ Tlx3 samples, we observe that in the presence
of Tlx3, Prrxl1 spots are dislocated towards a lower pH indicating a higher degree of
phosphorylation. Five percent of the total extract was used as the input sample.
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The present study addresses themolecular mechanisms that control
the expression of Prrxl1, an HD transcription factor that plays a crucial
role in the establishment of the DRG/dorsal spinal cord nociceptive
circuitry. It departs from previous data showing that Prrxl1 expression
depends on Tlx3 at late stages of spinal cord development [13], and
investigates how Tlx3 acts on the recently identified Prrxl1 promoters
P1, P2 and P3 [9]. Tlx3 was here proved to control Prrxl1 transcription
at P1/P2 and at P3 in two different ways: indirectly, at P1/P2 promoter,
as a Tlx3/Prrxl1 complex via the action of Brn3a; and directly, by
binding to an HD motif at P3 promoter. Tlx3 was also shown to induce
Prrxl1 post-translational modifications, namely, phosphorylation (see
proposed model; Fig. 6).
4.1. Tlx3 uses transcriptional mechanisms to control Prrxl1 expression
At the Prrxl1 TATA-containing promoter P3, Tlx3 enhances Prrxl1
transcription through a bipartite regulatorymodule. One element corre-
sponds to a newly identified HD motif (position −683) recognized
directly by Tlx3, and the other one is located within the DNA region−889/−809 bp. This region should be the binding site of a still
unknown transcription factor. Putative candidates may be among the
TALE (three amino acid loop extension) protein family, a class of tran-
scription factors associated with developmental gene regulation that
often interact with HOX factors, such as Tlx3 [23,24]. Tlx3 forms a
DNA-binding complex with the TALE protein Pbx3 to enhance the tran-
scription of Tlx3-responsive elements in vitro [25]. Tlx3/Pbx3 interac-
tion is also likely to occur in vivo, as Pbx3 null mice have a respiratory
phenotype similar to that occurring in Tlx3 null mice [26]. The overlap-
ping expression of Tlx3, Pbx3 and Prrxl1 in second-order sensory
neurons additionally suggests that Tlx3 may complex with Pbx3 to
regulate Prrxl1 transcription [14,27].
On Prrxl1 promoters P1/P2, Tlx3 was shown to act in combination
with Prrxl1. However, Tlx3/Prrxl1 modulation was not performed
through direct DNA binding but rather required the presence of
Brn3a. Brn3a silencing in ND7/23 cells impaired Prrxl1 expression en-
hancement through Tlx3/Prrxl1 overexpression. Interestingly, Prrxl1
alone exerts no effect on promoters P1/P2 and acts mainly as an auto-
repressor on P3. This observation has relevant implications and will be
addressed elsewhere (Monteiro F.A., unpublished data).
Although studies approaching Brn3a's implication on the control of
Prrxl1 spinal cord levels are missing, Brn3a null mice present a marked
decrease in Prrxl1 expression in primary afferent neurons [18], pointing
to the important role of Brn3a in the positive modulation of Prrxl1 tran-
scription in vivo. Promoters P1 and P2 control the transcription of two
distinct Prrxl1 5′UTR variants (5′UTR-B and 5′UTR-C, respectively),
which are predominantly expressed at early stages of spinal cord
neurogenesis (maximum expression peak at E12.5; [9]). On the other
hand, Prrxl1 expression is maintained in the developing spinal cord up
to E14.5 in Tlx3 null mice, and only later on does it start to vanish. This
implies that at early spinal cord developmental stages, expression of
Prrxl1may be triggered by DNA elements that do not respond directly
to Tlx3. The possibility that Prrxl1 early stage transcription does not re-
quire the presence of Tlx3, but instead relies on Brn3a, should not be
ruled out. Indeed, in the developing spinal cord, co-localization between
Brn3a, Prrxl1 and Tlx3 is only observed in glutamatergic neurons at
early stages [13,14,28,29]. Brn3a would then be primarily required to
initiate the transcription of promoters P1/P2 and the Tlx3/Prrxl1 com-
plex would, through a positive feedback mechanism, later enhance
Brn3a activity (see model; Fig. 6). This hypothesis is further supported
by genome-wide ChIP assays with anti-Tlx3 and anti-Prrxl1 antibodies,
which resulted in the identification of shared binding events for
Tlx3 and Prrxl1 transcription factors on the Brn3a gene (Monteiro F.A.,
unpublished data).
4.2. Distinct Tlx3 protein domains are required to control Prrxl1 transcription
Using protein sequence alignment and Tlx1 biochemical data al-
ready reported by others [22], we were able to define three Tlx3 func-
tional domains (Fig. 5D) besides the already known Homeodomain
(amino acids 167–224) and PIM motif (amino acids 125–129). These
are the NH2-terminus Domain I, which contains an Engrailed homology
1motif (Eh1; amino acids 17–24), theCOOH-terminal Domain II (amino
acids 256–291) and a newly identified proline-rich domain III (PRD;
amino acids 76–111). We then investigated whether the various Tlx3
protein domains are differentially implicated in the multi-component
transcriptional activity of the Prrxl1 alternative promoters. The N-
terminal domain was shown to be responsible for the overall transcrip-
tional activity of the Tlx3 protein, inducing promoters P3 and P1/P2.
This domain includes an Eh1 motif, a short peptide sequence that is
totally conserved in the other two members of the Tlx family (Tlx1
and Tlx2). In Tlx1 protein, this Eh1 motif is required for Tlx1-mediated
target gene activation through interaction with the co-repressor
Groucho/transducin-like enhancer of split protein (Gro/TLE), a co-
regulator for many developmental transcription factors [21,22]. It is
therefore reasonable to postulate that the Tlx3 N-terminal domain
Fig. 5.Mapping of functional Tlx3 domains relevant for Prrxl1 transcription and phosphorylation. A. Schematic representation of Tlx3-FLAG truncated versions (HD, homeodomain).
B. Relative luciferase activity from ND7/23 cells transfected with pGL3-P3-prom or pGL3-P2/P1-prom as luciferase reporter constructs, together with wild-type or truncated versions of
Tlx3. Multiple Tlx3 functional domains are revealed. The representative immunoblot confirms the correct expression of all Tlx3 constructs. C. Western blotting analysis of the Prrxl1
band pattern when co-expressed with different Tlx3 truncated forms in ND7/23 cells. The graph depicts the amount of hyperphosphorylated (black bar, upper band) and
hypophosphorylated Prrxl1 (gray bar, lower band), normalized for the total Prrxl1 signal in each lane. Tlx3-induced hyperphosphorylation is not observed with Tlx3(111–291) and
Tlx3(156–291). D. Alignment of mouse Tlx1, Tlx2 and Tlx3 primary sequences. The alignment was performed using the CLUSTALW algorithm and the stars represent conserved amino
acids. Highlighted in gray are the homeodomain, the Eh1 (engrailed homology 1 motif) and PIM (Pbx-interaction motif) domains, previously characterized in Tlx1 protein, and the
newly characterized proline-rich domain. Tlx3 functional domains (Domains I, II and III) with impact on Prrxl1 alternative promoters are indicated. E. Schematic representation of con-
served functional domains identified in the Tlx3 primary sequence. The N-terminal domain (amino acids 1–38), which contains the Eh1 motif, is required for the overall transcriptional
induction of Prrxl1 promoters, whereas C-terminal domain (CD; amino acids 256–291) is exclusively required for P1/P2 activity. A proline-rich domain (PRD; amino acids 76–111) is
essential for transcriptional repression of Prrxl1 promoter P3 and also for the induction of Prrxl1 hyperphosphorylation.
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by recruiting Gro/TLE protein via the Eh1 motif.
A C-terminal domain identical to that here identified is also present
on Tlx1 protein, where it is required for Tlx1 efficient transcriptional
transactivation [22]. Likewise, the analogous Tlx3 domain (amino
acids 256–291) was shown here to be responsible for Prrxl1 transcrip-
tion only at promoters P1/P2, when transcription is accomplished by
Tlx3/Prrxl1 protein complex. The fact that this C-terminal domain
does not have any influence on the modulation of promoter P3 rein-
forces the occurrence of distinct transcriptional mechanisms at each
promoter region.
4.3. Tlx3 induces Prrxl1 hyperphosphorylation
A domain displaying a specific repressive trait of Tlx3 action upon
promoter P3 was delimited (amino acids 76–111). This domain is rich
in proline residues. Because the overall effect of Tlx3 on P3 promoter re-
sults in transcriptional activation, it is possible that this repressordomain is inhibited by another part of Tlx3 protein, such as the
N-terminal Eh1 domain. Although being an intrinsic limitation of trun-
cation approaches, we cannot exclude structural destabilization on
Tlx3 by the removal of an important part of the protein. Thus, deletion
of amino acids 1–38 may disturb the internal region 76–111, which
may lead to Tlx3 unfolding and subsequent decrease in transcriptional
activity. An alternative explanation is that the domain 76–111 reduces
Tlx3 activation of the Prrxl1 promoter by binding to cofactors. This in-
teraction could be modulated by the N-terminal Eh1 domain through
intramolecular events. This protein complex, composed of Tlx3 and
putative molecular partners, may act as transcriptional repressors on
specific DNA target regions. This hypothesis would explainwhy domain
76–111 only negatively regulates Tlx3 action on the P3 promoter
and has no effect on P1/P2 promoter. In fact, N-terminal deletions of
Tlx1 have different effects when we consider different promoters. Tlx1
action on the Aldh1 and SV40 promoters requires a fully functional
homeodomain. However, the same N-term deletion that eliminates
Tlx1 induction of the Aldh1 promoter bears no effect on Tlx1-
Fig. 6. Tlx3 displays a central role in the control of Prrxl1 expression and activity. A. Tlx3 positive effect on Prrxl1 promoter P3 requires a bipartite module composed by an HD3 motif
(position−683/−679), which is the binding site of Tlx3, and an element within the P3B-short region (position−889/−809), which is recognized by a still unknown transcription factor.
The N-terminal Eh1-containing domain activates the P3 promoter while the proline-rich domain (PRD) antagonizes this effect. P3 promoter was shown to transcribe the 5′UTR-AmRNA var-
iant, which is enriched at late-stage neurogenesis [9]. B. The promoters P1/P2 activity is enhanced by a synergistic interaction between Tlx3 and Prrxl1 and requires the presence of Brn3a. Both
Tlx3 N- and C-terminal domains (CD) are necessary for this regulatorymechanism. P1/P2 promoterswere shown to transcribe the 5′UTR-B and -CmRNA variants, which are enriched at early
stage neurogenesis [9]. C. The Tlx3 proline-rich domain (PRD) is required for the induction of Prrxl1 hyperphosphorylation through an unknownmechanism. Tlx3modulation of kinase and/or
phosphatase activity is hypothesized. Eh1, engrailed homology 1 motif; PRD, proline-rich domain; PIM, Pbx interaction motif; HD, homeodomain; CD, C-terminal domain.
1130 I. Regadas et al. / Biochimica et Biophysica Acta 1839 (2014) 1121–1131mediated repression of the SV40 promoter. This shows that although
the protein structure is preserved, as there is still repression and
thus HD integrity, the Tlx1 N-terminus is capable of modulating Tlx1
activity [22].
In addition to its action in the repression of Prrxl1 transcription, we
present strong evidence that this Tlx3 Pro-rich domain is also responsi-
ble for increasing Prrxl1 phosphorylation state and thereby altering
its conformation to a more exposed structure [19]. We have recently
shown that this phospho-dependent conformational change has a sig-
nificant impact on Prrxl1 transcriptional activity [19]. Prrxl1 is
hyperphosphorylated in the dorsal spinal cord from E10.5 until E14.5
[19], a developmentalwindowwhere spinal cord neurogenesis is occur-
ring and extensive co-localization between Prrxl1 and Tlx3 is observed
[14]. Thus, we suggest that until E14.5, the high Prrxl1 phosphorylated
state is sustained by the presence of Tlx3. From E16.5 onwards, Prrxl1
is progressively dephosphorylated [19], which correlates well with
the vanishing expression of Tlx3 in spinal neurons. Indeed, it was
shown by us and others [13,14] that, at later stages of spinal cord devel-
opment, part of the Tlx3/Prrxl1-positive neuronal population loses Tlx3
expression.
We here ascribe a new role for Tlx3 as a positive modulator of Prrxl1
phosphorylation. However, themechanism bywhich Tlx3 induces Prrxl1
hyperphosphorylation remains elusive. HowTlx3 exerts this effectwill be
investigated in future studies. Nevertheless, it is well established that the
balance between kinases and phosphatases activity acts as a molecular
switch on protein function. The effect of Tlx1 in the activity of serine-
threonine phosphatases, namely, PP1 and PP2A, was already reported
by the use of enzymatic assays [30]. It is possible that the Pro-rich domain
is implicated in the repressionof PP1 andPP2A transcription and/or activ-
ity, and therefore in maintaining high levels of phosphorylated Prrxl1.
Future studies should determine whether Prrxl1 is indeed a substrate
for PP1 and PP2A activity. We also cannot exclude the possibility that
Tlx3 promotes Prrxl1 phosphorylation via kinase recruitment. A recent
work gave new insight on how the complex of TALE/Hox proteins func-
tion to regulate transcription [31]. The authors showed that following
promoter occupancy, TALE proteins promote an active chromatin profile
and recruit RNApolymerase II, which ismaintained in a poised state until
the Hoxb1b protein binds the target promoter to drive an efficient tran-
scription. Hoxb1b triggers the recruitment of P-TEFb kinase, which in
turn phosphorylates RNA polymerase II and other associated factors.
This converts the RNApolymerase II poised state into an active elongatingone. It is tempting to speculate that Tlx3, similarly to Hoxb1b, holds the
capacity to recruit the P-TEFb or other kinase, which could promote the
induction of Prrxl1 hyperphosphorylation, switching Prrxl1 to a more
active transcriptional conformation.
Collectively, the presentfindings give important insights into the close
relationship between Tlx3 and Prrxl1 transcription factors. They also
point out that Prrxl1 depends on Tlx3 not only for the regulation of its
transcription but also for the modulation of its phosphorylation levels
(see model; Fig. 6). This novel finding has important implications in the
molecular understanding of Tlx3 biology. The fact that Tlx3 has an impact
on phosphorylation-dependentmechanisms can be helpful to explain the
role of Tlx3 in other systems, such as in the establishment and mainte-
nance of the T-cell acute lymphoblastic leukemia, a pathology derived
from the aberrant expression of TLX genes.
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4. DISCUSSION 
 
The general purpose of the investigation presented in this dissertation was to 
shed additional light on the molecular mechanisms and genetic relationships that 
govern the expression of Prrxl1 during the development of pain-processing neurons. 
The study was motivated by the defective phenotype exhibited by Prrxl1 null mutant 
embryos, a feature that encouraged our team to believe in the crucial requirement of 
this gene for the correct development and assembly of the pain circuit. 
 
MOLECULAR MECHANISMS REGULATING PRRXL1 TRANSCRIPTION AND POST-TRANSCRIPTION 
Previously to the beginning of this study, three discrete Prrxl1 5’-UTRs were 
identified by RACE analysis (Rebelo et al., 2009). These variants would only differ at 
their 5’ mRNA sequences positioned in exon 1, without interfering with the primary 
structure of the protein, since the Prrxl1 start codon is located in exon 2. This feature 
motivated the attempt to investigate their function and related post-transcriptional 
regulatory mechanisms that could be controlling Prrxl1 expression. Indeed, in this 
study we successfully identified differences in the distinct 5’-UTRs concerning mRNA 
stability and translation efficiency. The control of mRNA rate of synthesis and decay is 
among the mechanisms by which a cell tightly defines the precise amount of mRNA, in 
a spatiotemporal way, conferring an additional step in the programmed fine-tune 
regulation of gene expression. A few mechanisms that may be involved in the 
regulation of mRNA stability include the mRNA binding by specific proteins (RNA-
binding proteins), mRNA targeting by microRNAs (Filipowicz et al., 2008) and non-
sense mRNA decay (Mendell et al., 2004). Although this is an issue that still remains to 
be explored in detail, we suggest in Publication I that RNA-binding proteins bind cis-
regulatory elements present in the 5’-UTR region of the Prrxl1 molecules and affect 
their stability in the developing neurons. This assumption is the most reasonable given 
the large number of RNA-binding proteins present in the eukaryote proteome (Lasko, 
2000; Keene, 2001). Among them there is the family of the ELAV-like Hu RNA-binding 
proteins, which are involved in various aspects of mRNA regulation, from transport and 
stability to translation, being competent to control several features of neuronal 
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differentiation (Wakamatsu and Weston, 1997; Akamatsu et al., 1999). In fact, neuron-
specific Hu proteins, such as HuC and HuD, are likely to bind the 5’-UTR-A and confer 
this variant the capacity to last longer than the other Prrxl1 mRNA molecules and to 
have a higher translation rate (Perrone-Bizzozero and Bolognani, 2002). Post-
transcriptional regulation is a common mechanism employed by the cell to control the 
amount and duration of transcript expression during nervous system development. 
Variation in the half-life of the different Prrxl1 5’-UTRs could be understood as a 
mechanism Prrxl1 use in situations where the precise level of this protein is 
determinant to accomplish distinct functions. Indeed, we previously observed that the 
levels of Prrxl1 change according to neuronal subtype and developmental age. We 
hypothesize that Prrxl1 5’-UTR-A mRNA gives rise to high amount of protein in neurons 
where its presence is needed to regulate genetic programs associated to processes 
that occur during an extended developmental period, such as axon guidance and cell 
adhesion. In opposition, Prrxl1-dependent transcriptional program active during a 
narrow developmental stage, such is the one that regulates the differentiation of 
spinal cord dI3 and dI5 early-born neurons (E10.5 - E11.5), requires a transient Prrxl1 
presence, which may be accomplished by the use of the less stable 5’-UTR-B/-C mRNA 
variants. Further experiments consisting in the assessment of Prrxl1 5’-UTRs stability in 
cells lacking or with decreased expression of HuC and HuD would help to demonstrate 
their involvement in the regulation of Prrxl1 mRNA decay. 
 The existence of 5’-UTR mRNA variants is usually indicative of a mechanism of 
alternative promoter usage. Indeed, in the selected region of the highly conserved 
1351 bp upstream of Prrxl1 translation initiation site, we identified three promoter 
regions, each one adjacent to each of the 5’-UTR sequences previously characterized. 
These promoters were named P1, P2 and P3 and control, respectively, the 
transcription of Prrxl1 5’-UTR-C, 5’-UTR-B and 5’-UTR-A sequences. The transcriptional 
potential of the most conserved promoter (P3) was thoroughly analysed and evidence 
that it displays in vivo activity was presented. Further studies using transgenic 
zebrafish showed that the region adjacent to the TATA box, that comprises a highly 
conserved module of 172 bp containing the cis-regulatory HD and EBox motifs, is 
transcriptionally active in the developing hindbrain and cranial ganglia (Publication I, 
Figure 6), regions where the expression of zebrafish drgx had been previously 
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observed (McCormick et al., 2007). Additional analysis of the transcriptional activity of 
each promoter in distinct cell models revealed that only P1 and P3 display neuronal-
specific properties, whereas the CpG island-containing promoter P2 is constitutive. 
Because the TATA-containing promoter P3 activates the transcription of the also 
neuronal-specific 5’-UTR-A, the existence of a promoter-mediated coordination 
mechanism of mRNA decay is suggested. In the past years, strong evidence of the 
intimate relationship between DNA promoters and transcription factors and the 
stability of the transcripts they give rise to, have been reported (Bregman et al., 2011; 
Trcek et al., 2011). These and other large-scale studies demonstrated that DNA 
regulatory elements present in yeast promoters are coordinated with mRNA 
degradation in the cytoplasm (Dori-Bachash et al., 2012), a graceful mechanism that 
appears to have evolved to become a fundamental aspect of gene regulation. When 
specific promoters elements (the upstream activating sequence) responsible for the 
transcription of a certain gene are replaced by the upstream activating sequence of 
another gene, the decay rate of the transcript is affected (Bregman et al., 2011; Trcek 
et al., 2011). Although the majority of these studies are performed in yeast, there is 
evidence that a similar process is applied to gene regulation in mammals (Enssle et al., 
1993; Dori-Bachash et al., 2012). A strong evidence of the coordinated regulation of 
transcription and mRNA degradation is demonstrated in cases when an increase in 
mRNA levels occurs following the increase in the rate of mRNA degradation, rather 
than the expected decrease (Dori-Bachash et al., 2012). This positive correlation points 
to the existence of a cross-talk between the nuclear DNA promoter elements and the 
stability of cytoplasmic transcripts. Thus, variation in mRNA levels shapes the kinetics 
of gene transcription (Elkon et al., 2010), in a manner that guarantees the rapid 
response of promoters and continuous expression of transcripts when these are 
quickly degraded but their presence is still required. Unpublished results gathered 
during the research that conducted to this thesis showed that interference with 
transcription by Actinomycin D in primary cultures of mouse DRG, led to an increase in 
the levels of endogenous Prrxl1 mRNA. This strongly suggests the existence of a direct 
response from Prrxl1 promoters that leads to an increase in the transcriptional activity 
when a decay in the mRNA levels is sensed. This observation contrasts to what is 
observed in ND7/23 and HeLa cells (Publication I, Figure 1E) transfected with 
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constructs containing the different Prrxl1 5’-UTRs coupled to a SV40-containing 
promoter, where a decrease in the amount of mRNA was observed over time. 
Nevertheless, this is logically explained. As these constructs do not contain the Prrxl1 
5’-UTRs linked to their wild-type promoters, the coordinated transcription/mRNA-
decay regulation could not be observed. 
 
REGULATORY ELEMENTS CONTROLLING PRRXL1 TRANSCRIPTION 
The search for alternative promoters in the conserved sequence of 1351 bp led 
to the finding that some DNA regions, even though containing core promoter 
elements, did not display any transcriptional activity. This is explained by the presence 
of an element (RRA) that completely abolishes the transcription of the three 
alternative promoters (Publication I, Figure 2). Another element (RRB) suppresses the 
negative action of RRA, resulting in the activation of Prrxl1 transcription as the overall 
effect. Despite the fact that still no transcription factors that may act on these 
sequences have been identified, the existence of these elements with such 
antagonistic behavior suggests they may be relevant to the tight modulation of Prrxl1 
expression in distinct neuronal populations. This is the case observed during the 
development of the dorsal spinal cord, where the expression of Prrxl1 is positively 
regulated in the glutamatergic neurons and suppressed in the population of GABAergic 
neurons. Although these two populations derive from the same progenitor domain, 
they are molecularly and functionally mutually exclusive. Thus, it is suggested that 
molecular players in either inhibitory or excitatory neurons, suppress each other 
expression. For instance, Tlx3 acts as an inhibitor of Lbx1 action inducing the 
glutamatergic transmitter phenotype (Cheng et al., 2005), whereas Ptf1a represses 
Tlx3, specifying a GABAergic cell fate (Glasgow et al., 2005). As already referred in 
Publication I, it is possible that in GABAergic neurons, Prrxl1 expression could be 
prevented by a specific transcription factor acting on the RRA element. This repressive 
effect could be suppressed in glutamatergic neurons through the RRB element. In this 
light, it is reasonable that the transcriptional activity of the entire Prrxl1 promoter 
region analysed was elevated (see Publication I, Figure 2), as the experiments were 
performed in the DRG-derived ND7/23 neurons, which are glutamatergic. This 
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supports our hypothesis that the inhibitory RRA element is repressed in this system. 
Among the candidates likely to bind the RRA element, are the transcription factors 
involved in the establishment of the GABAergic neuron cell fate in the dorsal spinal 
horn, such as Lbx1, Pax2 or Ptf1a. Lbx1 is present in both populations of late-born 
spinal cord neurons (Gross et al., 2002; Muller et al., 2002) but its activity is 
antagonized by Tlx3 in dILB, an action essential for the specification of glutamatergic 
fate (Cheng et al., 2005). In these neurons, the binding of Lbx1 to the RRA element 
would be prevented by the presence of Tlx3, bound to Prrxl1 gene in a bipartite motif 
nearby (close to RRB), and Prrxl1 transcription would normally occur. Concomitantly, in 
GABAergic neurons lacking Tlx3, Lbx1 would be able to bind the RRA element and 
Prrxl1 transcription would be repressed. Alternatively, another protein present in the 
glutamatergic but not in the GABAergic neurons, could bind the DNA at the RRB motif. 
Similarly, Pax2 or Ptf1a could bind the RRA element and inhibit Prrxl1 transcription in 
GABAergic neurons. Experiments consisting in the capturing and posterior 
identification of the transcription factors bound to RRA and RRB elements are required 
to understand the context of this transcriptional regulation. 
 
TRANSCRIPTION FACTORS CONTROLLING PRRXL1 TRANSCRIPTION 
We demonstrated that Phox2b is required for Prrxl1 transcription in the 
zebrafish visceral sensory neurons. Nonetheless, it has been described that mouse 
visceral sensory neurons where the expression of Phox2b was suppressed, acquire a 
molecular profile similar to that of somatic sensory neurons, with increased expression 
of Brn3a and Prrxl1 (D'Autreaux et al., 2011). The increase in Prrxl1 expression was 
suggested to be mediated by the increase of Brn3a levels, which in its turn, is directly 
repressed by Phox2b. This appears to conflict with results presented in Publication I, 
where Prrxl1 expression in zebrafish glossopharyngeal, vagal and facial ganglia neurons 
is severely diminished when Phox2b expression is affected. However, it was 
demonstrated that Phox2b only functions as a Prrxl1 repressor in the visceral sensory 
ganglia, since Prrxl1 expression in the solitary nucleus is not affected by Phox2b 
inactivation (D'Autreaux et al., 2011). Hence, the hypothesis that in zebrafish and at 
that particular stage, Phox2b can work as a Prrxl1 transcriptional activator instead of a 
repressor cannot be excluded. Indeed, Phox2b is mainly regarded a transcriptional 
DISCUSSION 
 
 
104 
 
activator rather than a repressor. This is in accordance with the fact that this protein 
lacks the Eh1 domain responsible for conferring repressor activity to other HD 
transcription factors (Dubreuil et al., 2002). Moreover, Phox2b promotes general 
neuronal differentiation by increasing the levels of Ngn2 and Mash1 in cranial motor 
neurons (Dubreuil et al., 2002). It is then conceivable that when Phox2 is suppressed, 
the downregulation of these or other bHLH transcription factors, could lead to a 
decrease in Prrxl1 expression. 
Subsequently, we dissected in more detail the molecular mechanisms by which 
Tlx3 and Brn3a regulate the expression of Prrxl1. Tlx3 induces Prrxl1 transcription by 
two distinct mechanism – either by acting directly on the promoter P3 or indirectly on 
the region that comprises promoters P1/P2, via Brn3a action. It is shown here that at 
the Prrxl1 TATA-containing promoter P3, Tlx3 acts upon a bipartite regulatory module, 
recognized directly by Tlx3 and by another transcription factor that remains to identify. 
One of the candidates considered in Publication II is a member belonging to the TALE 
(Three Amino acid Loop Extension) family of transcription co-factors. TALE factors are 
associated with developmental gene regulation and interact often with HOX genes 
(Moens and Selleri, 2006; Penkov et al., 2013). In particular, Tlx3 forms a 
transcriptional complex with the TALE protein Pbx3 to enhance the transcription of 
Tlx3-responsive elements in vitro (Rhee et al., 2004) and this complex is also likely to 
occur in respiratory neurons in vivo (Shirasawa et al., 2000). Expression of Pbx3 is 
detected both in cranial ganglia and in DRG from E13.5 to E16.5 (Di Giacomo et al., 
2006) and in several classes of spinal cord postmitotic neurons by E15 (Rottkamp et al., 
2008). Given the high degree of overlapping expression of Pbx3 and Tlx3 and the 
phenotype of Pbx3 null mutant mice in spinal cord, it has been hypothesized that Pbx3 
cooperates with Tlx3 in the specification of glutamatergic fate in the superficial dorsal 
horn (Rottkamp et al., 2008). Because Tlx3, Pbx3 and Prrxl1 expression also overlap in 
certain populations of these neurons, we suggested that Pbx3 could be the factor 
interacting with Tlx3, to regulate Prrxl1 transcription. In fact, similarly to Prrxl1 (Chen 
et al., 2001) and Tlx3 mutants (Xu et al., 2013), Pbx3 mutant mice have reduced 
sensitivity to noxious and thermal stimuli (Rottkamp et al., 2008) as well as decreased 
number of cells expressing calbindin, calretinin and PKC-γ. Moreover, a recent work 
(Shimomura et al., 2015) reinforced the importance of the Tlx3/Pbx3 complex, 
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demonstrating that Tlx3 requires the presence of Pbx3 to enhance the interaction with 
the transcriptional co-activator CREB-binding protein (CBP) in order to promote the 
glutamatergic neuronal fate in embryonic stem cells. Binding events for the closely 
related protein p300 have been observed around the Prrxl1 promoter P3 region in 
neurons, but not in HeLa cells (Publication I, Figure 3B). This supports the suggestion 
that Tlx3 binds the Prrxl1 gene together with Pbx3, with the help of the chromatin 
modifier and transcriptional adaptor p300. In order to verify our hypothesis it would 
be interesting to determine whether Prrxl1 expression is affected in Pbx3 null mice. 
The employment of a distinct regulatory mechanism was observed on the 
Prrxl1 P1/P2 regulatory region. There, Tlx3 was shown to act in combination with 
Prrxl1 to enhance the transcriptional activity of these promoters. Nevertheless, the 
Tlx3/Prrxl1 protein complex does not activate Prrxl1 promoters P1/P2 directly, but 
rather requires the presence of Brn3a in order to modulate their activity. The control 
of Prrxl1 transcription by Brn3a has been observed before. Although studies 
approaching Brn3a's implication on the control of Prrxl1 spinal cord levels are missing, 
Brn3a null mice present a marked decrease in Prrxl1 expression in primary afferent 
neurons (Eng et al., 2007). Moreover, it has been suggested that Brn3a controls the 
expression of Prrxl1 in the somatic sensory cranial ganglia, since the increased 
expression of Prrxl1 following Phox2b inactivation is likely to occur due to Brn3a de-
repression (see Figure 8, Introduction) (D'Autreaux et al., 2011). In the developing 
spinal cord, co-localization between Brn3a, Prrxl1 and Tlx3 is only observed in 
glutamatergic neurons at early stages (Gross et al., 2002; Muller et al., 2002; Qian et 
al., 2002; Rebelo et al., 2010). As Tlx3 is required to maintain the expression of Prrxl1 
only from E14.5 in the developing spinal cord (Qian et al., 2002), it is hypothesized that 
Brn3a would be primarily required to initiate the transcription of promoters P1/P2 and 
the Tlx3/Prrxl1 complex would, through a positive feedback mechanism, later enhance 
Brn3a activity or transcription. Indeed, Tlx3 is able to activate the transcription of 
Brn3a, as demonstrated by the partial loss of Brn3a expression in Tlx3/Tlx1 double 
mutants (Xu et al., 2008). It was also reported that the transcriptional induction of 
Brn3a by Tlx3 is a required condition for the expression of Tac1 in Tlx3-containing 
neurons (Xu et al., 2008). Hence, it is reasonable to consider that a subsequent 
activation or maintenance of Brn3a expression by Tlx3 (together with Prrxl1) is a 
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condition for the Tlx3-dependent transcriptional activation of Prrxl1 promoters P1/P2 
at late stages of spinal cord neurogenesis. Corroborating this hypothesis, there is data 
from the group collected by genome-wide ChIP assays with anti-Tlx3 and anti-Prrxl1 
antibodies pointing to the existence of shared binding events for Tlx3 and Prrxl1 
transcription factors on the Brn3a gene (Monteiro, F.A. et al., unpublished results). 
 
POST-TRANSLATIONAL REGULATION OF PRRXL1 BY TLX3 
 One of the most important findings in this thesis unravels the dual role of Tlx3 
as modulator of Prrxl1 transcription and phosphorylation. By reporting a novel role for 
Tlx3 as inducer of Prrxl1 hyperphosphorylation, rather than only enhancing its 
transcription, we add relevant information to the current state of the art. Ours is a 
sensible observation since Prrxl1 is hyperphosphorylated in the dorsal spinal cord from 
E10.5 until E14.5 (Soares-Dos-Reis et al., 2014), a time that encompasses the 
occurrence of spinal cord neurogenesis and extensive co-localization between Prrxl1 
and Tlx3 is observed (Rebelo et al., 2010). Considering this, it is hypothesized in 
Publication II that the Prrxl1 high phosphorylated state is induced and maintained by 
the presence of Tlx3. From E16.5 onwards, Prrxl1 is progressively dephosphorylated, 
an observation that correlates well with the vanishing expression of Tlx3 in dorsal 
spinal neurons. To clarify this issue, it would be valuable to assess Prrxl1 
phosphorylation pattern in the dorsal spinal cord of Tlx3 null mutant embryos. 
Although the role of Tlx3 as modulator of protein phosphorylation has not been 
reported before, the effect of the functionally related Tlx homeobox gene Tlx1 in the 
activity of serine-threonine phosphatases PP1 and PP2A has already been described 
(Riz and Hawley, 2005). It is likely that similar Tlx3 protein domains are implicated in 
the repression of PP1 and PP2A transcription or activity, in order to maintain the high 
levels of phosphorylated Prrxl1. In addition, it cannot be excluded the recruitment of 
kinases by Tlx3 to promote Prrxl1 phosphorylation, which would be in accordance with 
what has been observed before for a complex of Hox/TALE proteins. In that case, TALE 
proteins promote an active chromatin profile and recruit RNA polymerase II, which is 
kept nearby in a poised state, until Hoxb1b triggers the recruitment of P-TEFb kinase, 
which in turn phosphorylates RNA polymerase II and other associated factors in order 
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to initiate active elongation (Choe et al., 2014). Genome-wide ChIP assays with anti-
Tlx3 and anti-Prrxl1 antibodies showed great overlap in chromatin occupancy for these 
two transcription factors (Monteiro, F.A. et al., unpublished results). Because it is 
known that alterations in Prrxl1 phosphorylated state significantly impact on Prrxl1 
transcriptional activity (Soares-Dos-Reis et al., 2014), one may hypothesize that Tlx3 
promotes the phosphorylation of Prrxl1 bound to the DNA in its vicinity, in order to 
endorse an active transcriptional state of Prrxl1. The observation that some kinases are 
able to directly bind DNA helps to support our hypothesis. For instance, Erk2 is 
recruited to certain DNA motifs to specifically phosphorylate poised RNA polymerase II 
on Polycomb Repressive Complex 2 (PRC2)-targeted developmental genes (Tee et al., 
2014). Prrxl1 contains five phosphorylation sites predicted to be substrates for Erk 
kinases (Soares-dos-Reis et al., unpublished data.). Thus, it is conceivable to 
hypothesize that Tlx3 recruits Erk2 (or other kinase) to occupy DNA motifs nearby, in 
order to phosphorylate Prrxl1 and thereby modulate its activity. ChIP-Seq experiments 
in mouse embryos with disrupted Tlx3 expression would provide valuable information 
regarding the importance of Tlx3 on the chromatin deposition of Erk or other 
candidate kinases. 
The fact that Tlx3 can modify the phosphorylation status of Prrxl1, raises the 
hypothesis that this could be a general feature of Tlx3 mechanism of action. Indeed, 
the potential role of Tlx3 as strong modulator of protein activity has been mentioned 
before. Tlx3 antagonizes Lbx1 in the dorsal spinal cord neurons, allowing them to 
differentiate towards a glutamatergic fate, and in the absence of Tlx3 those neurons 
become GABAergic (Cheng et al., 2005). Because Tlx3 does not repress the expression 
of Lbx1, it has been suggested that Tlx3 antagonizes Lbx1 protein function. However, it 
remained to further elucidate which mechanisms were responsible for this 
suppression. It would be interesting to disclose whether Lbx1 is phosphorylated and 
the contribution of Tlx3 on that feature, with additional studies evaluating the 
functional significance of such alterations on Lbx1 function.  
In another situation, because Tlx3 was shown to act in cooperation with Runx1 
to establish the Runx1-dependent nociceptive lineage in the DRG (Lopes et al., 2012), 
one may argue that Tlx3 also modifies the Runx1 phosphorylation pattern to promote 
this pathway. The effect of Runx1 phosphorylation on its transactivation potential has 
DISCUSSION 
 
 
108 
 
been widely reported over the years in hematopoiesis and leukemia (Kurokawa et al., 
1996; Tanaka et al., 1996; Yoshimi et al., 2012), but information regarding the 
specification of DRG neurons is still missing. In addition, ChIP-Seq analysis in E14.5 
mouse DRG embryos demonstrated that in DNA regions occupied by Prrxl1 and Tlx3 
there is an enrichment in a DNA-binding motif recognized by Runx1 (Monteiro, F. A. et 
al., unpublished data). This data suggests that a transcriptional protein complex may 
be formed by these three factors, with Tlx3 being the molecule responsible for 
switching on the transcription of their common targets by activating Prrxl1 and Runx1 
through the modulation of their phosphorylation state. This hypothesis should be 
further explored, primarily by assessing potential alterations in the phosphorylation 
pattern of Prrxl1 and Runx1 in the DRG of Tlx3 mutant mice and then by identifying the 
intermediary players in this mechanism. 
Collectively, the present findings bring important insight on the molecular 
mechanisms that control Prrxl1 at several levels and add interesting and novel 
information to the current state of the art dealing with the genetic and molecular 
network involved in the development of neurons in the somatosensory system. 
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5. CONCLUSIONS 
 
The scientific results achieved during this work led to the following main conclusions 
(depicted in Figure 9): 
 
1. Prrxl1 transcription is controlled by a mechanism of alternative promoter 
usage. Three alternative promoters – named P1, P2 and P3 – are located 
immediately upstream of the Prrxl1 start codon, in the evolutionary conserved 
region of 1351 bp. P1 and P3 present promoter activity only in neuronal cells, 
whereas P2 is constitutive. Each promoter is responsible for the transcription of 
one of three Prrxl1 5’-UTR variants (5’-UTR-A, 5’-UTR-B and 5’-UTR-C). These 5’-
UTR variants confer distinct mRNA stability and translation efficiency to the 
Prrxl1 transcript. The 5’-UTR-A variant is the most stable in neuronal cells and 
presents the highest translation rate. 
 
2. The most conserved promoter is P3 and it displays in vivo enhancer activity in 
zebrafish, in a pattern that overlaps with the endogenous Prrxl1 homologue, 
drgx. Regulatory modules present in this sequence were identified and 
characterized. These include one motif that completely abolishes the 
transcriptional activity regulated by the three promoters (RRA), one that 
inhibits the repressive effect of RRA (RRB) and binding sites for Phox2b and 
Tlx3. 
 
3. Phox2b is required in zebrafish for the expression of drgx in the facial, 
glossopharyngeal and vagal visceral cranial nerves. 
 
4. Tlx3 induces the transcriptional activity of the Prrxl1 promoters by two distinct 
mechanisms – It promotes the activity of P3 by directly binding to a bipartite 
DNA element and it synergistically interacts with Prrxl1 to indirectly activate 
the Prrxl1 TATA-less promoters P1/P2 via the action of Brn3a. 
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5. A novel mechanism is described here, where it is shown that Tlx3 also 
modulates Prrxl1 activity by promoting its hyperphosphorylation. Altogether, 
these data demonstrate that Prrxl1 and Tlx3 are intimately related and share a 
genetic pathway, which may be essential for the regulation of downstream 
effectors responsible for the establishment of the nociceptive phenotype in the 
spinal cord. 
 
 
 
Figure 9: Distinct molecular mechanisms control the transcription and activity of Prrxl1. Three 
alternative promoters – P1, P2 and P3 – control the transcription of three Prrxl1 5’-UTR mRNA variants. 
P1/P2 regulates 5’-UTR-B and -C, whereas P3 regulates the transcription of 5’-UTR-A. The latter is the 
mRNA variant that displays the highest stability and translation rate in neuronal cells, probably due to 
the binding of RNA-binding proteins such as HuC or HuD. Two elements positioned between -958 and -
772 exert a strong modulation upon Prrxl1 transcription: RRA totally suppresses the transcriptional 
activity of the three promoters and RRB inhibits the negative effect of RRA, resulting in an overall 
increase of transcription. We suggest that RRA may be the binding site of transcription factors that 
promote the GABAergic neuronal fate, thus repressing the expression of Prrxl1 in this population. The 
most conserved promoter is the TATA-containing P3 and includes binding sites for the HD transcription 
factors Phox2b (HD1/2) and Tlx3 (HD3). Phox2b is required in zebrafish for the expression of drgx in the 
facial, glossopharyngeal and vagal cranial ganglia. Tlx3 activates the transcriptional activity of promoter 
P3 by directly binding to a bipartite DNA element composed by the HD3 motif (the binding site of Tlx3) 
and an element within the P3B-short region. Pbx3 or other TALE factor are among the candidates that 
may bind the P3B-short motif. Tlx3 synergistically interacts with Prrxl1 to indirectly activate the Prrxl1 
TATA-less promoters P1/P2 via the action of Brn3a. In addition, Tlx3 modulates Prrxl1 activity by 
promoting its hyperphosphorylation. The mechanism remains to be characterized but Tlx3 modulation 
of kinases or phosphatases activity is suggested. 
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